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Introduction
From isolated cells up to whole organs, dynamic responses to changes occurring in their
environment are a vital issue. For this purpose, perception of chemical cues is one of themost
fundamental, and subtle, mechanisms that cells from all kingdoms have developed. Though
rooted in simple molecular events – basically speciﬁc binding of molecules to receptors
on the cell outer membrane – complex signal inputs can be interpreted by cells. They can
take various shapes, like concentration thresholds or gradients of molecular cues. Diverse
ﬁelds of biomedical research are actively studying the cellular mechanisms that govern
the response to concentration patterns of external molecules, including embryogenesis
(morphogen gradients and gradients of guidance cues [1]), neurobiology (e.g. neuron
excitation/inhibition), immunology (inﬂammatory responses mediated by cytokines), etc.
(for more details, see appendix A, p. 171). Results on the control of signaling gradients
and cross-talks between signaling pathways ﬁnd important echoes in actual biomedical
research (e.g. on cancers), in tissue engineering and developments of techniques for organ
healing.
Modern experimental studies of the cell response to external molecules have reached a
high degree of control of the spatial and temporal variations of concentrations. Depending
on the considered system, the nature of signaling molecules and the range of relevant
times and length scales totally diﬀer. A vast variety of experimental devices have been
implemented accordingly to the variety of contexts. In brief, experiments seeking to observe
fast responses (≪ 1 hour) on a local scale (e.g. micrometer resolution) are essentially carried
out using micropipette injections [2–5]. In the opposite case of long incubation/observation
times (hours – days) and large length scales, well-controlled gradients of concentrations
are produced based on ad hoc positioning of one or several slow-releasing source(s) and
sink(s) distributed in the cell-culture medium. Microﬂuidic devices designed in the last
10 years have achieved impressive successes in this ﬁeld, with unprecedented degree of
control of concentration gradients generated over 100 µm to 1mm (see references [5, 6]
and section 1.2 Characteristic scales: concentrations, time and lengths, p. 7). The control of
exposure to bioactive peptides and proteins remains however a challenge because these
molecules are fragile, sometimes available in limited amounts, and in practice may diﬀuse
freely only on very short distances. In particular, communications between mammalian
cells involve proteins that can:
• be prone to denaturation or aggregation;
• adsorb on the walls of devices and interact with the gels used for cell culture (interplay
with the extracellular matrix).
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These constraints motivate the quest for alternatives to conventional (diﬀusion-based)
gradient-forming devices. New means/tools for protein delivery should accordingly provide
closer mimicry of a localized secretion of activating agents and protect proteins against
degradation until it is delivered. The purpose of this thesis is to explore possibilities of
designing artiﬁcial cargoes, that ideally should be versatile (compatible with most peptides
and proteins), easy to manipulate in conventional cell culture systems, and should enable
quantitative control of uneven spatial and temporal delivery. In this context, we will
identify the possible systems that can “trap” proteins of interest into cargoes, and achieve
on-demand and remote-controlled release.
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1. Overview of (mammalian) cell
sensitivity to uneven spatial
distributions of external peptides or
proteins
This chapter brieﬂy derives the speciﬁcations delivery systems must follow. The aim
is to provide sound basis to comments in the bibliographic listing (next chapter) about
feasible approaches. The main speciﬁcities rely on characteristic and relevant conditions of
use (length scales, time scales, environment), and the need for compatibility with protein
handling and release. With regard to the biological context, we focus on themore demanding
conditions of recent experimental assessments, which basically address the question of
sensitivity of eukaryotic cells and/or tissues to gradients – for instance, we do not consider
studies of bacterial chemotaxis that are nicely performed in conventional, gradient-forming
devices. Threemain ﬁelds dominate the studies of mammalian cell responses in the literature
of controlled heterogeneous distribution of biomolecular cues:
1. experiments on cell polarization, growth and/or migration related to embryogenesis
and development;
2. polarization and migration of leukocytes related to immunology;
3. migration of cancer cells motivated by works on metastasis.
The typical properties of the corresponding molecular cues and conditions of cell responses
are summarized below, as important framework for the design of new relevant experimental
tools.
1.1. Representative proteins of interest
A limited collection of activating molecules regularly appears in model studies, as prototyp-
ical representatives of a vaster range of the peptides and proteins that are secreted in vivo.
They belong to diverse families – basically cytokines, growth factors, peptide components
of the extracellular matrix or formed upon degradation of pathogens (ﬁgure 1.1). Progress
in cell engineering enables to produce these model proteins and peptide factors under forms
that are overexpressed by secreting cells and/or can be puriﬁed in solutions.
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EGF
53 AA TGF-β
220 AA
NGF 2.5S β subunit
214 AA
Wnt-8, with hydrophobic anchor
≈ 330 AA
Netrine-1 (murine)
600 AA
Laminin trimer,
schematic representation
α-Chain
ɣ-Chainβ-Chain
Figure 1.1. The diversity of sizes and structures of proteins involved in cell guidance or communication. “AA”
means “amino acids”, the crystal structure may show part of the whole proteins. EGF, epidermal
growth factor (6.4 kDa, pdb 1EGF), small soluble and rigid, activate transcriptions in cell and cell
growth; Wnt proteins (35 kDa, pdb 4F0A) involved in signaling pathways use either nearby cell-cell
communication; NGF, nerve growth factor (53 kDa as dimer, pdb 1BET), small secreted protein
important for the growth, maintenance, and survival of certain target neurons; TGF, transforming
growth factor (26 kDa, pdb 1KLA), family of bone morphogenetic proteins, typically non-covalent
dimer of about 220 amino acids; Netrin-1 (≈ 70 kDa under the monomer form, pdb 4OVE) a class of
proteins of involved in axon guidance; laminin are heterotrimer glycoproteins (400–1,000 kg/mol)
strongly interacting with the extracellular matrix.
It is obvious from ﬁgure 1.1 that no characteristic size emerge among these proteins. Their
size ranges from the smallest N -formylated oligopeptides (e.g. N -formyl-methionine-leu-
cine-phenylalanine, fMLP, released by bacteria) to high-molecular weight complex mul-
tidomain glycoproteins that may polymerize in even larger networks (e.g. laminin ∼ 400–
1,000 kDa). The solubility and free diﬀusion of some cues may even be an issue, and im-
mobilization on surfaces can be preferred for both avoiding uncontrolled adsorptions, and
implementing relevant biological conﬁgurations (e.g. studies of mechanical coupling with
the substrate). For instance, laminin was used in so-called “substrate-bound” gradient [5]
that were prepared by printing, or controlled diﬀusion-adhesion processes of laminin solu-
tions. Present systems manage with the deposition on the top of ﬂat substrates (usually
covered with cationic biomolecules to trigger strong adsorption), prior to cell seeding. In
situ attachment (permanent, or transient) of cues interacting with the matrix (laminin, netrin,
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1.2. Characteristic scales: concentrations, time and lengths
epidermal growth factors, etc. [7]) is clearly a challenge, in particular with a control in the
three dimensions of the samples (i.e. 3D-controlled release).
Presentation of smaller domains, under the form of soluble recombinant proteins, may be
suﬃcient to study cell responses. Accordingly, the usual range of molar masses goes from
< 500 g/mol up to 400 kg/mol, with many examples of proteins having 200–400 aminoacids
(20–50 kg/mol). This point to one important constraint for the design of generic cargoes:
the “open” form shall be compatible with the release and fast (free) diﬀusion of relatively large
molecules (10–20 nm), but the closed form shall also trap/hide relatively small ones (< 1 nm).
A second general feature is the possible need for speciﬁc interaction of the proteins
with their environment. The presence of hydrophobic moieties can for instance reﬂect the
importance of binding to lipid bilayers, and a trend to form clusters in solutions. This is
the case of Wnt proteins (35 kDa) involved in signaling pathways of either nearby cell-cell
communication (paracrine) or for same-cell communication (autocrine). The Wnt proteins
are secreted glycoproteins that are lipid-modiﬁed (e.g. palmitoylation) on a conserved
pattern of cysteine residues. Palmitoylation initiates targeting of the Wnt protein to the
plasma membrane for secretion and it allows the Wnt protein to bind its receptor. The
requirement for the binding onto lipid membranes hampers its delivery in simple aqueous
solutions, which may explain that most experiments on exposure to Wnt were carried out
using secreting cells [8–10]. The use of complex solutions, containing lipid membrane mimics,
shall thus not be overlooked.
As they are strongly regulated in vivo, these proteins may not always be stable under
their active form, and for instance they can be highly sensitive to proteases present in
the extracellular medium. This is the case for the tumor necrosis factors (TNF) which are
primarily produced by macrophages – but it is produced also by a broad variety of cell types
to promote inﬂammatory responses – as a 233-amino acid-long transmembrane protein
arranged in stable homotrimers, and released via proteolytic cleavage by themetalloprotease
as a homotrimeric cytokine (sTNF). The soluble 51 kDa trimeric sTNF tends to dissociate at
concentrations below the nanomolar range, thereby losing its bioactivity. Mild handling
conditions (physiological pH, ionic strength, T, etc) are of primary importance to preserve
the activity. As an example, thermally treated cues (deactivation upon heating solutions at
70℃ for a few minutes) can be used in blank experiments [11].
1.2. Characteristic scales: concentrations, time and
lengths
Co-cultures (cell-based biomolecule sources embedded in gels such as explants or transfected
cell lines) are predominantly used by biologists to create and assess conditions of inter-cell
stimulation and communication. It is certainly highly relevant in biology. However, no clear
characteristic scales can be inferred from these experiments, due to high variability and
diﬃculties to quantitatively characterize the environment (unknown level of biomolecule
7
1. Sensitivity of cells to uneven distributions of peptides and proteins
Culture gel
Studied cells Secretring cells
L
d
Figure 1.2. 1D gradient generated in a culture gel by the coculture method. The gradient is represented in purple,
and is established around the cluster of generated cells. The typical distance between the studied cells
and the secreting cells 𝐿 is 1mm; the size of both clusters 𝑑 is in the 100 µm – 1mm range. Collagen
is often used as the culture medium, at a concentration of 2–3 g/L [12, 13].
secreted by the cells, poor repeatability of inter-cellular distances and limited possibilities to
control inter-cellular gaps shorter than 100 micrometers). Measurements of concentrations
(e.g. using ﬂuorescent fusion proteins) is technically very challenging due to eﬀective
elicitation of cell responses at nanomolar concentrations of cues.
Characteristic features of eﬃcient cell stimulations are thus deduced from experiments
practiced in artiﬁcial devices, based on eithermicropipette injection or spontaneous diﬀusion
of soluble cues between source compartment(s) and sink(s) (see ﬁgures 1.3 and 1.4, and
appendix B, p. 179 for technical details). We summarize here the typical features of the
distribution/delivery of cues that can be obtained in these conventional devices. Simply
reproducing these features with an alternative tool would be of low interest. In addition, we
identify the challenges and complexities that are worth to address and motivate alternative
approaches.
Cell (neuron)
~ 10 µm
Growth cone
45°
~ 100 µm
Pipee filled with the 
molecule of interest
Figure 1.3. A pipette is used to create a local source of a molecule of interest in a culture medium. The gradient
is represented in purple. The scale of the targeted cell (leukocyte) or part of cell (the growth cone of a
neuron) is typically 10 µm. The pipette is located 100 µm away from the cell. The concentration of the
molecule is assumed to be 1/1000 of the one in the pipette.
8
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PDMS chamber
Collagen source Collagen sink
Source Sink
Gradient zone (1 mm)
Figure 1.4. A gradient of molecules is established in the collagen junction between two chambers ﬁlled with
collagen. One of the chambers contains the molecule and acts as a source, while the other one does
not contain the molecule initially, and acts as a sink.
1.2.1. Characteristic times of exposure to cues
Diﬀusion-based gradients are not established immediately. The characteristic diﬀusion time
can be estimated from Fick equations: 𝜏 ∼ 𝐿2/𝐷, where 𝜏 is the characteristic diﬀusion
time, 𝐿 is the characteristic diﬀusion length and 𝐷 the diﬀusivity of the cues. For a protein
which does not bind to the culture substrate (gel or surface), diﬀusivity is faster and of the
order of 100 µm²/s. At distances as long as one millimeter away from the source, 𝜏 ∼ 104 s:
a few hours are needed to reach the target, and this time drop down to about one minute
at distances of a few tens of micrometers. This kind of experiment is therefore limited to
relatively “slow” stimulations. Microﬂuidic devices can be designed to ﬂush gradients of
concentrations that are perpendicular to the ﬂuidic channel, which enables to modulate a
ﬂow directly applied to the cells.
Fast gradient modulation in time is therefore possible, at time scales only limited by
the ﬂow rate. However, the shear stress induced to the cells in those conditions has been
reported to alter their behavior [14, 15]; the observed eﬀects ranges from modiﬁcation of
the cytoskeleton, shape distortion, to detachment of cells from the culture plate. The fastest
system – used to study the chemotaxis of leukocytes to fast-switching linear gradients – is
able to modify the steepness of the gradients in the timescale of 5 seconds [16].
The fastest microﬂuidic switches to date can establish a linear variation of concentration
over a region of 200 micrometers, within 10 seconds for small molecules (GABA, 101 g/mol),
but 15 minutes for large proteins (netrin-1) [17]. In a device reported in reference [18], a
linear gradient is obtained in a channel 200 µm wide, in 2 minutes for 70 kg/mol dextran.
Similar devices shown in ﬁgure 1.5 were used to study neuron chemotaxis in netrin gra-
dients [19] and the eﬀect of Wnt3a on melanoma cells [20]. Fast transverse variation of
concentration at zero shear has also been achieved via diﬀusion through a thin membrane
ﬂowed on one side with an aqueous solution (so called “dynamic gradients” by Melosh et
al. [21], as described in appendix B, p. 179). The authors claim that gradients are established
in the timescale of 45 seconds.
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(a) (b)
Figure 1.5. Microﬂuidic devices used to rapidly modulate changes of concentrations and gradients in 2D cell
cultures in liquid media, (a) at low ﬂow near the neurons [19] or (b) zero ﬂow [21].
1.2.2. Characteristic spatial range of gradients
At timescales longer than 𝜏, a gradient of concentration establishes and stationary state
may be reached. The gradient feature is usually expressed by its relative slope over a
characteristic length. The relative slope, noted 𝑠, is calculated as 𝑠 (in %) = 100 ⋅ Δ𝐶/𝐶,
where Δ𝐶 is the diﬀerence of concentration between two ends of the cell, or over a test
segment of the cell (e.g. one neurite), and 𝐶 is the mean value of the concentration along
the cell. The characteristic length is in the range of 10 µm, and often assumed to be exactly
10 µm (see ﬁgure 1.6).
Reproducible gradients of high steepness and localized around a microsource can be
obtained using pipette microinjections (in typically one minute to 10 minutes [4], but it
is considered stable for one hour [23, 24]). By this method, the average concentration of
cues around the cell is controlled by the concentration in the pipette, and pulsed injections
stabilize gradient steepness in the range of 10–30% [4, 11, 25]. This system has been
applied on various kinds of cells, ranging from neurons cultured in 3D collagen gel [2]
to leukocytes [26] or cancerous cells [27] in 2D culture conditions. The same diversity is
found for the released molecules, ranging from proteins [2, 28] to peptides [26]. Cells may
respond at short time scales by spatial redistribution of their membrane receptors (< 30 s),
of organelles and/or cytoskeleton (minutes), shape distortion (e.g. angular redirection of
growth cone in neurites, < 60 minutes). But faster events cannot be captured, such as
recruitment/activation of signaling proteins on the activated regions.
Quantiﬁcation of micropipette observation may also be an issue. Authors derives the
concentration pattern based on theoretical models that have been the subject of vivid
discussions and criticisms [4–6]. The assumed linear relationship between the released
molecule from the pipette and the pulse duration and frequency is not always true. The
gradient is also often considered 2D, neglecting the vertical component, which was shown
experimentally to matter (confocal imaging, using labeled dextran).
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Figure 1.6. A cell in a gradient of a molecule of interest. The relative gradient steepness, 𝑠 in percentage, is
deﬁned as 𝑠 = 100 ⋅ Δ𝐶/𝐶, where 𝐶 is the mean concentration on the cell level [22].
Figure 1.7. Schematic view of the Dunn chamber,
widely-used for cell culture. Reprinted
from [29].
Figure 1.8. Gradient generated from a sink and a
source through a channel. Reprinted
from [30].
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These remarks suggest that pipette-based stimulation is preferred for qualitative tests.
The technique suﬀers from others drawbacks, the main one being that it is invasive in
gels (breakage of the matrix) and not easy to adjust in real time to cell movements (risk of
mechanical damage on cells). Another constraint is that concentration in the pipette must be
about 1000 time higher than the concentration activating the cells – usually in the nanomolar
range. Namely, eﬃcient concentration in the pipette were experimentally measured at
about 10 micromolar NGF [2] or 0.1 micromolar netrin [11] on neurons, 1 micromolar fMLP
or interleukins on leucocytes [26], 50 micromolar EGF to induce locomotion of cancer MTL
cell lines [27]. Such concentrations on the order of 1mg/mL (or below) are reasonably
reached in available samples (e.g. commercial or home-puriﬁed solutions), though using
hundred of microliters can become rapidly expensive – the typical price of recombinant
netrin-1 is ∼ 400 € for 50 micrograms.
Smoother and more robust gradients with slopes < 10%, generally 1–5%, are formed
by diﬀusion between a source compartment and a sink one in various geometries of
microchambers, as shown in ﬁgures 1.7 and 1.8, and in annexe B, p. 179. Cells fairly respond
to smooth gradients, and even shallow ones (0.1 %). This is the case of neutrophils exposed
to cytokines such as fMLP [30–33], neural explants exposed to NGF around 1–3 nM [34–37],
cancer cell line exposed to growth factors (MTL) [30, 38, 39]. Access to long duration and
accurate control on concentration patterns suggested that cell responses can be highly
subtle. For instance, locomotion was not activated on neutrophils in stable stationary
gradients lacking ﬂuctuations [40], or the direction of motion could be reversed upon slow
decrease of the concentration of chemokines [41]. Similarly many open questions are
debated in the ﬁeld of morphogenetic control of neurons in embryos. Important parameters
of control include concentrations of guidance cues (and their gradients), time of exposure to
guidance molecules, degree of interaction with extracellular matrix (that may modulate the
cross-talk with e.g. mechano-transduction pathways). The studies of signaling events have
thus to encompass the response to delivery of controlled amounts of guidance molecules,
with micrometer resolution at the spot of release, while enabling to manage with the local
mechanical rigidity and force applied on the cells in hydrogel (ideally 3D) substrates. Part
of these goals are reachable in microchambers, until modulation at long distances (> 100
micrometer) of the test cell is suﬃcient. But binding of cues in gel substrates, cell migrations,
and importance of short activation or dual activation (by activators and inhibitors) motivate
to broaden the toolbox of cell biologists. A mild (non-invasive) local release can nicely
complete the presently available systems.
1.3. Summary and conclusion
Quantitative assessments of cell responses to soluble protein cues rely nowadays on delivery
systems based on micropipette and/or gradient-forming devices. Interestingly, the order
of magnitude of concentration conditions that cells can interpret has been determined.
Representative cases show that cells, in particular neurons, can detect threshold concen-
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1.3. Summary and conclusion
trations below nM, and shallow gradients (0.1 %), but reaching steeper gradient (1–10%)
may also be required. The whole complexity and sensitivity of cells to its environment
cannot however be explored with the available systems. First, cell-activation and control of
local delivery of cues at (sub)second time scales is diﬃcult due to experimental constraints
on distances between cells and protein sources. This hampers observations in real time of
important steps in the mechanisms of responses, such as the reorganization of receptors
rapidly moving on the top of cell membranes. Second, at long time scales – from hours to
days – cells may move or grow, requiring to modulate the concentration pattern, to keep
constant the activation conditions. Third, studies of cells grown in gels with adhesion and
motion allowed in the three dimensions of space would certainly avoid the artifacts likely
to occur in 2D ﬂat substrates, but is hardly accessible with conventional manipulations (e.g.
pipettes break the gels). The history of samples may also matter (e.g. memory eﬀect of cells,
dual activation and/or activation by sequences of exposure to diﬀerent molecules, etc.).
Next challenges in the ﬁeld are accordingly the design of tools capable to mimic secretion
as follows:
• release of adjustable aliquots of signaling proteins directly in contact to, or at mi-
crometer distance from, the cell membrane (to achieve fast stimulation);
• non-invasive in situ modulation of position of the source and/or the release rate (to
adjust conditions to cell motion or shape evolutions);
• versatile on/oﬀ switch of delivery (to study memory eﬀects).
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Part I.
Light-controlled release, a review
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Introduction
The aim of this thesis is to develop a system able to release arbitrary molecules in a
3D cell culture medium, with a control in space and time. As shown in the last part,
systems targeting a transient (second scaled) release and conﬁned (micrometer scale) are
scarce in the toolbox proposed to biologists. The representative technique is based on
micropipette manipulations, which causes damages to culture medium, and which may not
be as quantitative as they are claimed1. Two constraints are therefore added to our system:
it must preserve the integrity of the cell culture medium and release a known amount of
molecule. We also want the system to use as few molecules as possible, as the availability
of the released molecule can be problematic.
One technique, shown in references [43–45], relies on the in-situ release of the entrapped
molecule from an artiﬁcial carrier. Here, hollow polystyrene beads or liposomes are reported.
The principle of this technique is to entrap the molecule in a carrier, which remains tight
under physiological or experimental conditions. These vehicles are dispersed in the cell
culture medium; the molecule, entrapped, is never seen by the cells, thus inactive. Under
an external stimulus, the vehicle becomes leaky or destroyed, and the entrapped molecule
is released and becomes active.
Our system should target various molecules, including peptides or proteins, which must
stay biologically active after their release. The activity of a protein can be hindered by
several factors, like the pH, the ionic strength, the redox potential, an increased temperature,
freeze/thaw cycles, freezer-drying, the presence of organic solvents or the presence of
amphiphilic molecules [46–49]. This suggests that proteins must stay in a buﬀered aqueous
medium of controlled temperature, from its encapsulation to its release.
Concerning the modalities of release, several are available: enzymatic degradation, pH,
temperature, ionic strength, redox potential modulation, magnetic ﬁelds, light or sound
waves are reported [50, 51]. Due to the previous remark on the protein activity, only a
few can still be considered. The same can be done for the studied cells. Their “normal”
behavior is subjected to the culture conditions; any deviation from the standard conditions
of pH, salinity, temperature or redox potential may hinder its activity. This excludes de
facto chemical stimulations, which are not relevant anyway: the diﬀusion of molecules in
the culture medium means that even a local stimulation will extend quickly and create a
large source of encapsulated molecules.
Cell sensitivity to shear stress also excludes any sound wave stimulation. The last two
candidates are magnetic ﬁelds and light. Our aim is to develop a system that can be useful
1For details on the micropipette technique, see references [5, 6, 42]
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in a standard biological experiment, with live imaging. They rely mostly on the observation
of the culture medium with an epiﬂuorescence microscope or a confocal microscope. The
possibility to control light illumination of the sample in term of time and space, and the
availability of illumination systems on standard biology equipments make the light an ideal
stimulus.
So, we are looking for an encapsulating system for proteins, peptides and small molecules,
able to release its content on a short timescale upon light illumination. From this point
of view, the available light-sensitive systems can be classiﬁed in two set of binary classes:
slow/fast release and “preserve protein activity” or not. Systems based on molecule en-
trapment in a dry polymer matrix are automatically excluded from the selected systems:
the entrapment conditions (dried hydrophobic polymer) and the kinetics of release (in the
timescale of the hour) are crippling. This includes the particles developed by A. Almutairi’s
team, based on poly(lactic acid)/poly(glycolic acid) heated by infra-red light [52] and the
photolysable ones based on coumarins and orthonitrobenzenes [53–58]. To this, we may
add a system based on a cinnamic acid-based 2+2 cyclization [59] and one based on photo-
manipulated permanent sources made of PLGA [60]. Three main classes of candidates
remain: the lipids vesicles, the microgels and the polymer capsules; all three give the
possibility to encapsulate the molecule in an aqueous medium and release it using light.
They will all be reviewed in the next sections.
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Figure 2.1. A: a schematic view of a liposome slice, made from a lipid bilayer shaped as a sphere surrounding
an aqueous core. B: an example of a phospholipid, here DOPC. The hydrophilic part of the molecule
is highlighted in green, the hydrophobic one in grey.
Since their discovery by Bangham et al. [61], liposomes have been of great help to build
molecule delivery systems, with applications ranging from cosmetics to drug delivery [50,
62]. Liposomes are vesicles made from phospholipid bilayers and an aqueous core, as
shown on ﬁgure 2.1. Vesicles of various composition and size can be formulated. Diameters
range from 10 nm to 10 µm; unilamellar vesicles, with only one lipid bilayer constituting
the membrane, as well as multilamellar vesicles, made of multiple stacked bilayers, can be
prepared as almost monodisperse objects [63].
Hydrophilic molecules of interest, when entrapped inside the aqueous core of the vesicle,
can escape either by passive diﬀusion through an intact membrane or by breaking the
membrane; these events can be triggered by external stimuli. Membrane tightness can be
modulated using several additives, like cholesterol [64, 65]. Other routes involve the loss of
the membrane integrity; they rely on the creation of pores, the disruption of the membrane
or the dissolution of the membrane and its dispersion as micelles. They are illustrated on
ﬁgure 2.2.
Assembled in a bilayers, lipids can be viewed as a two dimensional system, in which lateral
movements are possible. Each lipid is characterized by a phase transition temperature (Tm),
corresponding to the transition from a gel – solid – state to a liquid state. In the gel state,
lipids can be considered as frozen and immobile, while any lateral movement is allowed
in the liquid state. Transition temperatures of natural lipids cover roughly the [− 50℃,
100℃] range. Thus, increasing the temperature leads to the disorganization of the lipids;
less tightly packed, the permeability is increased. Packing can also be aﬀected by speciﬁc
molecules inserted in the bilayer.
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(A) (B) (C)
Figure 2.2. Release of a drug entrapped in the aqueous core of a liposome. (A) the permeability of the lipid
bilayer is increased, allowing molecules to escape the liposome by diﬀusion. (B) the encapsulated
molecule escapes the liposome through a pore created in its membrane. (C) release of all the content
of the liposome by breaking the membrane.
Figure 2.3. Mechanisms of pore stabilization. On the left, the pore is stabilized with a molecule (blue cylinder)
with a hydrophobic face in contact with the bilayer and an hydrophilic one in contact with the
aqueous buﬀer; On the right, a surfactant (blue heads) with a small packing parameter permit this
stabilization.
In ﬂuid state, pores spontaneously open and close in the lipid bilayer. In regular mem-
branes, their lifetime is too short to allow the release of the entrapped content. Phospholipids
are cylindrical-shaped molecules which assemble in bilayers in aqueous media, and take the
shape of spheres. This organization in spherical objects leads to an inner tension referred
to as the membrane tension; the smaller the radius of the vesicle, the higher the tension.
This tension is responsible for the opening of the pores. When a pore opens, the inner
part of the bilayer – hydrophobic – comes into contact with water. This unfavorable event
is associated with an energy called the line tension, and is in favor to the closing of the
pore. Adding cholesterol to the lipid bilayer is known to increase the line tension, thus
reducing the lifetime of the pores, while adding surfactants has the reverse eﬀect [66]. The
stabilization of the pore with surfactants – or other amphiphilic molecules like polymers [67,
68] – relies on masking the hydrophobic layer, as shown on ﬁgure 2.3. Cylindrical bi-faced
molecules (e.g. permeabilizing peptides [69]) lead to the left case, while conical surfactants
and hydrophilic polymers grafted with hydrophobic anchors lead to the one of the right.
The last route leads to the complete dissolution of the bilayer. The phospholipids are
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dispersed into micelles, either by a modiﬁcation of their structure or by adding a surfactant
inside the medium.
2.1. Light-induced increase of permeability
Optical control of the packing and the orientation of molecules inside the bilayer appears to
be by far the most studied system. Basically, any molecule inserted in the bilayer aﬀects the
packing of lipids. Accordingly, phototriggered variations of the conformation and/or the
degree of insertion of this molecule in the bilayer are expected to change the permeability
of the liposomes.
2.1.1. Retinoic acid-based sensitizer
Figure 2.4. Tretinoin, also know as all-trans retinoic acid.
Retinoic acid (see ﬁgure 2.4) is a light-isomerizable molecule which has been used to
increase liposome permeability [70]. One or both of the alkyl chain of a phospholipid is
replaced by this molecule. Upon UV irradiation, the trans bonds of retinoic acid isomerises
to cis, which perturb the packing of lipids in the bilayer, thus permeabilize it. They have been
used to build liposomes 50 to 300 nm large, entrapping carboxyﬂuorescein, and releasing
their content upon continuous UV light irradiation (360 nm, 50W/m²). The kinetics of
release were fast, as it was reported to be complete within 30 seconds at 25℃ (see ﬁgure 2.5).
However, these liposomes were not tight: ≈ 20 % of the entrapped carboxyﬂuorescein is
released in one hour at 25℃. Increasing the temperature to 37.5℃ makes this value rise to
≈ 60%, which means that in a few hours at a physiological temperature, the capsules are
empty. This probably explains why this system did not lead to further developments.
2.1.2. Azobenzene-based additives
Another light-isomerizable molecule is the azobenzene. Its thermodynamically stable
isomer, the trans – apolar – one, can be converted into a cis – polar – one by UV irradiation.
The reverse isomerization occurs with visible light irradiation or thermal relaxation (see
ﬁgure 2.6). These light-sensitive groups have been included into the lipid bilayer; light
irradiation causes the azobenzene to isomerize, perturbing the packing of the lipids and
increasing the permeability of these objects.
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Figure 2.5. Reprinted from reference [70]. A: leakage of carboxyﬂuorescein upon UV irradiation. DRPC stands
for diretinoyl-glycerophosphocholine and PRPC for pamitoyl retinoyl-glycerophosphocholine. B:
carboxyﬂuorescein leakage from DRPC liposomes in the dark.
Figure 2.6. Trans and cis isomers of the azobenzene moiety. This group
isomerizes with light: UV light turns the trans (apolar) group in
the cis (polar) one. Cis to trans reverse isomerization is obtained
either by visible light irradiation or by thermal relaxation (Δ).
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N      
UV
Δ
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Azobenzene-modified lipids
Figure 2.7. Lipid “bis-azo”, used in reference [71]. Figure 2.8. Lipid “bis-azo”, used in reference [72].
As shown on ﬁgures 2.7 and 2.8, azobenzene groups have been introduced in phopholipids,
replacing both of the hydrophobic tails. The one shown on ﬁgure 2.8 has been mixed
with other natural lipids (DMPC, DPPC, DPEPC, DSPC) to make 400 nm size vesicles
encapsulating carboxyﬂuorescein. The content of these vesicles was released using pulsed
laser irradiation (355 nm, 15mJ, 3mm²), and occurred in the timescale of 10ms [72, 73].
Increasing the temperature of the sample below the phase transition temperature of the
lipids increased the kinetics of release. In the case of DPPC/bis-azo liposomes, at least 3 %
mol. of bis-azo were required for the UV irradiation to trigger a release [74].
The same group reported that adding cholesterol to the lipid bilayer decreased the amount
of trans to cis isomerizations required to trigger the release [73, 75]. A continuous blue light
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irradiation (470 nm, LED) was suﬃcient to trigger the release from DPPC/6 % mol. bis-azo
liposomes, as shown on ﬁgure 2.10. The release was slower than with UV irradiation, and
occurred in the timescale of 10 seconds. In fact, irradiating azobenzene with a visible light
does not lead to 100 % trans isomers; irradiating an all trans sample lead to a cis:trans isomer
mixture. The cis:trans ratio at steady state depends on the azobenzene and the wavelength
used. In this case, the ratio obtained with the 470 nm irradiation is not reported. This set of
experiments suggests that an unknown minimal amount of cis isomers are required for the
release to occur.
Figure 2.9. Reprinted from reference [73]. Increase in
ﬂuorescence intensity due to calcein release,
following exposure to a single 355 nm laser
pulse, from liposomes of DPPC at 16℃ con-
taining 6 % mol. Bis-Azo PC and (a) 0 %
mol., (b) 5 %, (c) 10 % and (d) 15 % choles-
terol.
Figure 2.10. Reprinted from reference [75]. Liposomes
prepared from DPPC and 6% mol. bis-
azo. Kinetics of release as a function of
the cholesterol content. A: start blue light
irradiation (470 nm, LED, continuous)
The permeability upon cis isomerization has been attributed to the H-aggregation of
azobenzenes in the lipid bilayer [71, 76]. This phenomenon can occur only when the azoben-
zene lipids are next to each other. The lipids used in the previously reported experiments
were mostly DPPC, whose phase transition temperature is 41℃. These experiments were
conducted at 25℃, where the lipid bilayers are in gel state. Under such conditions, the
diﬀusion of lipids in the bilayer is limited; for the azobenzene to aggregate, they have to be
close to each other from the beginning. Adding cholesterol at concentration below 20–25 %
mol. increase the ﬂuidity of the bilayer, while increasing the packing of the lipids. The
lipids are thus allowed to diﬀuse in the membrane and regroup themselves, which explains
why in presence of cholesterol the required amount of cis isomers to trigger the release is
lower. In the same references is also reported that the release can only occur when the lipid
is in the gel state. Increasing the temperature above the lipid melting temperature disables
the release. This conﬁrms that leakage depends on the formation of defects between rigid
lipid domains in the lipid bilayer. In general, these defects create small gaps, whose size
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permits only the escape of small molecular weight molecules. This has been conﬁrmed in
reference [77], where doxorubicin (543.5 g/mol) escaped the liposome 20 times slower than
acridine orange (265.4 g/mol).
Azobenzene-based surfactants
Another method to destabilize the lipid bilayer relies on the incorporation of azobenzene-
based surfactant inside it. The ﬁrst reported system demonstrates the release of bromothy-
mol blue from 30 nm sized liposomes made of DPPC, sensitized with the surfactant shown
on ﬁgure 2.11. The release is triggered by the exposure of the liposome suspension for 5
minutes to UV light (366 nm) [78, 79]. The release constants, assuming a ﬁrst-order release
Figure 2.11. Light-sensitive azobenzene-based surfac-
tant used in references [78, 79].
Figure 2.12. Light-sensitive azobenzene-based surfac-
tant used in references [80].
Figure 2.13. Reprinted from reference [79] Rates of
bromothymol blue (BTB) release ([BTB]
= 8.3 µM) from DPPC liposomal mem-
branes ([DPPC] = 0.17mM) containing
amphiphatic azobenzenes in trans- and
cis-conﬁgurations at 25 ℃: ○ trans-C₄Azo;
□ cis-C₄Azo; ● trans-C₂Azo; ■ cis-C₂Azo.
Figure 2.14. Reprinted from reference [81]. Release
of calcein. Top: sample kept in the dark.
Bottom: periodical UV and visible light
irradiation.
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rate, are shown on ﬁgure 2.13. According to the authors, the surfactants are inserted in
the lipid bilayers; the release occurs under UV light irradiation, as the surfactant perturbs
the packing of the lipids. However, when heated above the melting temperature, these
liposomes remained light-sensitive. This suggests that the mechanism of release is not the
same as the one observed with the azobenzene-modiﬁed phopholipids, as pointed out by
the authors. They suggest that the entrapped molecules escape through channels in the
bilayer, induced by the conformational change of the surfactant.
Azobenzene has also been incorporated in cholesterol-based surfactants, to sensitize
liposomes loaded with calcein [81]. Here the lipid (egg PC):surfactant ratio equals 1:1.
The release leak under UV irradiation (365 nm, power unknown) was slow: 40 hours were
required to release only 25 % of the entrapped dye. This system suﬀers also from a constant
release when kept in the dark (see ﬁgure 2.12). 8 % of the initial amount of entrapped calcein
is released within 1 day.
Figure 2.15. Phosphate based surfactant, from reference [82].
Phospholipid-less vesicles have also been sensitized with azobenzene-based surfactants.
In reference [82], vesicles are made from dihexadecyl phosphate (24mg) and an azobenzene-
based surfactant (1–2mg, cf. ﬁgure 2.15). 30 % of entrapped potassium ions are released
after 35 minutes, upon UV light irradiation (360 nm). These vesicles suﬀer also from a high
passive release rate: 10 % of the encapsulated potassium is released in 6 hours without
stimulation; the light stimulation multiplied by 5 the release rate of potassium.
In reference [80], the vesicle is composed of cholesterol sulfate (75 % mol.) and an
azobenzene-based surfactant (25 % mol., cf. ﬁgure 2.12). They have been proved to be
less permeable than their phospholipid-based counterparts; the kinetics of release are still
behind the ones of the bis-azo liposomes, suggesting that the mechanism of release do not
rely on the perturbation at the interface of lipid domains. 80 % of entrapped sulforhodamine
B is released in 300 s upon UV (365 nm) irradiation. The main advantage of this system
over the previous one is the low passive release: ≈ 7 % within 30 days in the dark. This
system reminds the ones shown in paragraph 2.1.2 Azobenzene-modiﬁed lipids, p. 22. But
the membrane made is described as ﬂuid, which means that the mechanism of release is
diﬀerent. Yet, this may explain why the release upon UV irradiation is slow. The precise
mechanism of release is not known; the authors only claim that the isomerization of the
azobenzene disturbs globally the packing of the lipids initially tightly packed.
25
2. Light-sensitive liposomes
Figure 2.16. Light-sensitive channels, made of azoben-
zene and cyclodextrine. Reprinted from
reference [83].
Figure 2.17. Artiﬁcial bilayers made of azobenzene-
based surfactant assemblies. The presence
of cyclodextrines made these objects light-
sensitive. Reprinted from reference [84].
Supramolecular associations
Cyclodextrine/azobenzene associations have also been used to build light-sensitive vesicles.
On its trans isomer, the azobenzene molecule (the guest) is able to enter a cyclodextrine
cycle (the host). On UV irradiation, the azobenzene turns into a cis isomer and escapes the
cyclodextrine.
In reference [83] is reported an artiﬁcial light-sensitive channel, made of azobenzene/cy-
clodextrine association (see ﬁgure 2.16). 100 nm DOPE:DOPC:cholesterol (2:1:1mol.) vesi-
cles have been sensitized with these molecules (10–30% mol.). The highest release rates
were obtained with 30 %mol. of the channel: sulforhodamine B was released in the timescale
of 2 hours upon UV light irradiation (350 nm). However, this is only 3 times faster than
the release occurring in the dark. Moreover, this system is limited to the release of small
molecules, as they have to pass through the channel.
The system presented in reference [84] is based on non-phospholipidic bilayers, made
of an azobenzene-based surfactant and cyclodextrines (see ﬁgure 2.17). These vesicles are
destroyed upon UV light irradiation (340 nm), and reassembled upon blue light irradiation
(450 nm). The associated timescales are in the 10–50 s range. Neither the encapsulation nor
the release has been characterized yet.
2.1.3. Spiropyrane based sensitizers
Spiropyrane is converted into a zwitterionic merocyanine upon UV irradiation, and can
be transformed back to its initial form upon irradiation with visible light or by thermal
relaxation (see ﬁgure 2.18). They have been integrated in surfactants (see ﬁgure 2.19) and
have been proved to increase the permeability of lipid bilayers to ions. Here K⁺ and a
cobalt(II) complex have been encapsulated in bilayers made hexadecyl phosphate and this
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Figure 2.18. Spiropyrane cycle opens upon UV illumination, going from a neutral form to a zwitterionic one.
The reverse process occurs upon visible light irradiation or thermal relaxation.
Figure 2.19. Spiropyrane-based surfactant, from refer-
ence [85].
Figure 2.20. Spiropyrane-based surfactant, from refer-
ence [86].
surfactant at a ratio in the 0.5–2.0 % mol. range. In this system, the permeability of the
membrane is increased when irradiated with visible light and decreased with UV light. The
authors claim that the spiropyrane takes more space in the membrane than the merocyanine,
thus perturbs it more. Irradiating the samples with visible light (> 400 nm) released both
cobalt(II) complexes and potassium ions, in the timescale of several hours [85].
Another kind of surfactant has been reported in reference [86] (see ﬁgure 2.20). This surfac-
tant has been added to DPPC SUV, at a 10–20 % mol. amount. Entrapped carboxyﬂuorescein
was released within 2 minutes after 1 minute of UV irradiation (365 nm, 5.76mW/cm²).
The fast kinetics of release is explained by the abrupt change of behavior of the surfactant
upon light isomerization. In its initial state, the quaternary ammonium head is the only
hydrophilic part of the molecule, the spiropyrane-terminated alkyl chain is implanted in
the lipid bilayer. Upon isomerization, the spiropyrane become hydrophilic and gains the
surface, letting only an alkyl loop in the membrane. This disturbs the packing of the lipid
bilayer, increasing its permeability without disrupting it [86].
2.1.4. Light-induced polymerization of lipids
Unsaturated lipids, as shown on ﬁgure 2.21, can be crosslinked under UV-light irradiation.
Initially reported as a way to stabilize the bilayer and reduce the passive leakage from
liposomes [89, 90], the photopolymerization of lipids has been used to trigger the release
from the same objects. In reference [87], these lipids are mixed at 20 % mol. with a satu-
rated lipid (DSPC, DAPC, DPPC) and a PEG-bearing lipid to build 200 nm sized liposomes
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Figure 2.21. Light-polymerizable phopholipid, from reference [87].
Figure 2.22. Light-polymerizable phospholipid, from [88].
encapsulating ANTS/DPX – a ﬂuorophore/quencher couple. The release of the entrapped
dye occurred in the timescale of 20 seconds upon UV (254 nm, 20–40mW/cm²) irradiation.
An alkyne-bearing polymer was also used, which enabled to use visible light to trigger the
polymerisation (see ﬁgure 2.22). UV light (254 nm) could be used to trigger the release, but
it was also conﬁrmed with a continuous blue laser irradiation (488+514 nm, 166mW/cm²)
for several minutes. In the UV irradiation conditions, entrapped calcein was release in
the timescale of 10 minutes. High concentration of photopolymerizable polymer (> 20%
mol.), entrapped calcein is spontaneously released in the dark, at 4℃ within 24 hours. Blue
irradiation has been proposed for the release of doxorubicin in cancerous cells, as blue light
can increase the toxicity of this drug by photoactivation [88, 91].
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Figure 2.23. Reprinted from reference [88]. Eﬀect of various concentrations of DC8,9PC on kinetics and extents
of UV-induced calcein release from liposomes. Liposomes containing varying concentrations of
DC8,9PC were treated with UV for 0-–45min and calcein release was measured. The mole % of
DC8,9PC in the formulations are given in parentheses. The data are reproducible from at least three
independent experiments.
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The permeabilization mechanism here is similar to the one reported for azobenzene-
based phospholipids, and relies on a phase separation of the lipids. As before, the lipids
have to be in the gel phase for the release to occur. This has been conﬁrmed by mixing
photopolymerizable lipids with DOPC, whose melting temperature is − 17℃. With this
ﬂuid membrane, no release occurs upon UV light irradiation [87].
2.1.5. Temperature-elevating systems
The permeability of lipid bilayer can be aﬀected by the temperature. The properties of
light-absorption of several dyes and nanoparticles have been used to convert locally the
light into heat. The dye or the nanoparticle can be attached to the lipid, be entrapped inside
the bilayer or inside the vesicle core, or even be dispersed outside the vesicle [92].
Figure 2.24. Reprinted from reference [92]. UV light-induced calcein release from liposomes at constant temper-
ature (37 ℃).
Gold nanoparticles, covalently attached to the lipid bilayer, have been used to sensi-
tize 200–500 nm sized liposomes made of DSPC/DPPC mixture. Entrapped calcein was
released in the timescale of 10 minutes upon continuous UV (250 nm) light irradiation (see
ﬁgure 2.24). The release is triggered as soon as the phase transition temperature is crossed.
For DSPC/DPPC mixture, it is in the 34–48℃ range, depending on the lipid ratio [92].
As for dyes, temperature-sensitive liposomes – made of a mixture of DPPC and DPPG
with a phase transition temperature of 41℃ – have been loaded with calcein and dispersed
in an artiﬁcial blood stream [93]. The release occurred within 5 seconds upon yellow laser
irradiation (588 nm, 200ms, 20–80mW/0.13mm²). The light is absorbed by the hemoglobin
and turned locally into heat. When the phase transition temperature of the lipids is reached,
the release occurs.
2.1.6. Summary
In such systems, the kinetics of release is driven by diﬀusion through the lipid bilayers
or packing imperfections at the limits of lipid domains. The smaller and hydrophobic the
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molecule, the faster the diﬀusion [85]. It should not be too hydrophobic though or it may
become trapped inside the bilayer, as it was observed with doxorubicin [77]. The application
potential to proteins is low, as there is no proof of release with such light-sensitive systems
in the literature.
2.2. Light-triggered pore formation
2.2.1. Phase transition of phospholipids/lysolipids mixtures
Figure 2.25. Skeletal representation of 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine (16:0 Lyso PC), a
lysolipid.
The release from the vesicles can be signiﬁcantly accelerated by creating pore in the
membrane bilayer, which makes liposomes also permeable to nanometer-large molecules
such as globular proteins. Pores can be created by heating vesicles made of speciﬁc lipids, as
reported in reference [94]. This allowed to release BSA at 42℃ in the timescale of the minute
from liposomes of 100 nm diameter, made of a 16:0 Lyso PC:PEG-DSPE:DPPC mixture, with
a 10:4:90 mol. ratio. 16:0 Lyso PC is a lysolipid, which is a particular type of phospholipids
lacking one of the two hydrophobic tails (cf. ﬁgure 2.25). Therefore, they do not have the
typical cylindrical shape of a two-tailed phospholipid, but rather a conical one. Thus, they
are able to stabilize pores – created by increasing the temperature – by reducing the line
tension, as mentioned in the introduction of this chapter.
Figure 2.26. Reprinted from reference [95]. Carboxyﬂuorescein release rate from lysolipids vesicles, sensitized
with gold nanoshells.
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In references [95, 96], gold nanoshells have been used to convert the light into heat.
Their absorption is partly due to the plasmon resonance eﬀect, which allowed to use
infrareds (800 nm, 2.4mW/cm²) to trigger the release. Carboxyﬂuorescein was released
in 1 minute from 200 nm liposomes made of DPPC:DSPE-PEG:MPPC – monopalmitoyl
phosphatidylcholine, a lysolipid (see ﬁgure 2.26). A temperature of 41℃ is suﬃcient to
release completely the encapsulated carboxyﬂuorescein. The same system has successfully
been used to release locally doxorubicin in an in-vivo prostate cancer model.
2.2.2. Polymer stabilized pores
Figure 2.27. Amphiphilic polymer, bearing hy-
drophilic side-groups (carboxylates),
hydrophobic side-groups (C₈ alkyl chain)
and azobenzenes. From reference [97].
Figure 2.28. Reprinted from reference [97]. Leakage
proﬁles of polymer-sensitized GUV.
Amphiphilic azobenzene-bearing polymers, as shown on ﬁgure 2.27, have been used to
create or stabilize pore in the membrane of giant vesicles made of DOPC [97]. As reported
before, DOPC is an unsaturated lipid whose melting temperature is − 17℃; the lipids in
the lipid bilayer are in the liquid crystal state, where pore spontaneously opens. In its cis
conformation, the azobenzene groups grafted on the polymer are hydrophilic and do not
interact much with the lipid bilayer. Irradiating the polymer with visible light switches
the azobenzene in their trans conformation; more hydrophobic, they will interact with the
membrane. Grafted on a polymer chain, they are able to stabilize pores and maintain them
on timescales suﬃcient for the encapsulated content to be released. The pores created by
this polymer have been reported to be in the range of 10 nm. The release of encapsulated
dextran (4 kg/mol) occurred in the timescale of 30 minutes upon visible light irradiation
(see ﬁgure 2.28).
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Figure 2.29. Photolabile phospholipid: DLPC modiﬁed with an orthonitrobenzyl ester. From reference [98].
2.2.3. Photolysable phospholipid
Light-induced lysis of lipids has also been used to trigger the release of molecules en-
trapped in liposomes. Liposomes have been made of DLPC modiﬁed with orthonitrobenzyl
ester at the end of their alkyl chain (shown on ﬁgure 2.29). Irradiating the lipids with
UV light (Hg lamp) cleaves the ester bond and leaves two carboxylic acid functions per
chain. This molecule is able to stabilize pore in the lipid bilayer, as explained for the am-
phiphilic azobenzene-bearing polymer. Encapsulated ovalbumin (45 kg/mol) is released in
the timescale of the 20 seconds. A prolonged irradiation of the liposomes leads to their
destruction.
Figure 2.30. Photolysable phopholipid, based on a
dithiane group. Irradiation with UV light
breaks the bond marked with a purple
cross. From reference [99].
Figure 2.31. Reprinted from reference [99]. Release of
a ﬂuor labeled probe from POPC:choles-
terol:dithiane-lipid vesicles, followed by
NMR. ◆: UV irradiated sample. △: sam-
ple kept in the dark.
A dithiane-based light-sensitive lipid has also been developed. Irradiated with light, the
aromatic part of the lipid is excited; an electron transfer to the dithiane group leads to the
destruction of the lipids (see ﬁgure 2.30). The resulting aromatic aldehyde, connected to
two hydrophobic tails, is apt to stabilize pores. Liposomes made from a mixture of this lipid,
cholesterol and POPC have been reported to release their content upon UV light irradiation
(λ ≥ 300 nm), but are not destroyed in the process [99, 100]. This supports how hypothesis
concerning the ability of the cleaved lipid to stabilize pores. A ﬂuorinated pyridinium based
probe is released in the timescale of one hour and half (see ﬁgure 2.31).
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2.3. Membrane disruption
This mode of release is the most brutal one, as it relies on the complete disruption of the
membrane. All the content of the vesicle is abruptly released, with no distinction of the
molecular weight or the hydrophilicity of the encapsulated object.
2.3.1. Bare vesicles
The simplest reported method consists in using focused laser pulses of high power to break
a vesicle. No light-sensitive molecule was required to induce the liposome rupture. As
reported by Torre et al. [43, 44], several pulses of 1 µJ coming from a 355 nm laser focused
on 1–10 µm vesicles are suﬃcient to break it; the vesicles were made of cholesterol:L-α-
phosphatidylcholine:stearylamine 10:70:20 % mol. The release was estimated to occur in
timescales lower than the second. This method was successfully used to release netrin-1
and semaphorin, and study their eﬀect on a 2D culture of neurons. The mechanism leading
to the vesicle breakage is not known; it may be based on a local heating of the medium, a
cavitation caused by the high power laser pulse or a photodegradation of the lipids. While
seducing, this technique suﬀers from several limitations. Only one liposome is manipulated
at a time, and this manipulation requires a custom-made optical setup of optical tweezers,
built from an infrared laser. The high power of both the breaking laser and the optical
tweezers (1,024 nm, ∼MW/cm²) are reported not to cause damages to the cells. Yet it seems
rather diﬃcult to achieve either high throughput experiments or long term release with
this system, due to the single-liposome release.
2.3.2. Dye-sensitized vesicles
Finally, dyes have also been used to sensitize the membrane of giant vesicles (diameter
ranging from 2 to 5 µm). Sulforhodamine encapsulated in the liposomes is able to release
Figure 2.32. Reprinted from reference [101]. Release of sulforhodamine from giant vesicles, upon pulsed light
irradiation. Sulforhodamine initial concentration: 50mmol/L.
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itself by pulsed light irradiation (532 nm, 0.5 J/cm²) [101]. This lead to the instant destruction
of the vesicle, and has been shown to occur in less than 1 µs. Concentration of dye as high
as 50mmol/L are required for this eﬀect to occur. Lower concentrations require higher
light power. The beneﬁt of using a dye is the reduction of light power required to break
the vesicle, compared to bare ones. In the bare liposomes assay, 1 µJ were focused on
≈ 4 µm², which leads to 25 J/cm², while only 0.5 J/cm² (1/50) are required with the dye. The
release here is caused by a local elevation of the temperature above the phase transition
temperature of the lipid mixture (41℃, mixture of L-α-phosphatidylcholine and dicetyl
phosphate). In fact, to release the same amount of dye while decreasing the temperature,
the power of the laser must be increased (see ﬁgure 2.32). The same eﬀect was observed by
adding cholesterol at concentration below 33% mol., as it is known to increase the melting
temperature. The exact temperature generated by the laser pulse is unknown.
The dye can also be stuck in the bilayer of giant vesicles, as it is the case with DiD (a lipid
tracing dye) [102–104]. A single pulse from a 645 nm laser (3 ns, 560 nJ, area unknown) is
suﬃcient to break a 400 nm sized vesicle. The mechanism involved in the vesicle breakage
is also a photothermal one [103]. A high increase of temperature is reported with this dye.
The highest release occurs when the lipids are in the gel state; the dye – segregated into
raft domains, thus concentrated in restricted areas – is expected to increase locally the
temperature between 100 and 200℃ above the one of the bulk. Due to the small size of
the heat source, no temperature increase should be detected few micrometers away. This
technique has been used to release a protein (O⁶-alkylguanine-DNA alkyltransferase) inside
CHO cells; the stimulation has been proved to preserve cell viability. However applied to
the encapsulation of proteins in submicronic vesicles, the generated heat will elevate the
temperature inside the vesicle and may denaturate encapsulated proteins.
2.4. Encapsulation yield and preparation conditions
Several methods for the encapsulation of molecules in liposomes have been proposed.
Some are compatible with the manipulation of proteins, while others not due to the use
of solvents or inadequate temperatures (see section 2.4.4 Other procedures below). One
important parameter is the encapsulation yield. As mentioned in the introduction, the
processed molecules may include proteins produced in low amounts (≤ 2mg) and/or diﬃcult
to concentrate in aqueous solution (≥ g/L). Preparation procedures of large unilamellar
vesicles will be reviewed with this constraint of a need for a high encapsulation yield in
mind.
2.4.1. The film hydration method
Theﬁlm hydration method relies on the hydration of a preformed lipid ﬁlmwith the solution
to encapsulate. The ﬁlm is made by the evaporation of a solution of lipids in organic solvents,
like methanol or chloroform. While these solvents may be harmful, extensive drying of
34
2.4. Encapsulation yield and preparation conditions
Figure 2.33. Lisposome formation by the ﬁlm hydration method. A ﬁlm composed of stacked lipid bilayers is
immersed in a solution containing the molecule to encapsulate. Spontaneously or mechanically, the
ﬁlm detaches to form vesicles, entrapping the surrounding solution.
the ﬁlm gets rid of all of them. The dried ﬁlm is hydrated with a solution of the molecule
to encapsulate. The concentration of the lipid is generally in the range of 1–10 g/L. The
steps involved in ﬁlm hydration may include suspension shearing, freeze/thaw cycles,
sonication, heating and extrusion on a syringe ﬁlter [105–107]. The techniques relying on
freeze/thawing, sonication and heating are not adapted to our application due to the risks
of protein denaturation.
As illustrated on ﬁgure 2.33, not all the engaged solution is encapsulated in the vesicles,
leading to a limited encapsulation yield. In a typical experiment, where 200 nm sized DOPC
liposomes are prepared, with lipid concentration of 10 g/L, the encapsulation yield is at best
8 % (see appendix C.4.1, p. 200). This technique has however the main advantage of being
compatible with mild handling conditions.
An encapsulation yield as high as 50% can be reached under certain conditions. If the
molecule to encapsulate can be made to have some aﬃnity for the lipid membrane, up
to half the initial amount of protein may stay in the liposome, while the other half will
be attached onto the outer leaﬂet and removed during the liposome isolation step. This
technique has been applied to the encapsulation of superoxide dismutase in liposomes made
of DPPC:cholesterol [108] or trypsin in DPPC:cholesterol:dicetyl phosphate liposomes [109].
Depending on how the protein is retained on the interface, the encapsulation yield may
depend on the pH or the ionic strength of the solution, e.g. in the case of electrostatic
interactions.
2.4.2. Detergent dialysis method
Vesicles can also be prepared from an initial suspension of mixed micelles, composed of
the phospholipid and a high-CMC surfactant. Removing the surfactant yields vesicles,
35
2. Light-sensitive liposomes
Figure 2.34. Lisposome formation by the detergent dialysis method.
Oil
Aqueous phase
Figure 2.35. Liposome preparation by the reverse emulsion method, as presented in reference [111].
whose size depends on the rate of surfactant removal (see ﬁgure 2.34). Various surfactants
have been used, from ionic ones (sodium cholate, CTAC), known to denaturate proteins,
to gentler non-ionic ones (Triton X-100, octyl-β-D-glucopyranoside, C12E8) [110]. The
surfactant is removed either by dialysis or using adsorbing beads.
The preparation conditions are compatible with protein manipulation, but this technique
suﬀers from the same drawback as the ﬁlm hydration method. The encapsulation yield
is low and limited to the volume fraction during vesicle formation, which makes it less
suitable for our application.
2.4.3. Reverse emulsion method
In this procedure, the aqueous solution to encapsulate is emulsiﬁed in an oil using phospho-
lipids as stabilizers. Aqueous droplets are transferred from oil to water by centrifugation,
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which allows to encapsulate most of the initial emulsiﬁed solution. This process is illus-
trated on ﬁgure 2.35. 60 % of encapsulation yield are reached with this technique [111].
Higher yields (98 %) are reported, using a surfactant as costabilizer during the emulsiﬁcation
phase [112]. Sonication, which may aﬀect protein activity, can be replaced by a microﬂuidic-
based emulsiﬁcation procedure [113], but leads to larger vesicles. This technique may be
used to process proteins.
2.4.4. Other procedures
The solvent injection method is a commonly reported method. It relies on the injection of
a lipid solution in an organic solvent miscible to water (ethanol, ether) into the aqueous
solution to entrap [114]. The reverse phase evaporation method is also a common preparation
procedure. The lipid is dissolved in an organic solvent immiscible to water. This solution
is emulsiﬁed into the aqueous phase to encapsulate. The liposomes are obtained after
evaporating the organic solvent. High encapsulation yields of 65 % can be reached through
this technique [115]. Less common techniques, relying on heating a solution of lipids in a
mixture of water/glycerol to 60–120℃, or using supercritical ﬂuids with organic solvents
are also reported [116].
All these techniques rely either on heating the protein solution or the use of organic
solvents in the contact to the protein. None are not compatible with the encapsulation of
proteins and will not be developed further. More details are available in references [63, 65,
107, 116, 117].
2.5. Summary on light-sensitive vesicles
2.5.1. Release mechanisms and associated timescales
In this chapter, we presented light-sensitive liposomes with various release properties.
Concerning the release time, a broad range is covered and ranges from the microsecond to
several hours. We are interested in fast releasing systems, with a characteristic time below
the second. Only two systems amongst the reported ones reach this criterion: the ﬁrst one
is based on the permeabilization of the membrane and the other one on the disruption of
the membrane.
The ﬁrst system family relies on the increase of permeability of the lipid bilayer. It is
possible to release small hydrophilic molecules, but nothing has been shown on the release
of proteins. In fact, they may not be able to cross the membrane at all, due to their size,
their ionization state and their hydrophilicity. Slightly hydrophobic molecules have been
reported to stay stuck in the lipid bilayer. Therefore, this system is not adequate to the
release of proteins. For these objects to escape, nanometer sized holes must be created in
the lipid bilayer.
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The second system family relies on a physical disruption of the membrane, which leads
to release of the entrapped content regardless of its molecular weight. This method has
successfully been applied to the release of active proteins in a cell culture medium. However,
the fast release relies on high-power laser irradiation. Several conﬁgurations have been
reported to this aim: either bare liposomes irradiated with pulsed UV light or liposomes
sensitized with dyes or nanoparticles. The mechanism of release is not always speciﬁed,
but the temperature elevation induced by the laser irradiation is predominant. Speciﬁc
lipids formulations – in particular the ones containing lysolipids – have been developed to
respond violently to a slight increase of temperature. In fact, the vesicles can be completely
tight at 37℃, but made permeable and released their content above 41℃. The increase
of temperature is thus neither harmful for the cells, if it ever reach them, nor to the
encapsulated material. Coupled to a dye or light-absorbing nanoparticles, these vesicles
can be used for a fast light-triggered release of proteins. One precaution should be taken
when used dye-sensitized liposomes, in particular with the ones inserted inside the lipid
bilayer. As cells and liposomes are similar by their membrane composition, the dyes can
also attach to the cell membrane; depending on the dye concentration, this may perturb or
even kill the cell.
2.5.2. Liposome size
As shown throughout this review, liposomes of various sizes can be obtained, roughly from
10 nm to 10 µm. In our case, the culture medium will limit the maximum size we can use.
The collagen gel in which the cells are cultured has a mesh size in the range of 10 µm [118].
To ensure the free diﬀusion of the vesicles in the gel, their diameter must be signiﬁcantly
smaller than the size of the mesh: 1 µm is the upper limit.
2.5.3. Yield of encapsulation
The last point of this discussion is the yield of encapsulation for these systems. Asmentioned
before, proteins used for cell stimulation are often valuable/fragile products. The losses
during encapsulation must be as small as possible, which is oﬀered by the reverse emulsion
technique. The encapsulation conditions must also preserve protein activity, and this is
abided by the same technique.
To conclude, lipid vesicles are a serious candidate for drug encapsulation and release.
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The second candidate for protein release in cell culture media are micro- or nanometric
sized hydrogels, referred to as nanogels in this document. These systems are constituted of
a hydrophilic polymer matrix entrapping an aqueous buﬀer and the molecules of interest.
As the major constituting part of those gels is water, the conditions are adequate for the
entrapment of peptides and proteins. Three main mechanisms of release are reported in the
literature for the release of molecules: passive diﬀusion, gel destruction and gel collapse
(see ﬁgure 3.1). Passive diﬀusion will not be considered here, as it opposes to triggered
release. It must be avoided and can be if the mesh size of the gel network is smaller than the
size of the entrapped proteins. Entrapped molecules can be released from this tight network
by breaking the gel apart. Similarly, stimuli-induced gel collapse leads to the expulsion of
the entrapped content. This is presumably due to a fracturing of the network during the
shape/volume transitions.
(A) (B) (C)
Figure 3.1. Mechanisms of release from a hydrogel which will be developed in this part. (A): passive diﬀusion
through the gel meshes. (B): release triggered by gel disruption. (C): gel collapse.
The light-sensitive systems based on the creation of reactive oxygen species (ROS) or
radicals have deliberately been excluded from the review below. Even generated locally,
e.g. with light irradiation, they can diﬀuse and cause damages to the cells, either as oxygen
species or secondary radicals. The targeted structures include the unsaturated phospholipids,
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the proteins, enzyme cofactors and DNA. They may even lead to the death of the cell [119,
120].
3.1. Photodegradable hydrogels
Photocleavable hydrogels
Figure 3.2. Photodegradable crosslinker used to build light-degradable hydrogels (n = 28). From references [121,
122].
PEG-based bulk hydrogels have been speciﬁcally designed to encapsulate proteins, as
reported in reference [121]. The so-called PARCEL system was built from the monomer
shown on ﬁgure 3.2; this acrylamide-derivative is polymerized by radical polymerization in
water in the presence of the proteins of interest. Several proteases (chymotrypsin, elastase)
have been successfully entrapped in the gel. In the gel, the proteases showed no activity
towards external proteins, and low activity towards themselves. The activity was regained
by releasing the proteins upon UV irradiation (365 nm, 20mW/cm², see ﬁgure 3.3). Several
monomers have been developed, all based on the same light-sensitive orthonitrophenyl
moiety. The smaller ones have been proposed to prevent protein escape by diﬀusion [123];
polymerized, they give a gel whose mesh size is 3.6 nm (calculated). NanoPARCEL is a
version of the gels synthesized as small particles in the 150 nm range, built only from the
“linker” shown on ﬁgure 3.2. This allows their dispersion in culture media [122, 124]. The
gels are prepared by radical polymerization between the acrylamide-based monomers and
ammonium persulfate in an aqueous medium, under agitation; this was suﬃcient to obtain
monodisperse nanogel suspensions. The size of the nanogels depends on the amount of
initiator introduced. As before, various proteases were successfully entrapped in these gels
– trypsin, chymotrypsin, thermolysin, papain, caspase and elastase – by adding them to
the reaction mixture before the polymerization. They were released from the particles also
by continuous UV light irradiation (365 nm, 20mW/cm², 10 s), but no information on the
eﬃciency of release nor on the gel hydrolysis have been given. The activity of the released
protein, here caspase, is assessed by a biological test, as its release inside the cell leads to
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Figure 3.3. Reprinted from reference [123]. Activity
of gel-encapsulated enzymes, before (in
blue) and after (in red) irradiation (365 nm,
20mW/cm², 1–4.5minutes).
Figure 3.4. Reprinted from reference [125]. Ab-
sorbance of para-nitrophenyl, a product
of the degradation of para-nitrophenyl
phosphate by the phosphatase entrapped
in the nanogel. ●: substrate only (para-
nitrophenyl phosphate); ■: substrate + en-
zyme loaded nanogel, without irradiation;
▼: same as before, with 2 minutes UV light
irradiation.
the cell death. These particles are internalized in cells and irradiated with UV light, leading
to the death of the cell within 10 minutes.
A similar system has been designed by Anseth et al. [125]. It diﬀers from the previous
one by the synthesis method, as the gels are prepared by radical polymerization in an
inverse emulsion. Alkaline phosphatase has been encapsulated in these objects. While the
encapsulation yield has not been characterized, it is suspected to be higher in this case
than in the previous one, due to the preparation method. The release was triggered by
UV light irradiation (365 nm, 10mW/cm²) and monitored by following the activity of the
released phosphatase on paranitrophenyl phosphate (see ﬁgure 3.4). The obtained curve is
a superimposition of the kinetics of release and the kinetics of the enzymatic degradation
of the para-nitrophenyl phosphate. The same absorbance curve plotted for the free enzyme
attains a plateau in 200 seconds. For the released enzyme the plateau is obtained in 600
seconds, which means that the characteristic time of release is in the timescale of a few
hundred of seconds.
In reference [126], hyaluronic acid is grafted with an orthonitrophenyl derivative. In
aqueous media, the chains self-assemble into nanogels with an hydrophobic core made
of the orthonitrophenyl moieties. Doxorubicin was entrapped in the hydrophobic core of
the nanogels, in its basic (hydrophobic) form. Continuous UV light irradiation (365 nm,
1.5mW/cm², 30minutes) doubles the rate of doxorubicin release. The associated release
time is in the timescale of the hour.
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Figure 3.5. Reprinted from reference [127]. Schematic illustration of the loading and release strategy for p(HEMA-
co-MAA) microgels. (1–2) Loading of large cationic functional compounds into the anionic gel: (i)
entrapment by pH-induced deswelling. (3) Diﬀusion controlled release: (ii) reswelling in PBS. (4)
Degradation controlled release: (iii) irradiation in PBS.
One protein – the myoglobin – has been entrapped in nanogels made of 2-hydroexyethyl
methacrylate (HEMA) and metacrylic acid (MAA) copolymers, crosslinked with orthoni-
trobenzyl ester based molecules (see ﬁgure 3.5). The nanogels are prepared in reverse
emulsion; the monomers in the aqueous phase are polymerized by radical polymerization.
The protein, cationic, is retained in the gel by electrostatic interactions. A high loading
eﬃciency is expected; a value of 53.2 % is reported. Loading occurs at pH 6.75, where the
carboxylic acids of the gel are ionized. When the pH is lowered, these acid functions proto-
nates and makes the gel to collapse, preventing the protein to escape. In a physiological
buﬀer (pH, salinity), the protein is spontaneously release by a reswelling of the gel and
a screening of the electrostatic interactions by the salts. 40 % of the loaded proteins are
released in the timescale of 3 hours, but only 60 % are reached after 26 hours. The protein
still in the gel can be released with UV irradiation to yield 100 % (1.5 hours or irradiation,
λ = 315–390 nm) [127].
Dextran-polyacrylamide gels are also reported [128]. Acrylate based monomers – contain-
ing a light-sensitive orthonitrophenyl ester – are grafted on dextran chains. These chains are
cross-linked by radical polymerization in reverse emulsion; the size of the obtained nanogel
depends on the size of the initial emulsion. These gels are light and dextranase sensitive,
but no encapsulation and release tests have been performed yet. With a turbidity-based
measurement, it has been reported that these gels are destroyed in the timescale of one
minute under continuous UV light irradiation (365 nm, 30mW/cm²).
Some other applications for these gels includes light-control of cell gel culture [129] and
on-demand light-triggered cell-release [130].
All the examples reported in this section are based on the same photocleavable molecule
(see ﬁgure 3.6), probably because it is commercially available and has decent light-sensitive
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Figure 3.6. Photocleavable orthonitrobenzyl-based group, developed and patented by C. P. Holmes (see refer-
ence [131]). This molecule is available from various commercial sources.
properties1. The molar extinction coeﬃcient (𝜀) of this molecule at 350 nm is 5,400 L/mol/cm
inwater:methanol 90:10 % vol and is reported to have an hydrolysis constant (𝑘) of 3.3⋅10⁻⁴ s⁻¹
under UV light irradiation [137]. However, no mention of its quantum yield of photolysis
(Φ) could be found. It should be comparable to molecules of the same class though (methoxy
substituted orthonitrophenyl esters); their quantum yield is often high, in the range of
0.2 [132]. This molecule is characterized by a low extinction coeﬃcient, but is counterbal-
anced by a high quantum yield of photolysis – the photolysis eﬃciency of photocleavable
molecules can be compared using the product 𝜀 ⋅ Φ [138]; this value is proportional to
the amount of release. For this molecule, 𝜀 ⋅ Φ = 1,080 L/mol/cm; this is relatively low,
molecules with a 𝜀 ⋅ Φ 10 times higher are described [132]. This would allow the same
result with a 10 times lower irradiation. However, this increase of photolysis eﬃciency is
done at the expense of a 10 times higher molar extinction coeﬃcient. This means that at a
constant amount of photocleavable links, the gels will absorb more the light. For the only
gel whose mesh size is reported – 3.6 nm, ref [123] – the concentration of photocleavable
molecules in the bulk gel can be estimated from the structure of the gel: approximatively 2
nitrobenzyl ester can be counter per 3D gel mesh. This gives a concentration in the order of
2/((3.6 ⋅ 10−9)3 ⋅ 𝒩𝐴) ∼ 70mmol/L. Dispersed as nanogels at a reasonable volume fraction
of 0.1 % in a culture gel of 2 millimeter high, the absorbance is already ∼ 0.8. This means
that the irradiation with light will not be homogeneous through the gel.
To improve the kinetics of release without modifying the structure of the gel, the photo-
cleavable dye must be replaced by one with the following properties. Its molar extinction
coeﬃcient must be low – in the order of 5,000 L/mol/cm – to allow the light to penetrate
the gel. Its quantum yield must be as high as possible, to rely on the lowest irradiation
power. And ﬁnally its photolysis kinetics must be faster than the one reported for the
nitrobenzyl group. The ﬁrst two points do not leave a lot of room for improvement, but
“faster” systems can easily be found in the literature, at the expense of a lower quantum yield.
In reference [139] is described a set of nitrophenyl-based molecules whose photocleavage
rate depends only on the intensity of light (𝑘 ∝ 𝐼0, where 𝐼0 in the intensity of incident
light). Contrary to the previously reported system, the molecule is directly cleaved upon
irradiation, without going to intermediate states – these intermediate states are often the
limiting ones, and are probably responsible for the slow time reported before.
1For reviews on photocleavable groups, refer to references [132–136].
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Azobenzene-based dissassemblies
As reported in the part about liposomes, azobenzene can be used to build light-sensitive
assemblies. The β-cyclodextrine/azobenzene host/guest association has been used as
crosslinks of a PEG-based hydrogel [140]. The polymer self-assembled into 250 nm sized
microgels, which are also covalently crosslinked. The host/guest crosslinks are destroyed
upon UV light irradiation (365 nm), which allows the gel to swell, without destruction due
to the covalent crosslinking. A blue light irradiation (450 nm) allows the gel to shrink again.
No encapsulation/release tests are reported with this system yet.
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Figure 3.7. Adapted from reference [141]. Azobenzene-crosslinked dextran nanogels, loaded either with (a)
aspirin or (b) rhodamine B. “trans” means that the sample has been kept into the dark, while “cis”
means that it has been irradiated with UV light continuously (365 nm).
Dextran hydrogels have also been crosslinked with azobenzene, relying on the self
aggregation of this molecule in its trans conformation. 200 nm sized particles, loaded with
aspirin or rhodamine B, release their content with UV light irradiation (365 nm). The release
rate is in the timescale of 2 hours [141].
Photo-polymerization/-depolymerization
Coumarin is another member of the light-sensitive molecules, which goes from their initial
state to another with a wavelength and comes back to the initial one with another (see
ﬁgure 3.8. Linked to polymers, they act as photodegradable cross-linking agents. They
have been introduced in hydrogels, as reported in reference [142]; this system is shown
on ﬁgure 3.9. Brieﬂy, a copolymer made of a PEG block and a coumarin functionalized
polyNIPAM block is self-assembled into micelle above polyNIPAM LCST. The micelles are
crosslinked with UV light (310 nm), thanks to the coumarins, and are turned into nanogels
by lowering the temperature below the LCST. A further UV irradiation (260 nm) breaks
the coumarin dimers and allows the gel to swell, releasing the entrapped molecules. Here,
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Figure 3.8. Light-induced (UV) coumarin dimerization. The process is reversible upon irradiation with UV of
shorter wavelength. From reference [142].
Figure 3.9. Block-copolymer assembled into light-sensitive hydrogels. The blue part is made of PEG and the red
one of polyNIPAM functionalized with coumarins. Reprinted from [142].
dipyridamole (504 g/mol) is released, but light stimulation only leads to a 1.5 increase in
release kinetics compared to non-stimulated gels.
3.1.1. Nucleid-acid based hydrogels
Recently a hydrogel encapsulation system made of plasmids crosslinked with ethylene
glycol diglycidyl ether (EDGE, a di-epoxide) was reported. The gel self-disassembles upon
blue light irradiation (400 nm, unknown power), which releases both entrapped material
and the plasmid itself. The mesh size of the system has been characterized experimentally
and is in the range of 30–40Å. The release of the plasmid occurs within 500 hours, with the
entrapped material, such as BSA, lysozyme or FITC-dextran (77 kg/mol). The timescales
associated with the release depends on the entrapped molecules 200 hours are reported for
BSA and dextran, while 48 hours are for lysozyme [143, 144]. The hydrodynamic radius of
the lysozyme is ≈ 16Å, smaller than the mesh size, while the radius of BSA is ≈ 35Å and
the one of the dextran 55Å; this explains why the release of lysozyme is faster than the
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other molecules. However, the comparison with the other systems is not obvious, as the gel
particles are macroscopic (millimetric). The mechanism of degradation suggested by the
authors is the self degradation of ethers in water under light irradiation. Linked to nucleic
acid, the wavelength of maximum degradation eﬃciency is 400 nm.
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Figure 3.10. Reprinted from reference [145]. Release of doxorubicin from plasmid nanogels crosslinked with
EDGE and polyethylene imine. ●: 0.08 %, △: 0.1 %, ■: 0.15 % EDGE cross-linking.
A slight variation of this system is shown in reference [145]. The size of the particle is
reduced to the range of 500 nm to 5 µm. The plasmids are crosslinked both with EDGE and
a diamine. While EDGE-based crosslinks can be destroyed with light, the diamine-based
ones are permanent. The synthesized particles do not dissolve upon light irradiation, but
rather swells. Several anti-cancerous drugs have been loaded in these gels, doxorubicin,
epirubicin, paclitaxel, and released also with blue light (400 nm). The characteristic time
associated with the release is approximatively 50 hours for these drugs (see ﬁgure 3.10).
3.2. Light-triggered gel collapse
PolyNIPAM based hydrogels
PolyNIPAM is a shortening for poly(N -isopropyl acrylamide). This polymer in water
undergoes a solubility transition when heated above a threshold temperature called the
lower critical solubility temperature (LCST). Above the LCST polyNIPAM is collapsed, while
below it, it swells. This phenomenon has been exploited to create temperature-sensitive
hydrogels, which have been then converted to light-sensitive hydrogels.
Gold nanoparticles and infrared light have been used to this aim [146–148]. Here, a speciﬁc
type of particles with a near-infrared absorbance peak is used. They are made of a gold
sulﬁde core surrounded by a gold shell. These particles have been used to sensitize 40 nm
size polyNIPAM nanoparticles loaded with methylene blue, ovalbumin or BSA. Irradiating
the samples with infrared light (1,064 nm) only doubles the release rate of methylene blue or
triples the one of ovalbumin or BSA (see ﬁgure 3.11); the resulting temperature in the sample
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Figure 3.11. Reprinted from reference [146]. polyNI-
PAM based gel loaded with ovalbumin.
Amount of release ovalbumin as a func-
tion of time, under continuous infrared
(1,064 nm, 10Hz pulses) light irradia-
tion. ◆: non-irradiated gels, ▲: irradi-
ated gel without gold nanoparticles, ■:
irradiated gels with nanoparticles.
Figure 3.12. Release of doxorubicin from polyNIPAM
nanogel sensitized with carbon nan-
otubes. Blue curve: sample kept in the
dark. Red curve: sample irradiated pe-
riodically (between the green and black
arrow) with infrared light (808 nm).
is unknown, but must be above 40℃, the LCST of the polyacrylamide used. The associated
timescales are in the range of 5 minutes for the methylene blue and 30 minutes for the
proteins [146]. The release relies here on a local heating of the nanogel with nanoparticles;
the density of nanoparticles must be suﬃcient to cross the LCST of the polymer. The
generation of heat is balanced by the dissipation: the smaller the particle, the higher the
dissipation. This suggests the existence of a threshold of nanogel size and of density of
gold nanoparticles below which the release will never occur. There is no mention of such
thresholds in the presented systems, though.
Another method to convert light to heat relies on the use of carbon nanotubes. 200 nm
sized nanogels were loaded with carbon nanotubes and doxorubicin. Heating the nanogels
above the LCST less than doubles the released amount of doxorubicin. The associated
timescale is the hour. Irradiating the sample with infrared light increased slightly the
amount of released doxorubicin, compared to the sample kept in the dark (see ﬁgure 3.12).
Only 40 % of the initial load of doxorubicin was released within 72 h, under IR irradiation
(808 nm, 1W/cm²) [149]. These nanogels were synthesized by radical polymerization, either
in reverse emulsions [150], or in aqueous media [146].
The LCST of “raw” polyNIPAM is 32℃ in water, which means that under physiological
conditions (37℃), the gel is already collapsed, and is of no use for hydrogel-based release.
One solution is to tune the LCST of the polyNIPAM using additives, often introduced
as co-monomers: hydrophilic ones increase the LCST, while hydrophobic ones decrease
it [148]. In reference [149], hydrophilic cross-linkers have been used to increase the LCST
above 37℃, which made the nanogels compatible with their experiments with cells.
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Other systems
The system developed in reference [151] relies on temperature-induced deprotonation of a
protonated amine. The hydrogel is made of PEG and polyacrylate chains bearing protonated
amine functions, decorated with gold nanoparticles. This polycationic network has the
ability to retain anionic molecules, by electrostatic interactions. When the hydrogel is
heated, the amines are deprotonated and the entrapped molecules can escape the gel. This
phenomenon has been attributed to a dependence of the pKa to the temperature [152]. A
high power green laser (514 nm, 39W/cm²) is used to heat the sample containing 200 nm
size hydrogels loaded with pyrene tetrasulfonic acid. About 25 % of the loaded amount of
acid is released during 8 minutes of continuous irradiation (see ﬁgure 3.13). The high power
of the laser combined with the absorbance of the particles lead to an elevation of 8℃ of the
suspension, going from 25℃ to 33℃. Heated in a quartz cell without light irradiation, the
nanogels were also able to release their content, and seems so occur since 25℃.
This review was essentially focused on nanometer-sized hydrogels, but a lot of light-
sensitive bulk hydrogels have also been developed [153, 154]. They include azobenzene
crosslinked hydrogels, azobenzene-modiﬁed LCST polymers (polyNIPAM notably), spiropy-
rane modiﬁed LCST polymers, orthonitro benzene or di-coumarin crosslinked networks.
One notable example – the azobenzene-modiﬁed polyNIPAM – did not lead to the devel-
opment of nanogels. In fact, the isomerization of azobenzene shifts the LCST by several
degrees. The typical shift obtained is at most 6℃, which is rather restrictive for biological
applications: to prevent an accidental release from such hydrogels, the temperature must
be regulated precisely. This may explain the absence of azobenzene-based polyNIPAM
nanogels.
Figure 3.13. Reprinted from reference [151]. Release of pyrene tetrasulfonic acid from a polycationic hydrogel, ■:
in the dark and ●: under continuous irradiation (514.5 nm, 39W/cm², starting at the black arrow).
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3.3. Encapsulation yield and loading constraints
Impact of the synthesis procedure on the protein encapsulation
Several methods have been reported for the synthesis of the nanogels [155]:
Micromolding The monomers or the polymer chains are molded in a PDMS matrix.
Particles as small as 100 nm have been reported. While it is possible to obtain arbi-
trary shapes with this method, the “2D” synthesis limits the throughput of the gel
production.
Reverse emulsion The gels can be prepared from the emulsion of an aqueous phase
containing the monomers and the molecule to encapsulate, dispersed in an oil phase.
The size of the emulsion ﬁxes the size of the nanogels. Several methods have been
proposed to prepare the emulsion: surfactants+ultrasounds, microﬂuidic devices and
injection of the aqueous phase in the oil through a porous membrane.
Homogeneous polymerization The monomers and a polymerization initiator can be
dissolved in an aqueous medium. The gels will grow from a nucleation point, until
the polymerization is stopped (either by lack of monomers or by losing the reactivity).
The size of the gels depends on when the polymerization is stopped.
At the exception of the technique relying on ultrasounds, all of them are a priori compatible
with the process of proteins.
The molecules of interest are loaded in the gel either during its synthesis or after. For the
emulsion-based procedures, the protein can be added to the emulsiﬁed aqueous phase. Un-
less the protein is excluded from the matrix during the polymerization, high encapsulation
yields are expected; the same is expected for the molding process. For the homogeneous
polymerization, the protein can also be added to the reaction mixture. If no speciﬁc aﬃnity
is developed between the encapsulated molecule and the matrix, the encapsulation yield
is limited by the volume fraction of the aqueous phase actually included in the matrix. If
the mesh size of the gel permits it, the protein can also be entrapped in the gel after its
synthesis; the role of the size mesh will be discussed further in this section.
Concerning the synthesis conditions, all the systems reported in the previous section
are made by radical polymerization. Adding the protein in this step is questionable, as the
protein activity can be damaged by radicals [156]. The damages are particularly important
in presence of oxygen, and include protein cross-linking (via the histidine residues), protein
fragmentation, protein oxidization and protein unfolding.
Impact of the mesh size
In systems encapsulating proteins by the entrapment in a polymer matrix, the mesh size
must be slammer than the encapsulated molecule to avoid the escape by passive diﬀusion.
Yet, the real mesh size is seldom characterized. The few examples we got can be compared
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to the characteristic size of a protein. First, the protein radius can roughly be derived
from its molecular weight by the formula 𝑅min = 0.066
3
√𝑀, where 𝑅min is its radius in
nanometers and𝑀 its molecular weight in g/mol [157]. The typical radius of a 50 kg/mol
protein is in the range of 2.5 nm, which means that the protein is retained by both the
nanoPARCEL system (3.6 nm) and the DNA based system (4 nm). To compare with usually
used hydrophilic drug, the size of doxorubicin is ≈ 0.5 nm, which means that the gel is not
able to retain them. For a complete oﬀ/on delivery, nanogels are therefore speciﬁc to high
molecular weight molecules like proteins.
The tight entrapment of the protein has a negative impact on the kinetics of release.
A complete release requires the hydrolysis of a signiﬁcant amount of the light-sensitive
cross-linkers, which leads to a slow release. The fastest reported system release caspase
within 20 s, but the characteristic response time of the other systems is rather in the 10
minutes scale The kinetics of release can be increased both by increasing the kinetics of
hydrolysis of the light-sensitive moiety, or by increasing the light intensity.
One possible solution to overcome the slow hydrolysis of the gel is proposed in refer-
ence [158]. The light-sensitive gel is used only to build the shell of the particle. The protein
is no longer entrapped in the gel, but rather in the aqueous core of the particle. And the
thinnest the membrane, the faster the release, while the amount of entrapped protein stays
the same. As soon as a hole is poked in this membrane, all of its content can be released.
The mechanism is the same as liposomes sensitized with the pore-making polymer. This
kind of objects belongs to the polymer capsule family, and will be developed in the next
part.
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capsules
Systems made of an aqueous core surrounded by a light-sensitized polymer shell combine a
priori the advantages of both liposomes – a mild aqueous medium – and the ones of gels –
mainly their mechanical resistance. Though most examples in the literature do not consider
protein encapsulation, they illustrate the degree of control that can be expected.
Polymer capsules can classiﬁed into three main classes, depending on their synthesis pro-
cedure. It can be done by covering a pre-formed liquid or solid core with alternating layers
of polyelectrolytes with opposite charges, leading to a layer-by-layer capsule. Polymers
– in particular amphiphilic diblock polymers – can self-assemble into vesicles, leading to
objects somehow similar to liposomes, and called polymersomes. Finally, the polymer can
also be synthesized or deposited at the water/oil interface in an emulsiﬁed system, leading
to also to capsules. All these systems are schematically represented on ﬁgure 4.1.
Layer-by-layer capsule (LbL) Polymersome Reverse-emulsion polymer capsule
Figure 4.1. Schematic view of the three classes of polymer capsules: the layer-by-layer assemblies, the polymer-
somes and the polymer capsules made by reverse emulsion. The hydrophilic part of the membrane is
represented in blue, while the hydrophobic one is represented in purple.
4.1. Layer-by-layer assemblies
4.1.1. System description
Layer-by-layer capsules are made from assemblies of polyelectrolytes of opposite charges
created around a pre-synthesized template. This template can be a solid organic or inorganic
sphere, or even a droplet in an emulsion [159]. The layers are deposited one after the other,
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Figure 4.2. Layer-by-layer capsule synthesis procedure. Adapted from reference [159].
as shown on ﬁgure 4.2. The core template is removed by various ways, depending of the
nature of the core itself. Compared to liposomes, they are claimed to be less permeable and
mechanically more resistant.
4.1.2. Light-induced release
Two mechanisms lead to the release of entrapped molecules from LbL capsules: namely,
the capsule can remain intact but its permeability increases, or the capsule can burst under
a mechanical stress.
Photochrome-doped LbL capsules
Figure 4.3. Congo red, an azobenzene-containing ionized dye.
Azobenzene has once more proven reliable to confer light sensitiveness to a drug-
encapsulating object. In the system shown in reference [160], an azobenzene-based dye is
added to a layer-by-layer assembly made from polystyrene sulfonate/polyamine, yielding
5 µm sized capsules. Irradiated with UV light, the dye isomerizes and perturbs locally the
organization of the LbL assembly, which is made permeable. While carboxyﬂuorescein
was not retained in the capsules, UV light irradiation (λ > 400 nm, unknown power) was
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Figure 4.4. Azobenzene-containing cationic polyelec-
trolyte. From reference [161].
Figure 4.5. Azobenzene-containing cationic polyelec-
trolyte. From reference [162].
required to release dextrans. Dextrans smaller than 66 kg/mol were released within 1 hours,
while a 464 kg/mol one required two hours. Bigger dextrans remained indeﬁnitely in the
capsule.
Azobenzene can also be covalently attached to one of the polyelectrolytes [161] (see
ﬁgure 4.4). Both a neutral dextran (10 kg/mol) and a polyanionic one (3 kg/mol) have
been loaded in polymersomes preformed with this polymer and poly(vinyl sulfonate), by
passive diﬀusion. All were released upon UV light irradiation, which caused the capsule
to shrink. Its diameter goes from ≈ 4.7 µm to ≈ 2.6 µm within 10 hours of continuous
irradiation. Nomore precisions were available from the article. Another polymer is reported
in reference [162] (see ﬁgure 4.5). 4 µm sized capsules were made with this polymer and a
polyanionic carrageenan, but no release experiments were performed.
Figure 4.6. Reprinted from reference [163]. UV induced release of BSA from azobenzene-based LbL capsules.
Azobenzene has been used to induce the disruption of a LbL capsule made with the
polymer shown on ﬁgure 4.4 and a poly(allyl dimethylammonium chloride) [163]. BSA was
introduced in these particles by precipitating it with calcium carbonate, in the template
synthesis step. After assembling the membrane, the dissolution of the core with EDTA yields
free BSA stuck in 5 µm scaled capsules. A continuous UV irradiation (366 nm, 55mW/cm²)
only multiplied the release rate by a value ranging from 2.5 to 4 (see ﬁgure 4.6). 2 hours of
irradiation were suﬃcient to break the particles, though. The limited amount of released
BSA (16% after 2 hours) is attributed by the authors to an irreversible interaction of the
protein with the capsule.
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Light-induced elevation of temperature
Inorganic light-absorbing particles have also been used to break layer-by-layer assemblies.
Silver nanoparticles were embedded in 2 µm capsules made of polystyrene/polyamine by
synthesizing them in situ from a silver salt [164, 165]. Less than 1 second of a green laser
irradiation (532 nm, 25mW) was suﬃcient to break the capsule shells. The burst mechanism
is based on the temperature elevation induced by the silver nanoparticles [164]. These
capsules have been used to release 10 kg/mol ﬂuorescent dextran inside living cancerous
cells [166].
Figure 4.7. Reprinted from reference [167]. LbL capsules loaded with Alexa Fluor 555 dextran. From the left to
the right: confocal pictures taken before and after irradiation at 830 nm, 65mW for 10 s; the graph
represents the percentage of opened capsules after irradiation (continuous line) and its derivative
(dashed line). A,B,C: LbL capsules without nanoparticles D,E,F: LbL capsules loaded with gold
nanoparticles
Gold has also been embedded in such capsules, with similar results. In reference [168],
5 µm sized capsules are used to deliver 10 kg/mol dextran into cells, upon laser irradiation
(830 nm, 2.3mW/25 µm², less than 1 second). However, it was shown that this high laser
intensity, while in the infrared region, impaired the cells. This even led to cell death at
higher powers (31mW). A similar system is reported in reference [169]. Aggregates of gold
nanoparticles have also been used, as this conﬁguration improve the absorption of light,
which lead to irradiations with lower intensities [167]. As the mechanism of release rely on
an elevation of temperature, the capsules are loaded in their permeable state, by elevating
the temperature of the buﬀer. Temperatures of 50–60℃ are reported, which is suﬃcient
to cross the LbL glass transition temperature; this makes the membrane porous and allow
the loading and the release. Fluorescent labeled dextran (10 kg/mol) has successfully been
released from these capsules upon infra-red light irradiation (830 nm, 65mW, 10 s), as
shown on ﬁgure 4.7. In reference [170], lysozyme is entrapped as crystals in poly(allyl
amine)/poly(styrene sulfonate) capsules, sensitized with gold nanoparticles. Lysozyme is
claimed to be released upon infra-red light irradiation (1,064 nm, 50mJ/cm²).
Layer-by-layer assemblies were also be dopedwith dyes. In reference [164], the membrane
of 2 µm LbL capsules made from poly(allyl amine)/poly(styrene sulfonate) is loaded with an
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IR absorbing dye (IR-806), and broken with a laser irradiation (830 nm, less than 1 second,
60mW/25 µm²).
4.1.3. Encapsulation yield and loading conditions
Synthesis of LbL capsules
Several templates are reported, both organic and inorganic ones, but most of them are
incompatible with the pre-encapsulation of proteins, due to the harsh conditions used for
their removal. Melamine beads are removed with hydrochloric acid at 0.1mol/L. Polystyrene
beads are also reported; their removal relies on dissolution with a water-miscible organic
solvent, e.g. tetrahydrofuran. Inorganic particles have also been used for this application.
Silica beads are removed with hydroﬂuoric acid, while calcium carbonate ones are dissolved
with EDTA. The template may also not be dissolved at all, if it is porous. In this case, the
molecule of interest can be loaded into the template before the synthesis of the membrane.
Loading conditions
The encapsulated protein or molecule can be entrapped in the template or loaded after its
dissolution. As reported at the beginning of this section, the dissolution procedures are
harsh and not compatible with the manipulation of proteins. Acids and organic solvents are
known to denaturate proteins, and EDTA is known to inactivate enzymes with a metallic
center, like the metalloproteases. Only a loading after the synthesis of the LbL assembly
and the dissolution of the core is conceivable.
Up to now, only two examples of protein release using light-sensitive layer-by-layer
assemblies has been found. We will however extend this discussion on large molecular
weight molecules, like dextran. A ﬁrst method relies on loading crystals of proteins in the
capsules, in conditions preventing the crystal dissolution. This has been applied successfully
to lysozyme [170], but it is limited to a small range of proteins, which are crystallizable in
conditions where the layer-by-layer assembly stays either intact or permeable. The principle
is interesting but not general, because only a few proteins can be crystallized properly at
the low salt conditions required to assemble the LbL membrane and after replacing the
encapsulation buﬀer by a physiological one.
The second method relies on the coprecipitation of proteins in calcium carbonate, to
build the template core. They are obtained by mixing calcium chloride (330mmol/L) and
sodium carbonate (330mmol/L). The pH of the sodium carbonate solution if above 11,
which can aﬀect the stability of the entrapped proteins, depending on how long they will
stay in this solution. BSA is known to unfold irreversibly to coat hydrophobic surfaces:
it may be encapsulated in a denaturated and aggregated form, which could explain the
low release yield obtained (16 %) [163]. The encapsulation yield also is unknown, and is
probably dependent on the aﬃnity of the protein to the inorganic cluster. The role of EDTA,
used to dissolve the core, has already been discussed.
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The third method relies on temperature-sensitive capsules that can be loaded at high
temperature; this temperature increase makes the membrane permeable. This has been
applied to the loading of dextrans. Temperatures as high as 60℃ are reported, which is
denaturing form several proteins. The encapsulation yield is limited by the volume fraction
inside the capsules and will not be substantial, except if the inner compartment binds the
protein – which is likely to slow down the release of the protein.
Size of the capsules
The size of the capsules reported as light-sensitive was never smaller than 1 µm. However,
the size of the layer-by-layer assemblies depend on the size of the core, and can be decreased
by using smaller ones: capsule ranging from 10 nanometers to several micrometers are
reported [159]. The thickness of the membrane can also be tuned, by varying the number
of layers deposited around the core.
Release rate
The faster releases are obtained by breaking the membrane. Characteristic times of 1 second
are evoked, but rely on pulsed or high-power laser irradiation.
Conclusion
Altogether, it is concluded that encapsulation is the major drawback to be solved in the
case of LbL capsules, to be immediately relevant for an application to proteins, where a
high encapsulation yield and a preservation of the protein activity is required. Concerning
the object itself, it can be noted that light-sensitive LbL capsules are not common objects.
Most of the stimuli-responsive LbL capsules reported respond either to pH, ionic strength
or temperature [159, 171, 172].
As a last remark against these capsules, we may also add that the dissolution of the core
can leave toxic species inside the capsules, as it has been reported with melamine [173].
If not impairing the activity of the proteins, it may aﬀect the cell activity and should be
avoided.
4.2. Polymersomes
4.2.1. System description
Polymersomes are self-assembled polymer capsules made of an aqueous core and an polymer
shell containing di- or triblock amphiphilic copolymers. The polymers self-assemble into
vesicles, due to the property of the hydrophobic blocs to aggregate and the balancing
steric repulsion between the hydrophilic blocs that alleviate micellization. Polymersomes
and liposomes share several features. However, using synthetic objects in place of lipids
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allows more chemical ﬂexibility and the possibility to build thicker membranes with several
advantages regarding their stability, their permeability or their mechanical resistance [174].
4.2.2. Light-triggered release mechanisms
Azobenzene-based systems
Figure 4.8. Azobenzene-containing diblock polymer. The hydrophilic block is made of a acrylate/acrylic acid
copolymer. The hydrophobic one is made of azobenzene pendant groups. From reference [175].
The light-induced isomerization of azobenzenes has been exploited to build light-sensitive
polymersomes. An example of a block copolymer sensitized with azobenzene moieties is
shown on ﬁgure 4.8. This acrylate/acrylic acid based polymer has been used to prepare
vesicles in dioxane/water (16 % vol.) mixtures, which disassemble under UV light irradiation
(360 nm, 34mW/cm²) and reassemble under blue light (440 nm, 24mW/cm²) [175]. Adding
water above 21 % vol. the polymer aggregated. No encapsulation and release experiments
have been conducted with this system.
A similar polymer (see ﬁgure 4.9) was reported to make light-sensitive vesicles without
organic solvents, when associated with a non-sensitive polymer [176]. It has been shown
that UV irradiation (365 nm, 1W/cm²) induced the rupture of 10 µm-sized vesicles by the
Figure 4.9. Polymers used to build UV-sensitive poly-
mersomes in reference [176].
Figure 4.10. Reprinted from reference [176]. Poly-
mersome pore opening, upon UV light-
irradiation.
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Figure 4.11. Dendrimer used to build polymersomes, from reference [177].
creation of pores (see ﬁgure 4.10). The timescale associated with the pore opening is 100ms,
but this phenomenon occurs randomly during the 5 minutes of UV irradiation.
A similar system is reported in references [177, 178], in which the linear acrylic polymer
is replaced by a PEG chain connected to several azo-bearing chains to build dendrimers
(see ﬁgure 4.11). The vesicles made with this polymer have been shown to break within 35
minutes of UV irradiation (365 nm, 150mW/cm²), with no other details on the kinetics.
In all the systems reported above, the azobenzene is present in the hydrophobic part
of the block copolymers. In its trans form, it is hydrophobic because its polarity is near
zero. Irradiating the polymer with UV light converts the azobenzene to the cis isomer,
whose polarity is signiﬁcantly higher than the trans one. This destabilizes the hydrophobic
assembly of the polymersome and leads to its disassembly [175].
A host/guest based system built around a synthetic supramolecular cycle and an azoben-
zene is reported in reference [179]. Mitoxantrone, a small hydrophilic drug, has been
encapsulated in these vesicles and released with UV light irradiation (365 nm, power un-
known). Irradiating the polymer with UV light yields cis azobenzene, which escapes the
supramolecular cycle and disassemble the vesicle. At a physiological pH, the kinetics of
release is slow: 3 hours are required to release 60 % of the entrapped drug.
Light-induced ionization
Block copolymer have been made with spiropyrane moieties [180]. The only reported
assemblies are micelles, which disassembles upon UV light irradiation. No polymersomes
were reported yet, though the adjustment of the block length should favor such assemblies.
Figure 4.12. Light-sensitive diblock polymer used in reference [181]. The hydrophilic part is made of poly(ethylene
glycol), while the light-sensitive hydrophobic part is made of malachite green. Upon UV irradiation,
the cyanide anion detaches from the triphenyl group.
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Malachite green is another example of molecule able to ionize under light irradiation.
The reverse process occurs spontaneously by thermal relaxation. PEG polymers ended
with malachite green, shown on ﬁgure 4.12, have been used to build 100 nm vesicles [181].
They disassemble within 500 s of UV light irradiation (Hg lamp, 900mW/cm²), and reform
themselves spontaneously when kept in the dark. No precise kinetics of disassembly or
release have been performed.
Photocleavable chains
UV light
Photolysis
Figure 4.13. Light-induced photolysis of a diblock polymer. UV light is absorbed by the orthonitrobenzene group,
highlighted in yellow. From reference [182].
Figure 4.14. Reprinted from reference [183]. Release of eGFP from light-cleavable polymersomes (●) and evolution
of the diameter of the objects in the sample (■) upon UV light irradiation (365 nm, 200mW/cm²,
10min).
Orthonitobenzyl esters have been used to link the blocs of diblock polymers, as shown
on ﬁgure 4.13. These polymers have been assembled in 70 nm sized vesicles loaded with
various molecules including a protein (ﬂuorescein, ATTO665 and eGPF). The encapsulation
eﬃciency of eGFP have been evaluated to 22%. Irradiating these vesicles with UV light
(365 nm, 700mW/cm²) triggers the lysis of the orthonitrobenzyl ester moieties, leading
to the breaking of the chains, as shown on ﬁgure 4.13. The characteristic release time of
vesicle lysis has been evaluated to 30 minutes by DLS measurements. 10 minutes irradiation
at 200mW/cm² are suﬃcient to release the entrapped eGFP (see ﬁgure 4.14), while 1 hour
was required to release only 60 % of the ﬂuorescein, suggesting that this small dye interacts
59
4. Aqueous core—polymer shell capsules
with the polymers [182, 183]. Encapsulation and release of biocytin in similar systems is
also reported [184]. The release occurred within 6 hours of UV light exposure (365 nm,
55mW/cm²). One strategy brought up in reference [185] to increase the kinetics of release
relies on adding multiple orthonitrobenzyl ester groups per polymer chain. It has been only
proved with micelles, though.
Figure 4.15. Diblock polymer, made of PEG and coumarin-bearing methacrylate. Upon light-irradiation (UV or
IR 2 hν), the coumarin ester bond hydrolyses to let place to methacrylic acid, turning the hydrophobic
block in an hydrophilic block. Developed in reference [186].
Coumarins groups can also be hydrolyzed by light irradiation. In the system reported in
reference [186], they are introduced along the hydrophobic chain, as shown on ﬁgure 4.15
and assembled into micelles. UV light (365 nm) or IR (2 photons, 794 nm) turned the
hydrophobic core in an hydrophilic one, by the creation of a poly(methacrylic acid). The
micelles were broken in the timescale of 2 hours. No vesicles were reported with this
polymer.
Light-induced local heating
Figure 4.16. A porphyrin complexing a zinc ion.
Porphyrines are macrocycles made of four pyrrole units, as shown on ﬁgure 4.16. Loaded
with ferritin in polymersomes made of PEG-b-polybutadiene block copolymer, the poly-
mersomes become sensitive to UV light (365 nm). Only a small amount (25 to 50 %) of the
entrapped biocityn is released after 4 hours of continuous irradiation [187]. The release
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relies on the presence of ferritin, but it can be replaced by dextran for the same eﬀect [188].
The mechanism involved here is a local heating due to the absorption of light by the por-
phyrin. The protein is suspected to adsorb on the inner membrane and cause a diﬀerential
stiﬀening of the leaﬂets, leading to budding and subsequently leading to the release of the
entrapped content [187].
Capsules sensitized with gold nanoparticles were reported in reference [189]. They
were inserted in the hydrophobic layer of vesicles made from poly(L-lactic co glycolic
acid)/polyNIPAM. These particles, irradiated with visible light (488, 532 and 633 nm), made
the polyNIPAM chains collapse and destroyed the vesicles in the timescale of the minute.
No speciﬁc release experiment was performed.
4.2.3. Preparation conditions and encapsulation yield
Several techniques are reported, enabling to control the size of the polymersomes and the
encapsulation yield1. Some techniques are based on organic solvents. One of the most
reported method relies on dissolving the polymer in an organic solvent. The aqueous
solution to encapsulate is added dropwisely to the organic solvent, yielding vesicles whose
size is in the 100 nm – 3 µm range. Details on the other techniques are available in refer-
ences [190–192]. Not compatible with the handling of proteins, they will not be discussed
here.
The lipids can be dissolved in a volatile solvent and made to dry on a ﬂat surface to
make a polymer ﬁlm [190]. Upon hydration, vesicles in the 50 – 800 nm range are formed;
monodisperse objects of a deﬁned diameter can be obtained by extrusion through a ﬁlter.
The size of the ﬁlter pores deﬁnes the size of the obtained polymersomes. Electroformation
applied to the polymer ﬁlm will lead to micrometer-sized polymersomes. However, low
encapsulation yields are expected. Similar to the techniques used for the preparation of
liposomes, yields in the 10 % range are expected.
Several case of self-assembly of the polymer directly in the aqueous medium are reported.
In the speciﬁc case of the formation of the vesicle via host/guest associations, encapsulation
yields as high as 76 % for the MTZ drug have been reported [179].
The reverse emulsion method – similar to the scheme shown on ﬁgure 2.35 page 36 –
can be used to process the block copolymers. 10 µm vesicles have been obtained with this
method [176]. Transposed to microﬂuidic devices, larger vesicles can be made; 200 µm
objects are reported [189]. The encapsulation yield is expected to be high, as most of the
aqueous phase containing the molecule of interest will be entrapped in a vesicle.
All the solvent-less process reported above are compatible with the processing of proteins.
Concerning the encapsulation yield, the results obtained with the liposomes suggests that
is should be the most eﬃcient method. This technique is compatible with the process of
proteins, and meets the requirements of encapsulation yield.
1The thickness of the membrane depends on the molecular weight of the chains [174].
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Conclusion
Light-sensitive polymersomes are a potential candidate for the release of fragile molecules
in a cell culture medium. However, the characteristic release time of the reported systems
is in the timescale of 10 minutes, which is slow. One system shows fast openings of pore
(100ms), but this event was not predictable and occurred randomly within the 5 minutes of
irradiation. This makes the polymersomes to respond slowly on average,
Finally, it should not be surprising to observe a slow release rate from polymersomes,
because their membrane is more stable than the one of liposomes. They are probably not
the good choice for our application, due to the kinetics of release.
4.3. Capsules made of solid polymers
4.3.1. Polystyrene capsules
Commercial polystyrene-acrylic based capsules have been loaded with carbachol (a small
hydrophilic molecule) or ﬂuorescein, by swelling the dry particles with a mixture of
propanol/chloroform/ammonia containing the molecule of interest. These capsules were
manipulated using optical tweezers, allowing to position them precisely in a culture medium.
They are broken with a high-power laser pulse (337 nm, 1 ns, 0.25 µJ) centered on the 1 µm
sized capsule. The release of the entrapped molecules occurs almost instantly: ﬂuorescein
escapes the capsule in the timescale in the timescale of 100ms. Cell experiments have also
been conducted with this system: carbachol released near a CHO cell was responsible for
the increase of calcium concentration inside the cell [45]. The mechanism underlying the
capsule rupture is not known yet, but may include light pressure, plasma generation of
photolysis [193].
Concerning the usefulness of these systems to protein release, it seems somehow com-
promised. Loading these objects in the propanol/chloroform/ammonia mixture will surely
lead to the protein denaturation.
4.3.2. Capsules made by the reverse emulsion technique
Synthesis conditions and encapsulation eﬀiciency
To obtain capsules with an aqueous core, the synthesis relies on creating a highly insoluble
polymer shell around drops in an inverse emulsion (see ﬁgure 4.17). The aqueous phase
dispersed in the oil phase contains the molecule of interest and one reactant, which alleviate
the loading step. The oil contains a second one of the reactant, leading to the formation of the
polymer shell upon contact between the two phases – e.g. by polyaddition. The choice of the
oil is crucial: the synthesized polymer must not be soluble in it, but the monomeric reactant
has to be well dispersed in it. Depending of the conditions, in particular the concentration
of both reactants, capsules or particles can be obtained with this procedure [194].
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Oil phase
Aqueous phase
(A) (C)
Figure 4.17. Preparation of polymer capsules with an aqueous core by the reverse emulsion method. (A): the
aqueous phase, containing the molecule to encapsulate (the orange stars) and a reactant (the red
rectangles) is made to contact of the oil phase, containing a stabilizer (the purple circle with a tail)
and another reactant (the green rectangles). (B): the system in (A) is emulsiﬁed to give (B), where
the water phase is dispersed in the oil phase. (C): the reactant in the oil phase reacts with the one in
the aqueous phase at the water/oil interface, to give a polymer shell.
A mild method used to disperse water phase in oil phase is based on a nano-emulsion
technique. Ultrasounds [194] or phase inversion temperature processes [195] are also
reported. In all cases, emulsion breaking is prevented by adding non-ionic surfactants in the
oil phase. The use of block copolymers leads to capsules in the range of 100 nm [196–198].
A typical system reported in the literature is based on the interfacial polyaddition between
an oil-soluble diisocyanate and a water soluble diol or diamine, leading respectively to
polycarbamates or polyureas. The reactivity of amines is high enough to perform the
reaction at room temperature – low reactivity of alcools requires heating to 60℃ [194, 199].
Once they have been synthesized in the continuous oil phase, the capsules must be
transfered into water. Several methods of transfer from the oil to water are reported in
the literature, and rely on the volatility of the oil (cyclohexane, hexane). The suspension
of capsules in the oil is basically re-emulsiﬁed in an excess of water. The oil is removed
by heating the suspension [196], or at room-temperature under stirring [200] or in an
ultrasonic bath [197]. One example of oil removal by freeze-drying has been reported.
This attempt was unsuccessful though, as the dried capsules stuck irreversibly, leading to
aggregates in dispersed in the aqueous medium [194].
The encapsulation yield has been characterized using a ﬂuorescent dye (sulforhodamine
101). A value of 90 % is reported [199].
This synthesis procedure is somehow versatile, as it can be “reversed” to produce oil-
containing capsules suspended in water [201], or even capsules ﬁlled with a mixture of
non-aqueous polar liquids suspended in an oil [202]. Various “monomers” have been
reported to build the capsules. They range from simple C₆ diols [194] to polyols like
glycerol [197] or even biosourced polymers like starch [196, 203], dextran [194, 197] or
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lignin [204]. Simple C₆ diamines, arginine [194], diethylenetriamine [197] can be added to
this list. Finally, proteins like albumin [205], are also reported to be crosslinkable at the
oil/water interface to form robust membranes of polymeric capsules.
Light-sensitive systems
Figure 4.18. Light and temperature sensitive polymer, from which nanocapsules have been built. From refer-
ence [200].
Figure 4.19. Reprinted from reference [200]. Release of sulforhodamine 101 from azo-capsules (Azo-D) and
hexane diol based ones (HDol-D), under continuous UV light irradiation. No release is expected
from hexane-diol based capsules, because they are not light-sensitive.
Photo-cleavable diazo moieties (see ﬁgure 4.18) has been used to build 200–400 nm sized
capsules [200]. The release is claimed to be triggered either by pH, temperature or light
stimulation; all these stimuli lysed the azo bonds, ultimately leading to the destruction of
the capsule. Entrapped sulforhodamine 101 is released in the timescale of the hours and
requires UV irradiation (Hg lamp, unﬁltered, unknown power), see ﬁgure 4.19. pH and
temperature did not perform better. The slow kinetics of release is attributed to the slow
decomposition of the azo molecule.
In reference [198], the lysis of a polyester membrane is triggered by UV irradiation
and light, as shown on ﬁgure 4.20. No speciﬁc light-sensitizer is required. However,
the conditions required to break the capsule are harsh: one hour at 80℃ and under UV
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Figure 4.20. Temperature and light induced degradation of a polyester-based polymer. From reference [198].
irradiation was required to release the entrapped sulforhodamine 101. No precisions on the
kinetics of release were given.
Discussion
Little is known yet about the compatibility of such an encapsulation method with fragile
proteins. As the capsules are synthesized around the aqueous phase containing the molecule
of interest, high encapsulation yields are expected as it was the case for liposomes prepared
by the reverse emulsion method. Only one evaluation of the encapsulation yield has been
performed though [199]. Values ranging from 80 to 96 % are reported for the encapsulation
of sulforhodamine 101 in polyurethane capsules. At this point, similar values should be
expected for proteins.
Various preparation conditions are reported, which should allow to optimize a procedure
that avoid harsh processing conditions for proteins. All are based on a reverse emulsion
synthesis, which should prevent any contact between the protein and the oil phase, thus
avoiding solvent-based denaturation. A surfactant is used to stabilize the reverse emul-
sions; non-ionic low-HLB ones are generally used, recognized as compatible with the
preservation of the protein activity. The emulsiﬁcation is mostly done using high-intensity
ultrasounds, which may aﬀect the proteins. However, PIT emulsiﬁcation, which relies only
on a temperature-based phase inversion, are also reported. Well-chosen surfactants can
prevent from crossing the limit of 37℃, thus alleviate or minimize protein denaturation.
A broad range of capsule size is accessible, and depends on the size of the emulsion. The
typical capsule size is 200 nm.
Concerning the synthesis itself, it can be conducted at room temperature. In a majority
of the cases reported, a primary amine reacts with the oil soluble monomer (a diisocyanate).
One should therefore pay attention to reactivity of the encapsulated protein itself, as it
also bears primary amine functions. This has even been exploited to build capsules from
BSA. Protein competes however with organic amines added to the aqueous phase; 24 hours
at 25℃ are required to synthesize the capsules from BSA [205], while 3 hours at 25℃ are
suﬃcient for diamine based ones [206].
Concerning the light-sensitivity of these systems, only a few examples are reported,
badly characterized and requiring long-lasting deep UV irradiation, one even combined
to 80℃ heating. This is redhibitory for any protein application. Yet, no speciﬁc eﬀorts
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have been made to introduce light-sensitive moieties in the membrane of these capsules.
The versatility of the synthesis procedure gives a lot of space for developing eﬃcient
light-sensitive capsules.
4.4. Hybrid membranes
We describe here some “exotic” light-sensitive systems which somehow mixed the principle
of building a polymer capsule around an aqueous core with another basic architecture,
such as a hydrogel or temperature-sensitive assemblies. They are all reported in this short
section, as only a couple of examples are reported in the literature for each of them.
4.4.1. Hydrogel capsules
An hybrid system, composed of a hydrogel capsule around a liquid core, is reported in
reference [158]. The synthesis procedure also diﬀers from the other systems: the capsules
are obtained from poly(N -vinylformamide) particles by a sequence of hydrolysis and
crosslinking, using sodium hydroxide and glutaraldehyde in methanol. This lead to ≈ 2 µm
sized capsules with a 300 nm thick shell. The capsules were found to be permeable to
ﬂuorescein and dextran, up to 250 kg/mol. Loaded by diﬀusion, the capsules are made
impermeable to dextrans down to 2 kg/mol with hyaluronic acid. Sensitized with gold
nanoparticles, the capsules are completely destroyed by pulsed laser irradiations (532 nm,
50mJ/cm²). However, no characterization of the release kinetics has been performed.
4.4.2. Nanoparticles bridged by organic polymers
The system reported in reference [207] is made of gold squares assembled in boxes, as
shown on ﬁgure 4.21. Box faces are kept together with polyNIPAM chains. When the
chains are swollen, the box is tight, but increasing the temperature make the chains collapse
and the particle release its content. The LCST of polyNIPAM has been tuned to 39℃, to
match the biological conditions. Several molecules have been encapsulated in these boxes
(doxycycline, lysozyme and alizarin-labelled PEG), simply by stirring a suspension of the
boxes in their leaky state and the molecule to encapsulate. The release was triggered by
infra-red irradiation (10–40mW/cm²) for 2 minutes, and occurred in the timescale of 2–4
minutes.
In reference [208] are reported 1 µm capsules made from the assembly of 20 nm spherical
particles. These particles were functionalized with a cinnamic acid derivate: a light irradia-
tion allowed to cross-link the particles by dimerization of the cinnamate (see ﬁgure 4.22).
These capsules are synthesized in a water/oil/water emulsion: the nanoparticles are sus-
pended in the oil sheet (toluene) and the inner aqueous drop contained the encapsulated
materiel (here cyclodextrines). UV irradiation leads to the crosslinking of the nanoparticles,
giving a mechanically resistant capsule. This step was followed by the removal of the
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Laser off
Laser on
Figure 4.21. Cubic boxes made of self-assembled gold faces, kept together with polyNIPAM chains (black lines).
The box is tight while the chains are swollen, and made leaky when they are collapsed. Reprinted
from [207].
Figure 4.22. Light-induced cinnamic acid derivative 2+2 cycloaddition.
toluene to yield a suspension of functional capsules. The release of the entrapped cyclodex-
trines occurred upon UV light irradiation (254 nm, unknown power). The kinetics of release
are unknown.
A similar system reported in reference [209], in which the capsules are made of gold
nanoparticles cross-linked by semi-ﬂuorinated PEG chains. At room temperature the 80 nm
sized obtained capsules are tight, but elevating the temperature to 62.5℃ or irradiating the
suspension with a green laser (532 nm, 250mW) make them leaky, which allowed to load
them with rhodamine B. With the green laser, the release of the encapsulated dye occurs in
the timescale of one minute.
4.5. Role of the stimulation wavelength
One major point has not yet been discussed, as it is common to all systems, and concerns the
stimulus itself. Three main parameters are relevant here: the wavelength of light irradiation,
its surface power and the duration of the stimulation.
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Various wavelengths are used to trigger the release from the light-sensitive systems
shown in this review, ranging from infra-red to deep ultraviolet. From a practical point
of view, infra-reds are preferred, as they are less scattered and can penetrate the tissues
deeper than lower wavelengths [210]. Anyway, this practical limitation is only relevant
for in vivo applications or for the study of thick samples. From another point of view,
high-energy photos can be harmful for the cell, the surrounding tissues and even the
encapsulated molecule of interest. 250 nm UV can be absorbed by virtually any organic
material, leading to its destruction. It is in fact one of the mechanism of rupture alleviated for
the polystyrene capsules. As it is not speciﬁc to the capsule, it can lead to the destruction of
the collagen gel and the encapsulated material. UV, in particular the UV-B (315–280 nm) and
the UV-C (280–160 nm), are known to cause oxidative damages to collagen network [211].
Cells behavior is also aﬀected by UV light, and the results ranges from a modiﬁcation
of its metabolism to its death, depending of the light intensity [212]. Concerning the
encapsulated material, UV in the 298–250 nm range is known to break disulﬁde bonds,
which results in protein denaturation [213], and has even been used as a method to break
disulﬁde-crosslinked hydrogels, as shown before. Therefore, visible or infra-red light must
be the preferred stimulus for our system. Three trails can be followed: tune the light
sensitive moieties to make them visible or infra-red absorbing, use two-photon stimulation
or use up-converting particles to generated UV from visible light in situ. The relevance of
using up-converting particles in contact with biological systems is discussed, as they are
made of toxic materials [52].
The harmfulness of the light-stimulation comes also from its intensity. The threshold
above which damages occur are wavelength dependent [214]. We need also to keep in mind
that the femtosecond lasers used for non-speciﬁc triggered release purposes have also been
used to disrupt organelles directly inside the cells [215]. In that case, a precise space control
is required to prevent any cell damage. Thresholds of 0.47 J/cm² for blue light (457 nm) and
1,900 J/cm² for IR (810 nm) are reported for epithelial cells [216].
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Several systems in the literature appear as promising to address the question of a fast and
localized protein delivery. All the systems used to release proteins or macromolecules
are summarized in tables on page 70. If we focus on fast-releasing systems not triggered
by UV light, several candidates arise. The polymer-sensitized liposomes are of interest,
even if the release time is 30 minutes. In fact, the slow kinetics is linked to the size of the
vesicle. The estimated characteristic release time of a 50 kg/mol protein from 10 µm sized
vesicles is 133 s, while it decreases to 8ms for a 200 nm sized one (see appendix C.4.2, p. 201).
The dye-sensitized liposomes are also of interest, thanks to the instant release and visible
light stimulation; the high energy required may be a problem, as the dye itself, due to its
potential cell toxicity. As for nanogels, no candidates arise. The fastest system reported has
a 20 s characteristic time; faster systems can probably obtained by building looser gels, at
the expense of a spontaneous protein release. The most promising systems are probably
the capsules, as they combine the advantages of both the liposomes and the nanogels. By
the reverse emulsion process, the protein can be encapsulated in an aqueous core, under
physiological conditions, with a high encapsulation yield. Only two light-sensitive systems
made by this technique are reported. They do not seem to have been developed for fast
and/or eﬃcient light-triggered release: hard and long-lasting UV irradiations are required.
The performances of the two other kinds of capsules, the polymersomes and the layer-
by-layer assemblies, suggest that there is a possibility to develop eﬃcient light-sensitive
capsules by this technique.
To conclude, two systems seem worth to be investigated: the liposome-based delivery
systems and the photo-breakable polymer capsules. Both have been studied during this
thesis and are developed in the next chapters.
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Introduction
This chapter addresses the question of liposome photobreakage, with a focus put on the
achievement of fast (< 1 s) response-times to irradiation; this is required to enable a local
delivery of the entrapped molecules. Systems that absorb light strongly are certainly fast
(cf. chapter 2). However, as they rely on a local heating to break the liposomes, they are not
compatible with applications in thick hydrogels used for cell-culture: the energy will be
dissipated throughout the whole cell culture medium and may cause structural damages to
it. From the bibliography, we identiﬁed photochrome-containing liposomes as promising
capsules. In fact, the release does not rely on a local increase of temperature and were
seemingly sensitive to exposure to light at low irradiance and low total power (< 10min
at ∼mW/cm²), diminishing the risk of increasing the temperature of the sample. Yet the
possibility to design fast-responsive photoliposomes and the optimization of their rate of
response to stimulation were generally not investigated.
Here we report experimental assessments of the rate of liposome breakage or permeabi-
lization in the presence of two models of photoisomerizable chromophores: an azobenzene-
containing surfactant (azoTAB) and amphiphilic macromolecules grafted with azobenzene
(150-15C8-10Azo). Both model photochromes bind to lipid bilayers and can break or per-
meabilize the membrane depending on their degree of photo-isomerization. The surfactant
is representative of systems that were reported for releasing small molecules in less than
100 s upon shining UV or blue light [72, 75, 79, 80]. The polymer comes from systems
launched in our team by F. Vial and S. Sebai [97, 217] and is a simple tool that adsorbs tightly
photochrome groups on lipid membranes, which in practice may alleviate toxicity issues
due to exchanges of surfactants or small azo-containing lipids with cell membranes [97].
Important results published on photochrome-containing liposomes suggested however that
the perturbation of the bilayer was rather weak, and essentially ascribed to shifts of lipid
phase transition, or local scrambling of the lipid order. No evidence for membrane breakage
or poration were shown. When this thesis was launched, it was accordingly decided to
experimentally assess the possibility to optimize liposome composition for on-demand
protein release, which needs either to form photo-breakable or photo-porable systems.
These systems should in addition be compatible with fast leakage. The ﬁrst section reports
the study by light scattering of “liposome to micelle” transitions in mixed lipid:azoTAB
solutions. The second part reports on polymer-coated small liposomes permeabilization
studied by light-scattering, and calcein leakage experiments.
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Introduction
In the presence of an excess of surfactant, liposomes may dissolve into mixed micelles of
nanometer size. The process has been extensively investigated, e.g. with Triton X-100. It can
be fast, but the details on the intermediate pathways involved in the lipid-bilayer dissolution-
mechanisms are still discussed [218]. A generally accepted scheme is summarized in
ﬁgure 5.1.
I
II
II′
III′
III IV
+
IV′
Figure 5.1. Adapted from reference [218]. I: detergent monomers inserted in the vesicle outer monolayer. II:
detergent equilibrates between the inner and the outer monolayer through rapid ﬂip-ﬂop. III: pores
are formed in the bilayer. IV: Lipid-detergent mixed micelles are formed. When rapid ﬂip-ﬂop is
not possible, then an alternative pathway occurs. II′: insertion of multiple curvophilic detergent
molecules cause a large increase in the curvature of the outer bilayer. III′: lipid-detergent mixed
micelles are shed from the bilayer, and this process leads to IV′: detergent trans-bilayer movements.
The system can then undergo processes III and IV.
Irrespective of the main pathway(s), the formation of pores is involved at the stage of
liposome “opening” (III) and formation of prolate or oblate mixed micelles. Liposome
dissolution is thus expected to indicate compositions and environment conditions (pH,
temperature, ionic strength, etc.) close to conditions of poration. As a rule of thumb, it is
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generally admitted that a critical lipid:surfactant ratio must be reached to make the bilayer
fragile and to enable the formation of pores. Experimentally, the ratio of lipid to total
surfactant is controlled, and the partition of surfactants between the aqueous phase and
the lipid one modulates the position of the systems above or below this critical ratio. Based
on this premises, it is expected that upon switching the polarity of azoTAB by shining light,
one should control the stability of lipid:azoTAB mixed assemblies.
Figure 5.2. Theazobenzene-based surfactant, referred to as azoTAB. Likemany azobenzene-containingmolecules,
azoTAB is isomerized with a speciﬁc wavelength.
Under UV light, the azobenzene is in a predominantly cis – polar – conﬁguration, which
means that the surfactant is more soluble in water. This should diminish or minimize the
perturbation of the membrane. Under visible light, the azobenzene shifts to its trans isomer
form, lowering at the same time its solubility in water, which makes it more prone to bind to
the membrane. The structure of the surfactant we used is shown in ﬁgure 5.2. AzoTAB was
straightforward to synthesize at the laboratory and its physico-chemical properties were
well characterized [219, 220]. Its molecular weight is 434 g/mol (with bromide counter-ion),
its CMC in water is below 0.8 g/L for the trans isomer and equal to 1.6 g/L for the cis
isomer. The micelle radius was measured by DLS: < 3.5 nm, and by SAXS: 2.7 nm outer
radius, aggregation number of 60 [220]. One advantage of azoTAB is its long characteristic
thermal relaxation time from the cis to the trans isomer, which takes about two days at
20℃ (see ﬁgure 5.3). When measurements – conducted in the dark – are short compared
to the relaxation time of the cis isomer, one can in practice neglect the variations of the
cis-isomer fraction. This enables to perform experiments without irradiating the samples
continuously, thus minimizing the amount of light shone on samples. Finally, the extinction
coeﬃcient of azoTAB (ca. 58 L/g/cm at 350 nm) enables to reach the photostationary state
of predominantly cis isomer in solutions up to 1 g/L using UV LED lamps at an irradiance
below 3mW/cm². It was determined that 84 % cis isomers and 16% residual trans ones
equilibrate upon shining 365 nm UV light (by ¹H NMR, ref. [219]).
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Figure 5.3. Left: trans and cis isomer of the azoTAB surfactant in water, at 9.2mg/L. The attenuation coeﬃcient
of trans azoTAB at 353 nm is 58.6 L/g/cm.
Right: thermal relaxation of azoTAB (34mg/L) in water, followed by the absorbance of the solution
at 350–370 nm. The characteristic time of relaxation (2,700min) has been inferred from the initial
absorbance (0.16), the measured all-trans absorbance (2.0) and the initial slope of the curve (see
appendix C.3.2 Measurement of azoTAB relaxation time by UV-Visible spectroscopy, p. 197).
5.1. Liposome solubilization by the azoTAB surfactant
5.1.1. Determination of azoTAB:lipid critical ratio
To determine the surfactant concentration required to dissolve the liposomes into mixed
micelles, we mixed DOPC lipid and azoTAB and measured by dynamic light scattering the
hydrodynamic diameter and scattered intensities of these samples. As lipid vesicles are
non-equilibrium assemblies, whose diameter strongly depends on production procedures,
the inﬂuence of the preparation of stock solutions was assessed. To this aim, lipid and
azoTAB were mixed in aqueous solutions using two diﬀerent protocols: at low (< 0.1 g/L) or
higher (> 1 g/L) lipid concentrations, with or without sonication, with azoTAB added before
or after the formation of lipid vesicles.
In the ﬁrst protocol, a suspension of 200 nm DOPC liposomes was prepared by the ﬁlm
hydration method in deionized water and extrusion. Aggregates of lipids were removed by
centrifugation (10minutes at 14,000 g) to yield small vesicles at approximatively 1 g/L lipids
(2.06mmol/L). Aliquots of DOPC vesicles were mixed with azoTAB solutions and incubated
at room temperature (detailed protocol reported in appendix E.2.2 “Low lipid concentration”
protocol, p. 210).
The second protocol consisted in the hydration for 30min of a dry ﬁlm of DOPC prepared
as above, with a 20 g/L solution of azoTAB in deionized water, then sonicated the mixture
and let the solution rest for 24 h at room temperature. A more detailed description of the
experimental conditions is given in appendix E.2.2 “High lipid concentration” protocol, p. 210.
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When the mixtures were prepared with trans azoTAB, and after 24 h incubation, both
the intensity of scattered light and the hydrodynamic diameter suggested the presence
of liposomes until the azoTAB:lipid ratio increased above a threshold value. Liposomes
prepared by the ﬁrst protocol dissolved into small, presumably micellar, objects above
azoTAB:lipid ratios between 6 and 8. In the more concentrated solutions prepared by the
second protocol, the signal from liposomes essentially vanished above a ratio of 5.5 (see
table 5.1). This ratio is similar to the usual dissolution ratios measured with conventional
surfactant:lipid mixtures [221–223]. In addition, it was not aﬀected by dilution of the stock
solutions into PBS buﬀer (not shown). The smaller diameter of liposomes prepared at higher
concentrations are not surprising due to the sonication step that usually form small vesicles
(< 50 nm diameter).
The initial radii and intensities measured within a few minutes after preparation of dilute
mixtures (by extrusion and post-addition of azoTAB) indicated however that at short times
vesicles were present in the whole experimental window of compositions. The dissolution
of liposomes by azoTAB added in the outer aqueous phase was clearly evolving during
incubation. This contrasts with the eﬀect of Triton X-100, able to dissociate the liposomes
within the time needed for mixing and DLS measurements.
CazoTAB (g/L) 0.00 0.17 0.34 0.50 0.67 0.84 1.68 3.36
Idiﬀ (kcps)
0 h 21 15 17 22 19 18 18 15
24h 22 14 21 16 3.0 1.4 2.7 3.0
Δ (%) +6 −3 +21 −25 −84 −92 −85 −79
Dh (nm)
0h 525 443 418 419 375 408 388 401
24h 468 462 413 312 79 no ﬁt no ﬁt no ﬁt
Δ (%) -11 +4 −1 −26 −79
Table 5.1. Hydrodynamic diameter (Dh) and intensity of scattered light (Idiﬀ, in kilo counts per seconds) of
mixtures of trans-azoTAB and vesicles (DOPC, 0.1 g/L), after preparation and 24 hours later. no ﬁt
indicates that correlograms were too noisy to enable the determination of Dh, indicating the absence
of detectable liposomes.
azoTAB:DOPC w. ratio 2.4 3.6 4.8 6.0 10.0
20 g/L azoTAB
Idiﬀ (kcps) 288 156 113 60 44
Dh (nm) 150 30 no ﬁt 2 2
PBS diluted
Idiﬀ (kcps) 95 12 9.5 7 8.2
Dh (nm) 75 11 9 5 no ﬁt
Table 5.2. Scattered light intensity (Idiﬀ) and hydrodynamic diameter (Dh) of azoTAB/DOPC mixtures after 24
hours of incubation. The results are shown for the “raw” mixtures (20 g/L azoTAB), and after dilution
in PBS (0.8 g/L azoTAB).
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When mixtures were prepared with predominantly cis azoTAB, the results were similarly
that at short time liposomes were always detected, whereas at time 24 h samples with
high a azoTAB:lipid ratio contained micelles. Liposomes were dissolved into small micelles
(Dh < 3 nm) above a critical cis-azoTAB:lipid w. ratio of about 16.
CazoTAB (g/L) 0.00 0.17 0.34 0.50 0.67 0.84 1.68 3.36
Idiﬀ (kcps)
0 h 21 24 25 26 26 27 35 24
24h 22 20 25 29 30 18 6.1 3.2
Δ (%) +6 −16 0 +11 +16 −34 −83 −87
Dh (nm)
0h 525 477 476 446 430 387 363 348
24h 468 438 408 369 349 295 no ﬁt no ﬁt
Δ (%) −11 −8 −14 −17 −19 −24
Table 5.3. Hydrodynamic diameter (Dh) and intensity of scattered light (Idiﬀ, in kilo counts per seconds) of
mixtures of cis-azoTAB and vesicles (DOPC, 0.1 g/L), after preparation and 24 hours later. no ﬁt
indicates that correlograms were too noisy to enable the determination of Dh, indicating the absence
of detectable liposomes.
It is observed for the trans isomers that the liposome dissolution upon post-addition of
the surfactant (ﬁrst protocol) occurs at a total azoTAB concentration close to the CMC.
Dissolution similarly occurs near the CMC of the cis azoTAB in the dilute lipid solution
(0.1 g/L, see table 5.3). CMC has been reported to be of the order of magnitude of the associ-
ation constant of surfactant near the saturation of lipid membranes. It is thus predictive of
liposome breakage essentially when the lipid concentration is well below CMC – i.e. when
binding of surfactants in the liposomes negligibly aﬀects the concentration of surfactant in
the aqueous phase.
5.1.2. Kinetics of dissolution
To estimate the characteristic time of light-triggered dissolution of liposomes, we choose
from table 5.3 the samples still containing liposomes in the presence of cis azoTAB at time
24 h. We describe ﬁrst the case of post-addition of azoTAB in preformed liposomes. Just after
addition of azoTAB (under its predominantly cis form), samples were irradiated with blue
light (470 nm, 1mW/cm²). These experiments were conducted at various concentrations
of azoTAB: 0.340 g/L, 0.503 g/L and 1.26 g/L. Immediately after shinning blue light, the
intensity of scattered light was recorded every 5 minutes for 14 hours. Details of the
experimental procedure are described in appendix E.2.2 Determination of azoTAB-mediated
liposome dissolution kinetics, p. 211.
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Figure 5.4. Dissolution of liposomes with azoTAB in water (no NaCl, no buﬀer) under blue light irradiation
(470 nm, 92mW/cm²), followed by dynamic light scattering. The initial suspension contained 0.06 g/L
DOPC and either 0.340, 0.503 or 1.26 g/L cis-azoTAB.
Thehydrodynamic diameter and the intensity of scattered light are shown in ﬁgure 5.4. For
the highest concentration of surfactant, both the diameter and scattered intensity decreased
regularly starting immediately. Diameters lower than 5 nm were reached beyond 20,000 s
(5.5 h). Tentative ﬁt of the intensity decay by an exponential decay yielded the relaxation
time of 4,700 s (1.5 h); this time gives us an order of magnitude of the characteristic time of
liposome dissolution. Obviously, membrane dissolution is hours-long, irrespective of the
details of the mechanism and/or model that may be used to analyze this data.
As regard to lower azoTAB concentrations, exposure to blue light triggered hours-long
slow increases of the scattered light intensity. The amplitude of increase was however below
30 %, suggesting that the variation of the shape or size of assemblies were small. A possible
interpretation is that this increasing intensity, with essentially unchanged diameter, can be
attributed to the adsorption of the surfactant in bilayers, as reported in reference [218].
5.1.3. Eﬀect of salt on the dissolution kinetics
The slow kinetics may be due to electrostatic repulsion between the surfactant molecules.
In order to evaluate the role of coulomb repulsion in the rate of reorganization of mixed
lipid:azoTAB solutions, the same experiments were conducted in buﬀers with added NaCl.
In pure water, the ionic strength is dictated by the surfactant. At 1.26 g/L (2.9mmol/L),
the associated Debye length is 5.6 nm. The typical area per molecule in azoTAB-related
CTAB micelles is 0.536 nm² [224], which corresponds roughly to 0.7 nm between two
surfactant molecules in the micelles. As it is much lower than the Debye length, this
can explain a signiﬁcant contribution of coulomb repulsion to kinetics of adsorption of
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azoTAB in liposomes. Adding 150mmol/L NaCl – which in addition brings the experimental
conditions closer to biocompatible osmolarities – reduces the Debye length to 0.77 nm. If
the electrostatic repulsion in the aqueous medium is responsible for the slow kinetics, the
presence of salt should signiﬁcantly accelerate these kinetics.
The following modiﬁcations were made to the previous protocol. The initial liposome
suspension was prepared by hydrating the ﬁlm with an aqueous solution of sodium chloride
at 150mmol/L, and extrusion. AzoTAB in 150mM sodium chloride was mixed to an aliquot
of liposome solution to reach 0.06 g/L lipids, and either 0.340, 0.503 or 1.26 g/L of cis azoTAB
in 150mmol/L sodium chloride.
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Figure 5.5. Dissolution of liposomes with azoTAB under blue light irradiation (470 nm, 92mW/cm²) in presence
of salt, followed by dynamic light scattering. The initial suspension contained 0.06 g/L DOPC,
150mmol/L sodium chloride and either 0.340, 0.503 or 1.26 g/L cis azoTAB.
The kinetics of dissolution in 150mM NaCl solutions (ﬁgure 5.5) were similar to the ones
obtained without salt. At 1.36 g/L azoTAB, the scattered intensity decayed gradually during
about 20,000 s, with an associated characteristic time of 5,300 s (1.5 h) from the ﬁt to a
monoexponential decay. A visibly slower initial decay of the decrease of the hydrodynamic
diameter, during about 8,000 s, is the major diﬀerence with the kinetics recorded with no
NaCl. At low azoTAB concentrations, the hydrodynamic diameter did not signiﬁcantly
vary, while one observed an increase of the intensity. Adding salt did not accelerate the
dissolution. This clearly rules out the hypothesis of a limiting rate due to coulombic
repulsions in the surfactant-containing liposomes.
Only a few references on the kinetics of liposome dissolution by surfactants are available
in the literature. From these references, it can be concluded that non-ionic surfactants [221,
222] dissolve liposomes faster than their ionic counterparts [223, 225]. Authors suggest that
one rate-limiting stage is the translocation of the surfactant through the bilayer, which is
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essential because the surfactant is generally added on preformed liposomes and is initially
adsorbed in the outer leaﬂet. The origin of the slow kinetics may be worth to study using
the “trick” of the photoswitchable dissolution as we showed here. These investigations goes
however beyond the scope of designing biocompatible capsules, which is in practice strictly
constrained by the ﬁxed pH, ionic strength and temperature of the biocompatible ﬂuids.
5.1.4. Investigating the light-sensitivity of azoTAB:DOPC mixtures
We restricted here the study to preliminary trials, seeking to conﬁrm the importance of
the presence of azoTAB in the internal and/or external compartments of liposomes, and
to estimate whether fast responses may be achieved in these conditions. To this aim, we
measured by DLS the eﬀect of exposure to light on liposomes prepared by the second
protocol, based on sonicated mixtures of azoTAB and lipids. These stock solutions were
diluted 25 fold, to reach 0.8 g/L azoTAB in PBS 1×.
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Figure 5.6. AzoTAB:DOPC mixtures, at 20 g/L azoTAB, submitted alternatively to UV light (365 nm, 35mW/cm²)
and blue light (470 nm, 92mW/cm²). The intensity of scattered light was recorded as a function of
time.
When mixed liposomes were present in the stock solution (azoTAB:lipid w. ratio below 5),
the absence of variations in the diameter and the decrease of scattered light intensity upon
UV-light irradiation indicates that cis azoTAB presumably desorbs from the membranes
(see ﬁgure 5.6). This variation occurred in a few seconds, which is the typical time needed
for trans to cis photoisomerization exposed to irradiances above 1mW/cm². Unfortunately,
the quantiﬁcation of the photoconversion rate was hampered by geometrical constraints
in the DLS measurement apparatus. Due to the high OD of the solution and variability
of the distance between the light source and the sampled volume in the DLS vials, only
an order of magnitude of 10 s can be estimated. The amplitudes of the scattered intensity
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Figure 5.7. Light scattering from solutions of azoTAB:DOPC (10:1 g/g) in PBS exposed to UV light at time zero.
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Figure 5.8. Light scattering from solutions of 0.4 g/L azoTAB:DOPC in PBS exposed to UV light at time zero.
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variations (≈ 20–30 %) are of the same order of magnitude as the slow hours-long increases
observed upon exposure to blue light of liposomes supplemented with surfactants in their
outer leaﬂet. The reversibility of variations suggests that neither signiﬁcant breakage, nor
liposome reorganization, has occurred, and that equilibrium with the azoTAB was quickly
reached in these conditions.
When the preparation procedure yielded mixed micelles of azoTAB:lipid – i.e. at azoTAB:
lipid ratios higher than 5 g/g – the solutions exposed to UV light showed much lower
scattered intensity. Yet the sensitivity to UV-vis irradiation, the responses in the timescale
of the second and the reversibility were preserved at irradiation times below 1min. Results
are shown in ﬁgure 5.6. An UV irradiation for typically longer times than 3 minutes was
needed to trigger a marked increase of scattering accompanied by the formation of objects
with diameters above 30 nm. At azoTAB concentrations lower than 0.8 g/L, and irrespective
of the azoTAB:lipid ratio, a long exposure under UV light (10mW/cm² on the top layer
of the sample) triggered an irreversible transition to slow formation of > 30 nm scattering
species accompanied by increasing scattered intensity after a lag time of about 3 minutes.
At higher concentrations, no eﬀect of light could be detected (see ﬁgures 5.7 and 5.8). Cis
isomerization presumably destabilized micelles, inducing formation of lipid aggregates.
Control experiments included:
• the stability of scattering, and absence of large objects, in solutions diluted 12 fold
(i.e. at azoTAB 1.6 g/L) and
• the stability of scattering and preservation of small (< 3 nm) micelles in the absence
of lipid in solutions of azoTAB.
Further investigations of these responses are going on, but were not completed during the
time of this thesis.
It is concluded that mixed DOPC:azoTAB assemblies can reorganize rapidly over second
to minute timescales, upon trans to cis isomerisation of the surfactant in dilute conditions.
When the surfactant is initially evenly distributed among the lipids (e.g. present in both
leaﬂets of vesicles, or in mixed micelles) the formation of cis isomers apparently decreases
the molecular weight of assemblies, conﬁrming the poorer aﬃnity for lipids of the cis
compared to the trans isomer.
5.1.5. Dissolution of liposomes from encapsulated azoTAB
Cutting the presence of azoTAB in the outer compartment/leaﬂet has a major practical
advantage. Upon dilution of liposomes, any azoTAB molecule present outside the liposomes
can desorb and be lost (e.g. by dialysis) and may be toxic to cell cultures. It was thus of
interest to assess the possible photosensitivity of liposome-encapsulated surfactants. To
this aim, lipid ﬁlms were hydrated with a cis azoTAB solution in PBS, to yield suspensions
containing 1 g/L lipid and either 1.0, 1.5, 2.0 or 5.0 g/L of cis azoTAB. When liposomes
84
5.1. Liposome solubilization by the azoTAB surfactant
CazoTAB (g/L) 1.0 1.5 2.0 5.0
Dh (nm) 251 183 98 21
Disp. 0.36 0.24 0.32 0.25
Intensity (kcps) 92.5 63.4 9.2 3
Table 5.4. Hydrodynamic diameter (Dh), polydispersity (Disp.) and intensity of scattered light of lipids:cis-
azoTAB samples. DOPC concentration: 1 g/L.
were obtained, the outer azoTAB was removed by gel ﬁltration. Samples in the dark were
characterized by DLS, as shown in table 5.4.
As expected from section 5.1.1, above an azoTAB:lipid w. ratio of 5:1 (ca. 9:1mol/mol),
the intensity and the diameters indicated the formation of mixed micelles. Below this
threshold ratio, stable liposomes could be manipulated. Both 1 g/L and 1.5 g/L samples
contained mixed liposomes. They were puriﬁed (to remove unbound azoTAB) by gel
permeation chromatography (fractionation ability of the gel: 4⋅10⁴–2⋅10⁷ g/mol, dextran).
The fraction with the highest concentration of liposomes was selected based on its scattered
light intensity. The evolution of the intensity of scattered light and the hydrodynamic
diameter were recorded by DLS, upon exposure to blue light (one measurement every 5
minutes for 14 hours). The detailed protocol is available in appendix E.2.2 Light-sensitivity
assessment of azoTAB-loaded liposomes, p. 211.
 140
 160
 180
 200
 220
 240
 260
 280
 300
 320
 0  10000  20000  30000  40000
H
y
d
ro
d
y
n
am
ic
 d
ia
m
et
er
 D
h
 (
n
m
)
Time (s)
1.0 g/L
1.5 g/L
 20
 25
 30
 35
 40
 45
 50
 0  10000  20000  30000  40000
S
ca

er
ed
 l
ig
h
t 
in
te
n
si
ty
 (
k
cp
s)
Time (s)
Figure 5.9. Liposomes loaded with surfactant, irradiated with blue light (470 nm, 92mW/cm²). They are made
here from a lipid ﬁlm hydrated with a solution of azoTAB at either 1.0 g/L or 1.5 g/L in water.
Under these conditions, the mass of azoTAB trapped in one liposome of diameter 200 nm
should be roughly the same as the mass of lipid. Any leakage of the surfactant should
accordingly markedly decrease the scattered intensity. The results shown in ﬁgure 5.9
85
5. Surfactant sensitized vesicles
indicate that the diameter did not vary and that no signiﬁcant evolution of the intensity
occurred. At 1 g/L or 1.5 g/L azoTAB in the sole internal compartment, dissolution of
liposomes was not phototriggerable.
Conclusion
Liposomes containing azobenzene-surfactants can be made light-responsive by adjusting
the azobenze:lipid ratio. Experimentally, light-sensitive liposomes were observed below
a weight ratio of 4–5 azoTAB per lipid, or in dilute solutions, below the CMC of the cis
azoTAB. The window of compositions was suﬃciently broad to enable robust responses,
in particular the adsorption/desorption of trans/cis azoTAB in bilayers. The breakage of
liposomes requires however stricter conditions.
When present outside the vesicle under its cis (polar) form at concentrations higher than
the CMC, the surfactant was able to dissolve highly diluted liposomes (< 0.1 g/L). However,
the hours-long kinetics observed is not compatible with the application to the fast and local
delivery. The limiting kinetic barrier has not been identiﬁed yet, and at least cannot be
managed by small variation of salt concentrations (in a range compatible with applications
in biology). The use of neutral surfactants may be an alternative to fasten the responses
We may also consider that a full dissolution is not required to achieve a controlled release.
As shown in reference [218] and on ﬁgure 5.1, holes can be opened in membranes with no
breakage of the liposomes. Assuming that the limiting steps of the breakage mechanism are
steps II′ and III′, the slow dissolution primarily depends however on translocation of the
surfactant, which should be fast in the presence of pores. A slow dissolution indicates there-
fore a slow translocation process. Failure to ﬁnd compositions showing fast micellization
clearly points to the lack of stable pores in the membranes.
Finally, a constraint with molecular surfactants is that they can rapidly diﬀuse in, and
partition between, all membranes present in the solution, including cell membranes. Toxicity
can thus be an issue. The trials to make light-sensitive liposomes after removal of azoTAB
from the outer medium was not convincing, indicating that optimization of membrane
breakage without an excess of surfactant in both leaﬂets is not an easy task. This lessens
the hope to build a functional system with azobenzene-based surfactants unless they are
not freely diﬀusing and exchanging in solution.
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Introduction
Choice of the system
This section summarizes studies of azobenzene-containing amphiphilic polymers. The per-
turbation of lipid bilayers by such macromolecules is likely to be similar to the one achieved
by small molecular surfactants. However due to the presence of multiple hydrophobic
side-chain groups on these macromolecules, they are unlikely to be removed from the
membranes by dilution – thanks to the multiple bindings of the polymer to the membrane
provided by these hydrophobic groups. Hence they can be prepared with negligible amount
of free (unbound) azobenzene-containing polymer in the solutions. This is an important
advantage for the design of robust, light-responsive lipid capsules.
In addition, polymer-coated liposomes become sensitive to light. As mentioned in chap-
ter 2, the photo-triggered release of FITC-labeled Dextran or proteins have been established
in the case of polymer-coated giant unilamellar vesicles. The compatibility of the polymer
with cell cultures has already been assessed, and no toxicity was found at the concentrations
required to permeabilize the giant liposomes [226].
Possible adjustments of these polymer-coated liposomes, for the sake of a local and fast
release, were thus worth to study. The major concerns were at the beginning of this thesis:
1. the slow (30–40 minutes long) release time from giant vesicles (5 to 30 µm diameter),
2. the absence of data on properties of small (< 300 nm) vesicles coated with azo-
polymers.
It was thought that the permeabilization time could be signiﬁcantly decreased in small
vesicles (≈ 200 nm) due to a smaller inner volume (see appendix C.4.2, p. 201).
As a model system, we studied an azobenzene-containing polymer, shown in ﬁgure 6.1.
This polymer has already been used for the permeabilization of giant vesicles in refer-
ences [97, 226]. Permeability was mainly studied by the leakage of a ﬂuorescent dye, calcein.
The section below describes these results.
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Figure 6.1. Azobenzene-containing polymer used to sensitize the liposomes. x, y and z are respectively the fraction
of acrylic acid, azobenbzene and C₈ alkyl chain in the polymer. The polymer used corresponded to
x = 0.75mol %, y = 0.10 % and z = 0.15 %, and a molecular weight of 9 kg/mol.
Permeabilization principle
Due to the presence of hydrophilic and hydrophobic moieties along the chain, the polymers
shown in ﬁgure 6.1 binds on lipid bilayers. With increasing the degree of grafting by
hydrophobic side groups, the chains can 1) stick to the membrane without signiﬁcant
perturbation, 2) scramble the lipid order, and ﬁnally 3) dissolve liposomes into mixed
micelles (cf. references [68, 227] and ref. therein). As for surfactants, the hydrophobicity of
azobenzene side-groups in the polymers can be switched by shining light: an UV irradiated
polymer will be more hydrophilic – thus less permeabilizing – than a blue irradiated one.
Due to the poly(carboxylic acid) nature of the polymer, permeabilization is also sensitive to
pH and ionic strength. With the adequate balance between the presence of octyl groups in
the polymer and the amount of azobenzene, it is thus possible to achieve a permanently
tight association with liposomes under both UV and blue irradiation, while preserving the
integrity of the membrane in the UV-adapted (predominantly cis) conditions. A switch to
the trans azobenzene isomer makes the liposomes permeable [97].
In the case of giant liposomes (GUV, made with DOPC) containing from 0.01 to 0.1
polymer:lipid w. ratio, the impermeable membranes prepared in the presence of UV-adapted
polymers turned leaky upon exposure to blue light. The average leakage time was of the
order of 30–40min, but a marked heterogeneity of the time pattern of release was observed
between isolated vesicles (see ﬁgure 6.2). The variety of observed release behaviors includes
for instance gradual leakage for several tens of minutes, as well as abrupt (faster than
1 s) transitions to an empty vesicle. It has not been possible from the investigation of
diverse GUV preparations to establish the origin of such an heterogeneity. The impact of
the average composition on the release rate was negligible at the level of the population-
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Figure 6.2. Reprinted from reference [97]. Left: Histograms representing the percentage of full pol-GUVs (dashed
columns) and DOPC control GUVs (gray column) with varying AMP:DOPC ratio, pH, and irradiation
conditions as a function of time. (a) 0.1 g/g pol-GUVs and DOPC GUVs were initially irradiated at
365 nm for 3min at pH 7. The vesicles were maintained in the dark for 60min. At t = 60min cis
pol-GUVs were brieﬂy (1min) irradiated at 436 nm. The percentage of empty vesicles was followed
over 1 h at pH 7. (b) Same conditions as (a) at pH 8.5. (c) Same conditions as (a) at a ratio of
AMP:DOPC of 0.01 g/g. (d) Same condition as (a) with 0.1 g/g pol-GUVs and DOPC GUVs irradiated
at 365 nm for 3min at pH 7 and immediately irradiated at 436 nm. The error bars represent higher
and lower values from three sets of experiments. Right: Leakage proﬁles of three isolated pol-GUVs.
(a) Sucrose leakage kinetics at pH 8.5 and 7 (full and empty squares, respectively) and FITC dextran
leakage kinetics at pH 8.5 and 7 (full and empty circles, respectively). (b) FITC-dextran leakage
proﬁle of another isolated pol-GUV at pH 7 as a function of time.
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averaged leakage time – i.e. neither the degree of azobenzene side group in the chains,
neither the polymer:lipid ratio changed the 30–40min leakage time needed in practice to
reach 40% of empty GUVs.
The purpose of this section is to assess whether leakage by induced by this polymer out
of LUV can be more robust and tunable.
6.1. Experimental conditions
6.1.1. Principle of the experiment
The kinetics of release from 200 nm vesicles was assessed by measurements of calcein
ﬂuorescence. Calcein is a commonly used ﬂuorescent dye for leakage studies [72, 76, 88,
91, 92, 217], due to its self-quenching properties. At concentrations higher than 15 µmol/L,
calcein self-quenches, which leads to a drop of ﬂuorescence down to a negligible value
compared to the ﬂuorescence of dilute solutions. The threshold concentration is typically
0.2mmol/L. At concentration below 200 µmol/L ﬂuorescence varies roughly in proportion
to concentration (see emission pattern in ﬁgure 6.3). Using an optimal (high) concentration
of calcein entrapped in liposomes, it is possible to assimilate the variation of ﬂuorescence
in suspensions to the emission of calcein being diluted upon release. This enables to follow
the release in situ.
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Figure 6.3. Fluorescence intensity of a calcein solution in water. Excitation wavelength: 495 nm, emission
wavelength: 515 nm. Reprinted from reference [228].
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6.1.2. Sample preparation
DOPC liposomes were prepared by the ﬁlm hydration method as described in appendix E.1.1,
p. 209. In the following experiments, the dry lipid ﬁlms (evaporated from a chloroform:
methanol solution) were always made of lipids mixed with the azo-polymer at 9:1 weight
ratio. Cholesterol was possibly present, and in these cases the total DOPC + cholesterol
was considered as the weight of lipids. Unless speciﬁed, the dry ﬁlm was hydrated with a
solution of 25mmol/L calcein in PBS 1× added at the ratio of 1 µL aqueous solution per 1 µg
of dry ﬁlm. Vesicles were obtained by mild shearing by pipetting, then sonication, three
cycles of freeze/thaw and 3 extrusions through a syringe ﬁlter with a pore size of 200 nm.
This process is used to avoid multilamellar objects, which may complicate the kinetics of
release.
This yields a suspension of liposomes at ca. 1 g/L, with 25mM calcein both outside and
inside the vesicles. At this step, the azobenzene-containing polymer was photoisomerized
to form cis isomers. At 25mmol/L, calcein solutions absorb signiﬁcantly the light at 365 nm.
Therefore, the vesicle suspension was deposited in a wide ﬂat-bottom glass container to
expose a thin layer (< 1mm) to irradiation.
Finally, the excess calcein present outside the liposomes was removed by gel permeation
chromatography. The fraction containing the highest amount of liposomes was collected
(identiﬁed as the one showing the highest scattering by DLS). N.B.: Prior to measurements,
the presence of calcein-loaded liposomes was evaluated. Fraction freshly collected from
gel ﬁltration were diluted in PBS buﬀer (addition of 20 µL of the puriﬁed sample to 2mL
of buﬀer), and the ﬂuorescence was recorded prior and after mixing with an excess of
Triton X-100 (20 µL of 100 g/L TX100). Samples showing a relative variation of ﬂuorescence
intensity lower than 10% upon TX100 treatment were discarded.
6.2. Interpretation of typical photo-triggered release
patterns
All the following steps were performed rapidly (within the 2 hours following the gel ﬁltration
step), in the dark or under weak ambient light, to prevent the trans isomerization of azobenzene.
In a typical experiment, the stock solution of liposomes was diluted (about 100 fold) in the
running buﬀer (1× PBS) and the ﬂuorescence of calcein was recorded (excitation at 495 nm,
emission at 515 nm) before and after exposure of the sample to blue light, and ﬁnally after sup-
plementation with TX100, a surfactant that fully dissolve the liposomes. A typical ﬂuorescence
pattern is shown in ﬁgure 6.4.
The initial ﬂuorescence intensity corresponds to solutions containing polymers in their
“predominantly cis” isomer form. It was checked that this intensity was stable for about
100–500 s in the ﬂuorimeter. The stability (absence of leakage) was also revealed by the
repeatability of the initial ﬂuorescence of liposomes solutions prepared from their stock
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solution at times 20min, and 40min after the ﬁrst measurement (i.e. subjected to additional
incubation in the dark).
The sample was then irradiated with blue light (370 ± 10 nm) for 1 or 5min (14mW/cm²).
(N.B.: during irradiation, the recorded signal had no meaning as the excitation mirror was
moved to prevent damages to the detector). After stopping the light source, ﬂuorescence
measurement was immediately resumed and its variation was recorded typically for 30 min-
utes. Finally, 20 µL of a 100 g/L Triton X-100 was added in the 2mL sample, which achieves a
ratio of 120 molecules of Triton X-100 per molecule of lipid (see appendix E.2.3 Forced release
test, p. 212). The immediate dissolution of vesicles in the presence of TX100 is reﬂected by
an abrupt jump of ﬂuorescence intensity that indicates the release of the entrapped calcein.
The ﬁnal intensity corresponds to a complete release from the liposomes (see ﬁgure 6.4).
The experimental procedures involved here are detailed in appendix E.2.3, p. 212.
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Figure 6.4. Representative ﬂuorescence variations by a solution polymer-containing liposomes loaded with
25mmol/L calcein. In this example, the weight ratio of components were 7:1:2 DOPC:polymer:choles-
terol, dispersed at a total concentration of 1g/L lipid, puriﬁed by gel ﬁltration, and ﬁnally diluted
100 fold in PBS.
Using a conventional interpretation, it is expected that leakage is primarily responsible
of the variation of ﬂuorescence, and one generally assumes that the diﬀerence between
intensities measured at time 𝑡 and at time 0 – here before irradiation – varies in proportion
to the amount of released calcein. However, we observed in practice that the intensities
measured immediately after exposure to blue light was always lower than before irradiation,
making the use of conventional interpretation diﬃcult. Possible bias or artifacts that may
aﬀect measurements are:
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Eﬀect of internal filter or turbidity In the case of high eﬀective absorbance of solutions
near wavelength of excitation or emission, variation of UV-vis spectra can change
the apparent ﬂuorescence.
Quenching Azobenzene molecules are eﬃcient quenchers. The cis-trans isomerization
may change the quenching eﬃciency and aﬀect the ﬂuorescence. The quenching
properties of the azobenzene are well-known, and they even lead to the development
of eﬃcient commercially-available quenchers, like the Black HoleQuenchers ® by
Biosearch Technologies and DABCYL by Invitrogen.
Bleaching Calcein absorbs blue light (470 nm) signiﬁcantly and may slowly bleach upon
irradiation in water.
In order to analyze the ﬂuorescence data, we estimated the possible contributions of each
bias cited above.
6.2.1. Negligible quenching and negligible internal filter eﬀects
First, the expectation of proportionality of the emission with the concentration of free
calcein shall be valid. The encapsulated volume fraction in the sample was lower than 8⋅10⁻⁵
(this value is obtained by assuming that all the lipids were collected from the stock solution
of liposomes, see appendix C.4.1, p. 200), the corresponding total concentration of calcein
was therefore below 180 nmol/L. This is the maximal possible value, and is ten times lower
than the threshold concentration of calcein self-quenching (see ﬁgure 6.3, p. 90).
Second, the absence of quenching and the absence of bias due to absorbance by the
polymer was experimentally controlled in calcein solution without liposomes. To this aim,
the ﬂuorescence of a 200 nmol/L calcein solution in PBS was measured before and after
addition of 10 g/L of cis azo-polymer to reach a ﬁnal polymer concentration of 0.99mg/L
(addition of 20 µL in 2mL). The drop of ﬂuorescence shown in ﬁgure 6.5 is essentially due
to the 1 % dilution, and any contribution of (cis)polymer absorbance represent less than 1 %
change in ﬂuorescence.
Every 5 minutes the sample was irradiated for 1 minute alternatively with UV or blue light,
to form predominantly trans or cis isomers. The details of the experiment are described
in appendix C.3.3, p. 199. The ﬂuorescence intensity for the 1 minute irradiation was
not sensitive to UV/blue irradiation cycles, showing that the eﬀects of absorbance of the
solution, and quenching by the polymer were negligible.
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Figure 6.5. Fluorescence intensity of a 200 nmol/L calcein solution in PBS. Green arrow: (cis) azo-polymer is
added to yield a solution of 198 nmol/L calcein and 0.99mg/L azo-polymer (1 % dilution). At each
plain vertical bar, the recording was stopped for 1 minutes and the solution was irradiated with
UV (purple bar) or blue light (blue bar). Blue light speciﬁcations: 470 nm, 14mW/cm². UV light
speciﬁcations: 365 nm, 5 W/cm².
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Figure 6.6. Fluorescence intensity of a 200 nmol/L calcein solution in PBS. (cis) azo-polymer was added in the
solution (ﬁnal concentration 0.99mg/L, green arrow). At each plain vertical bar, the recording was
stopped for 5 minutes and the solution irradiated with UV (purple bar) or blue light (blue bar) for 5
minutes.
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6.2.2. Contribution of bleaching at long irradiation times
To assess whether bleaching may occur, we considered longer exposure to blue light. Sim-
ilarly as reported above, a freshly prepared solution of calcein+polymer (no lipid) was
exposed to cycles of UV/blue irradiation, but for 5 minutes instead of 1. The resulting
ﬂuorescence variation is shown in ﬁgure 6.6. The initial addition of the polymer approx-
imately diluted the solution by 1%. The irradiation with UV light did not signiﬁcantly
aﬀect ﬂuorescence, compared to irradiations with blue light that decreased the ﬂuorescence
intensity by resp. 4 %, 9.5 % and 10 % at each successive exposure. The impact of 5 minutes
irradiation with blue light can not be neglected.
For that reason we controlled the preservation of total calcein ﬂuorescence by a compari-
son of the liposomes-containing samples prior and after exposure to blue light (comparison
of the total ﬂuorescence recovered after addition of TX100, by solutions prepared from
the same stock liposome, and subjected or not to 1min exposure under blue light prior to
addition of excess TX100). These controls revealed that exposure to 1 or 5min blue light did
not decrease the ﬂuorescence by more than the experimental uncertainty – the variation of
intensity ratios in TX100 containing solution are similar to the error resulting of pipetting
that is reﬂected by the variation of the ratios of initial intensities 𝐼0, see table 6.1.
Sample ref. S1 S1 NaCl S2 SChol50% S1 TX
Irradiation time 1min 5min 1min 5min 1min 5min 5min 5min
𝐼∞ (blue)
𝐼∞ (blank)
1.03 0.99 1.08 1.07 0.98 0.79 0.83 1.00
𝐼0 (blue)
𝐼0 (blank)
1.04 1.09 1.0 0.98 0.97 0.81 0.93 1.07
Table 6.1. Ratios of ﬂuorescence of liposomes solutions with (blue) or without (blank) exposure to blue light
(irradiation time shown in sample code). N.B.: blue and blank refer to diﬀerent samples. 𝐼∞ is
the ﬂuorescence measured after addition of TX100, 𝐼0 the initial ﬂuorescence before irradiation.
Sample codes refer to the following compositions: “S1” DOPC:polymer 0.9:0.1 g/g; “S1NaCl” = S1
supplemented with a NaCl solution at time zero; “S2” DOPC liposomes supplemented at time zero
with a solution of polymer; “Schol 50%” DOPC:cholesterol/polymer 5:5:1 g/g; “S1 TX” DOPC:polymer
9:1 g/g supplemented at time zero with TX100 at CMC/10 (details on sample preparation are given in
the next section).
It is concluded that the eﬀect of bleaching can be generally neglected, and if not, mea-
surements of intensities in presence of TX100 (such as reported in table 6.1).
6.3. Data analysis
Because themain origin of the “after-blue” drop of intensity was not identiﬁed, a quantitative
evaluation of the degree of leakage from curves such as the one shown in ﬁgure 6.4 were
not straightforward. The ﬂuorescence values of interest are the initial ﬂuorescence intensity
(𝐼0), the intensity measured immediately after exposure to blue light (𝐼𝑟), the intensity at
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long time, somewhat arbitrarily ﬁxed at time 20 minutes (𝐼+20m) and the total ﬁnal intensity
with excess TX100 (𝐼∞).
From these data an apparent degree of release – corresponding to the fraction of in-
tensity variation eﬀectively observed between 𝐼𝑟 and 𝐼+20m – is calculated by 𝐿app =
(𝐼+20m − 𝐼𝑟)/(𝐼∞ − 𝐼𝑟). A priori, this ratio underestimates the degree of leakage, because
it does not account for the release occurring during blue irradiation. In particular, the
𝐿app is systematically lower from measurements on samples that were irradiated for 5min
compared to similar samples irradiated for 1min. As shown in ﬁgure 6.7, longer irradiation
times lead to missing a fast initial leakage taking place in the 0–5min interval.
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Figure 6.7. Fluorescence intensity of a suspension of DOPC0.9/azo-polymer0.1 liposomes, recorded after blue light
irradiation. The ﬂuorescence increase after irradiation was ﬁtted by a monoexponential curve for 5
minutes irradiation (τ = 1590 ± 120 s) and a biexponential for the 1 minute experiment (τ₁ = 22.7 ±
1.3 s, τ₂ = 608 ± 33 s).
An alternative analysis of data is based on an assumption about the origin of intensity
loss just after exposure to blue light. We showed in the previous section that quenching
by polymer in the bulk solution, bleaching and absorbance do not provide adequate cor-
rections. We propose that the variation of the initial intensity is due to changes occurring
in liposomes, where polymer and calcein are both highly concentrated. Quenching of a
residual ﬂuorescence from the polymer-containing liposomes is possible for instance, and
is expected to increase upon cis to trans isomerization – due to the marked increase of
the azobenzene absorption peak at about 350 nm. The extrapolation of the value of the
initial intensity after photoisomerization toward the trans form should accordingly enable
to estimate the degree of leakage. To this purpose, we assumed that ﬂuorescence intensities
can be written before blue irradiation as follows:
𝐼0 = 𝛼
cis
bulk ⋅ [calcein]bulk + 𝛼
cis
ves ⋅ [calcein]ves (6.1)
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and after blue irradiation:
𝐼𝑟 = 𝛼
trans
bulk ⋅ [calcein]bulk + 𝛼
trans
ves ⋅ [calcein]ves (6.2)
𝐼∞ = 𝛼
trans
bulk ([calcein]bulk + [calcein]ves) (6.3)
where [calcein] is the concentration of calcein, and 𝛼 factors taking into account the
quenching by the azobenzenes ; ves stands for vesicles.
Our measurements showed that 𝛼transbulk and 𝛼
cis
bulk are equal. It comes at 𝑡 = 0 (extrapolation
of 𝐼𝑟 to an hypothetic zero time where all the trans isomers would already be formed):
𝐼𝑟 − 𝐼0 = 𝑘 (𝐼∞ − 𝐼0) ,with 𝑘 =
𝛼transves − 𝛼
cis
ves
𝛼bulk − 𝛼
cis
ves
(6.4)
The value of the correction factor, 𝑘, was constrained by physical relevancy of calculated
intensities. First, a minimum value was determined from calculation of (𝐼𝑟−𝐼0)/(𝐼∞−𝐼0) for
all the samples studied: if low or no leakage occurred in one sample, this ratio is expected to
be equal to 𝑘 and its absolute value diminishes when 𝐼𝑟 corresponds to a sample with partial
leakage. This constrained 𝑘 to be below –0.8. On the other hand, the correction applied to
𝐼0 cannot produce zero or negative ﬂuorescence intensities, which limited the value of 𝑘
to be above –1.4. Using this range of values, we could extrapolate the maximum degree
of leakage from experimental measurements. Interpolated leak results are summarized in
table 6.4, p. 99.
6.3.1. Liposomes without cholesterol
A representative variation of ﬂuorescence in samples containing DOPC:polymer (9:1w.)
liposomes is shown in ﬁgure 6.7. Somewhat arbitrarily the increase with time of ﬂuorescence
was ﬁtted by exponential variations, allowing to extract one (monoexponential) or two
(biexponential) characteristic time. If the permeability is low, or if poration/breakage of
liposomes is a random process, the concentration of calcein outside the vesicles should
follows an exponential-like law, as reported in appendix C.4.2, p. 201. Clearly, we could
essentially estimate the order of magnitude of the fast characteristic time, mainly captured
after 1min exposure to blue light. The time associated to longer processes was also a rough
estimate as it was of the same order as the experimental time. However we were interested
primarily by accelerating the release, and a lack of calcein release at time above 10min was
indicative of poor practical eﬃciency of the photo-stimulation.
The characteristic release time associated with diﬀerent external conditions of buﬀer are
shown in table 6.2.
In one set of experiments, quoted S2, DOPC:polymer (9:1 w.) liposomes were diluted in
PBS supplemented with additional “free” polymer (at a concentration of 0.001 g/L and under
its cis isomer form, this concentration almost double the total concentration of polymer
in the solution). This was performed to establish whether the polymer free in solution
may fragilize the membranes. In another set, the ionic strength was slightly increased.
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Sample ref. S1 S1 NaCl S2 S1 TX
1min blue irradiation
23 ± 1 14 ± 1 30 ± 1 –
610 ± 30 640 ± 20 – –
5min blue irradiation 1600 ± 100 2800 ± 100 – 1100 ± 100
Table 6.2. Release times obtained from the ﬁt of the ﬂuorescence curves by one or two exponential decay processes,
after 1 or 5 minutes of blue light irradiation. Sample codes refer to the following compositions: “S1”
DOPC:polymer 9:1 w. ; “S1NaCl” = S1 supplemented with a NaCl solution at time zero; “S2” DOPC
liposomes supplemented at time zero with a solution of polymer ; “S1 TX” DOPC:polymer 9:1 w.
supplemented at time zero with TX100 at CMC/10 (details on sample preparation are given in the
next section). The absence of results, due to non-ﬁttable data, are replaced by a dash.
The azo-polymer is a polyacid that behaves as a polyelectrolyte at neutral pH. Adding
sodium chloride to the buﬀer has been shown to increase the kinetics of release [217]
(case of an amphiphilic polyacrylate similar to the present one, but without azobenzene).
Phosphate saline buﬀer pH 7.4 (PBS) contains 150mmol/L sodium chloride and 10mmol/L
phosphate, reaching the ionic strength of 172mmol/L. To change the ionic strength of
liposomes, sodium chloride was added to the PBS buﬀer equilibrating the gel ﬁltration
column, and used to elute the liposomes just before leakage experiments. In the example
shown, a concentration of 62.5mmol/L of sodium chloride was used; the sample is quoted
S1NaCl.
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Figure 6.8. Fluorescence intensity of a liposome suspension (90 % DOPC, 10 % azo polymer) in PBS + 62.5mmol/L
sodium chloride. 1 minute and 5 minutes refer to the blue light irradiation duration.
In all these conditions, the order of magnitude of the “fast” release time – determined
after 1min exposure to blue light – was 15–30 s, and a longer time of about 10min was
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sometimes needed to match with experimental data. Obviously the apparent slow release
time estimated after 5min exposure under UV light may represents a tail of the initial
leakage (usually a residual 10% of apparent release), and converge to the experimental
time of observation suggesting that a longer measurement time is required to accurately
determine this slow process.
CTriton X100 (mg/L) 14.4 28.8 71.9 144
CMC fraction 1/10 1/5 1/2 1
Table 6.3. Triton X100 concentrations added to the sample prior ﬂuorescence measurement.
Finally, we considered the addition of a low concentration of TX100 to fragilize the
liposomes, prior to their exposure to blue light (sample quoted S1 TX ). Triton X100 was
added to liposome suspensions to obtain the concentrations shown in table 6.3. Even at
CMC/10, the concentration of surfactant (23 µmol/L) was higher than the concentration of
lipids (< 13 µmol/L).
At CMC/5 and above all the entrapped calcein was released prior to irradiation, indicating
that liposomes were leaky and emptied within the time needed to ﬁll the cell with the
sample. The sample at CMC/10, did not show signiﬁcant fast variation of intensity after 1
minute exposure to blue light. This may be due to either a much faster release, or to the
absence of release.
In order to evaluate whether initial release could be faster than a few tens of seconds,
and would have been missed in the ﬂuorescence variation, we used the correction of initial
intensity 𝐼0 described in the previous section. Results are summarized in table 6.4 and
show an order of magnitude of 30 % to 50 % release in most cases. Diﬀerences between the
renormalized degree of release, and experimentally observed (apparent) release ratios is
particularly important in the TX100 fragilized liposomes. This suggests that a fast release,
occurring in less than 10 s, was reached. However, the lack of release from at least 50 % of
the liposomes at time 20min, even after a 5min long irradiation, is not understood yet.
Sample ref. S1 S1NaCl S1 TX S2 S2NaCl
𝐿app 0.28 0.27 0.03 0.29 0.20
𝐿𝑘 = −0.8 0.11 0.30 0.35 0.29 0.33
𝐿𝑘 = −1.2 0.29 0.44 0.48 0.44 0.47
Table 6.4. Apparent and extrapolated release ratios of liposome preparations irradiated with blue light for 1
minute. S1: DOPC:azo polymer 9:1 w. S2, same as S1, with azo polymer added to the buﬀer. S1 TX:
same as S1, with Triton X-100 added to the buﬀer, at a concentration of CMC/10. NaCl means that
62.5mmol/L sodium chloride was added to the buﬀer.
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Figure 6.9. Skeletal representation of cholesterol.
6.3.2. Cholesterol-containing liposomes
Cholesterol is a small hydrophobic molecule present in the membranes of mammalian
cells. In vitro, it has been shown to modulate the membrane ﬂuidity and the packing of
phospholipids in bilayers, and to prevent their transition to gel phase at low tempera-
ture. The eﬀect of cholesterol on photoinduced leakage has been reported in the case of
azobenzene-containing lipids [73, 75, 77].
Samples were prepared as described in the experiments with DOPC:polymer liposomes,
by simply adding cholesterol at the stage of ﬁlm drying. The azo-polymer was kept at 10 %
by weight, and the 90 % lipids included DOPC plus cholesterol. The relative weight amounts
of cholesterol and DOPC are summarized in table 6.5.
Sample name SChol5 SChol10 SChol15 SChol20 SChol50
DOPC (%) 94.4 88.9 83.3 77.8 44.4
Cholesterol (%) 5.6 11.1 16.7 22.2 55.6
Table 6.5. Relative lipid composition of ﬁlms. The sample name derives from the global amount of cholesterol in
the lipid ﬁlm, made of azo-polymer (10 % w.), cholesterol and DOPC.
As before, the ﬂuorescence intensity of the suspension was recorded before and after
irradiation, and ﬁnally after adding an excess of Triton X-100. An example of ﬂuorescence
variation is shown in ﬁgure 6.10, here for the 20 % sample and does not signiﬁcantly diﬀer
from data recorded without cholesterol. The characteristic release times, the apparent
degree of calcein release at time 20 minutes, and the renormalized degree of leakage are
shown in table 6.6 and table 6.7.
Concerning the 5 minute irradiation samples, the amount of apparent release varied from
5% to 17%, which is comparable to values measured without cholesterol. The fraction of
cholesterol in the membrane does not make sense to rank apparent degrees of leakage, and
data seem rather subjected to ﬂuctuation from sample to sample. The strong variability in
the results does not permit to draw any conclusion regarding the evolution of the apparent
release. Renormalizing data to account for the initial drop of intensity after blue light
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Figure 6.10. Fluorescence intensity of a liposome suspension prepared from the DOPC(83.3 %)/cholesterol(16.7 %)
ﬁlm, after 1 and 5 minutes of blue light irradiation.
Sample name SChol5 SChol10 SChol15 SChol20 SChol50
Release times (s) 1254 ± 24 ∞
22.1 ± 4.1 18.62 ± 0.79 15.02 ± 0.83
985 ± 35 1083 ± 15 1043 ± 80
𝐿app 0.10 0.02 0.07 0.07 0.02
𝐿𝑘=−0.8 0.13 0.50 0.22 0.25 0.22
𝐿𝑘=−1.2 0.31 0.60 0.38 0.40 0.38
Table 6.6. Characteristic release times, apparent release ratios and extrapolated release ratios for liposomes
made of DOPC:cholesterol:azo polymer loaded with calcein, after 1 minute of blue light irradiation.
∞ means here that the ﬂuorescence intensity curve was almost ﬂat and the exponential ﬁt did not
converge.
Sample name SChol5 SChol10 SChol15 SChol20 SChol50
Release times (s) 2000 ± 100 920 ± 50 2300 ± 300 2900 ± 100 1600 ± 100
Table 6.7. Characteristic release times for liposomes made of DOPC:cholesterol:azo polymer loaded with calcein,
after 5 minutes of blue light irradiation.
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exposure, suggest that degree of fast leakage of the order of 20 % to 30% could be the
eﬀective leakage. This fraction of leakage is similar to the case of liposomes with no
cholesterol, and the fast release time is not accessible to our experimental setup.
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Conclusion
Light sensitive liposomeswere prepared by inclusion of azobenzene-containing cis-polymers
in the lipid, DOPC or DOPC:cholesterol, membranes. Exposure to blue light generally trig-
gers the release of loaded calcein in the medium. In practice, we never measured 100%
release. And reasonable order of magnitude leveled up to 30% (both apparent and renor-
malized degrees of release). It was surprising that a signiﬁcant fraction of calcein and/or
liposomes did not leak out, in particular in the presence of low concentration of Triton
X-100 (CMC/10) that fragilizes the membranes. A fast, partial release may be hidden behind
the blue light irradiation, but the lack of full release suggests that the eﬃciency of polymers
has to be questioned further.
The choice of calcein self-quencher, and more generally of ﬂuorescence, to study the
release from azobenzene-sensitized liposomes introduces diﬃculties of quantiﬁcation due
to possible quenching that are essentially unknown as it shall depends on molecular con-
ﬁgurations and local concentrations in and around the liposome membranes. It has been
chosen for its simplicity of implementation, and the possibility to follow the release in real
time. However, the origin of the ﬂuorescence intensity decrease after irradiation remains
unknown, and can be attributed neither to photobleaching nor quenching.
For accurate results based on ﬂuorescence, one should replace the calcein by a ﬂuorophore
with a red shifted absorption band, which may solve both the photobleaching with the blue
light irradiation and the undesired release caused by the ﬂuorescence excitation beam.
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Part III.
Temperature-sensitive capsules made
by the reverse emulsion method
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Introduction
This chapter presents polymer capsules based on thermo-responsive polymers. As men-
tioned in chapter 4, capsules containing stimuli-responsive polymer membranes are inter-
esting alternatives to liposomes, but they were often prepared in harsh conditions that are
not compatible with protein manipulation. Our goal was to adapt the mild procedures of
polymer capsule preparation to form capsules with an aqueous core that can be released on
demand. The shell of the capsule is composed of water insoluble polymers, which ensures a
tight encapsulation. Two main mechanisms can lead to the destruction of the capsule wall:
1. The polymer constitutive of the membrane can be hydrolyzed, or more generally
degraded into smaller chains (e.g. photo-cleavable monomers introduced in the chain).
Depending on solubility of the products, the membrane is broken into insoluble
aggregates or is dissolved.
2. The solubility of polymer constitutive of the membrane can depend on stimulation,
but is not involved in chemical reaction.
We implemented the second strategy, based on polymers which dissolve upon stimu-
lation. We believe that absence of hydrolysable monomers should be an advantage for
the preservation of stability in complex environments (e.g. enzyme-containing cell culture
media). As temperature-responsive systems can be readily turned into light-responsive
ones (see chapter 4, e.g. nanoparticle-doped capsules), we studied the introduction of
temperature-sensitive chains into capsules.
Polymer selection
Solubility of polymers depends on the temperature (T). In water, one distinguish polymers
that become insoluble at high temperature, and represent the majority of water-soluble
chains, from polymers soluble at high T and precipitated at low T.
The upper critical solution temperature (UCST) is the temperature above which a chain
becomes soluble. Conversely, below the lower critical solution temperature (LCST) polymers
are soluble, while they become insoluble at higher temperature, as shown in ﬁgure 6.1. The
transition between insoluble and soluble behavior is generally sharp.
To control the permeability of capsules, the critical temperature must be adjusted to the
practical conditions of use. A few examples of polymers with a UCST near 37℃ in biological
mediums are reported [229]. Several polymers with a LCST in water that can be varied
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Figure 6.1. Phase diagrams of LCST and UCST polymers in solution, as a function of temperature and the
composition of the solution. LCST polymers – left diagram – are soluble at low temperature and
insoluble when heated above theirs LCST. UCST polymers – right diagram – are soluble at high
temperature and become insoluble when cooled below their UCST.
to reach values of interest are reported. Popular examples include polyacrylamide and
poly(ethylene glycol) derivatives. One of the most developed LCST polymer for biological
applications is probably the poly(N -isopropyl acrylamide), abbreviated polyNIPAM, whose
LCST in biological buﬀers is near the physiological temperature, ≈ 32℃. It is commercially
available under various chain lengths and chains ends. Furthermore, polyNIPAM derivatives
– imparted with light sensitive properties by the introduction of azobenzene moieties – are
under investigations at the laboratory.
We studied one model system based on a LCST polymer, and another one based on UCST
polymers. On one hand, the LCST polymer – polyNIPAM – is commercially available.
This enables to obtain rapidly a proof on concept of temperature-sensitive capsules, and to
characterize the permeability and the degree of release as a function of the temperature.
On the other hand, UCST polymers present several advantages for application, in par-
ticular in biological experiments. When the release can be triggered by an increase of
temperature, ﬁrst the tight encapsulation at low temperature facilitate manipulations, and
second various localized heating procedures may be implemented – e.g. using an infrared
laser, or loading nanoparticles in the capsules1. However, neutral UCST polymers are nei-
ther common in water nor commercially available. Y. Zhao’s team (Sherbrooke University,
Canada) is currently developing such polymers [230], and they reported temperature-
sensitive polymer micelles, from UCST polymer:polystyrene diblock copolymers. He kindly
provided us three polymers, whose general formula is shown in ﬁgure 9.1. They diﬀer by
their UCST in PBS: 35℃, 43℃ and 47℃, and will be referred later by the value of their
UCST.
1Gold nanoparticles ability to convert visible or infrared light into heat has been described in part I. We
reported liposomes (p. 31), nanogels (p. 46) and LbL capsules (p. 54) made light-sensitive with such
particles.
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Figure 6.2. Common skeletal formula of the UCST polymers. Molecular weight: ∼ 15 kg/mol. The UCST of the
polymer depends on the acrylamide/acrylonitrile ratio. Polymer 35℃: α = 67.9 %, β = 32.1 %. Polymer
43℃: α = 66.1 %, β = 33.9 %. Polymer 47℃: α = 65.8 %, β = 34.2 %.
Capsule preparation
Three diﬀerent strategies have been used to prepare polymer capsules (see chapter 4
page 51): the layer-by-layer assemblies, the polymersomes and the capsules made by
interfacial polymerization. Layer-by-layer assemblies and polymersomes have however a
limited encapsulation yield and exhibit poor kinetics of release performances. We choose
therefore to form capsule shells based on polymerization on droplet surfaces. The group of
K. Landfester developed this kind of chemistry based on interfacial polyaddition in inverse
emulsion, one reactant being in the water droplets (hexamethylene diamine, HMDA), the
other in the oily continuous phase (toluene diisocyanate, TDI)2. This strategy allows to reach
almost quantitative encapsulation yields. Furthermore, the TDI reactant can be associated
with diﬀerent water-soluble reactants provided that they display amine or alcohol functions.
We adapted this strategy to the synthesis of thermoresponsive capsules using amino-
functionalized water-soluble polymers as one of the reactants, or introducing non-reactive
polymers in the nascent membranes by spontaneous adsorption. To facilitate the obser-
vation of permeabilization, we have in addition considered millimeter-sized capsules –
large enough to be viewed by optical microscopy – allowing to check the integrity of
the membrane or the ﬂuorescence of an encapsulated dye in real time. In the ﬁrst sec-
tion, we describe millimeter-sized capsules made from polyNIPAM, and their response to
variation of temperature. The next section presents the basic process that can be used to
form nanometer-sized capsules with polyNIPAM. Finally, the last section focuses on the
characterization of millimeter-sized UCST capsules.
2For details, see section 4.3.2 Synthesis conditions and encapsulation eﬃciency, p. 62.
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We aimed ﬁrst at building millimeter-sized capsules, whose shell was composed of a
thermoresponsive polymer, namely α,ω diamino terminated polyNIPAM (polyNIPAM-
(NH₂)₂, or “reactive” polyNIPAM). The shell was obtained by interfacial polyaddition in
inverse emulsions. This section is split into three parts. The ﬁrst one details themodiﬁcations
of the protocol of K. Landfester that were required in order to obtain millimeter-scaled
capsules. The second one presents the synthesis and properties of purely polyNIPAM based
millimeter sized capsules. Finally, the third one describes the inﬂuence of mixed membrane
composition on temperature-triggered release.
7.1. Adaptation of published protocols
7.1.1. Analysis of K. Landfester’s protocol
Figure 7.1. Polyaddition occurring between hexamethylene diamine (HMDA) and toluene diisocyanate (TDI).
This is the main reaction leading to the formation of capsules.
The nanometer-scaled capsules reported in reference [231] are made from hexamethylene
diamine (HMDA) and toluene diisocyanate (TDI). HMDA is highly soluble in the aqueous
phase, at concentrations as high as 100 g/L, but is not soluble into the oil phase – typically
cyclohexane. The diisocyanate is soluble in the oil phase, but not soluble in the aqueous
one. Polyaddition thus primarily takes place at the water/oil interface, yielding a polyurea
based shell, as shown in ﬁgure 7.1. This polymer is neither soluble in the oil phase nor in
the aqueous one, which leads to the formation of an impermeable and insoluble membrane.
To produce capsules with a diameter below 300 nm, the aqueous phase (containing
hexamethylene diamine) is dispersed in the oil phase by sonication in the presence of
surfactants. TDI (in the oil) is added at various ratios compared to HMDA, which was
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Figure 7.2. Nanocapsules made of HMDA and TDI, viewed by transmission electron microscopy (TEM), directly
from cyclohexane. The three samples diﬀers from the HMDA:TDI mol. ratios. (a) 1:2, (b) 1:1.5, (c) 2:1.
shown to modulate the thickness of the membrane, in the range of 10 nm: the higher the
TDI concentration, the thicker the membrane (see ﬁgure 7.2). Amounts lower than 1:1mol.
TDI:HMDA did not yield to stable capsules.
7.1.2. Synthesis of millimetric capsules
The preparation of millimeter sized capsules does not require high energy emulsiﬁcation
steps. A drop of aqueous phase is simply hanged from a needle in the oil phase composed of
cyclohexane and TDI. ≈ 12 drops could be made in each vial without collapse, nor inter-drop
attachment. The preparation procedure is detailed in appendix F.1.2 HMDA millimeter-sized
capsules, p. 218, and is summarized on ﬁgure 7.3. The aqueous phase was made of HMDA
dissolved in PBS, at the following concentrations: 10mg/L, 100mg/L, 1 g/L, 10 g/L and
100 g/L.
TDI / HMDA
reaction
pursued overnight
aqueous phase Detaching the drop from
the needle
(A) (B) (C)
Figure 7.3. Synthesis procedure of model HMDA millimeter-sized capsules. (A) A drop (1 µL) of the aqueous
phase is created in the TDI/cyclohexane mixture with a microsyringe/ Depending on the concentration
in HMDA, a crumpled membrane appears instantly. (B) The drop is unhooked from the needle at the
approach of the oil/air interface. (C) The TDI/HMDA reaction is pursued overnight.
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Sample (HMDA conc.) 10mg/L 100mg/L 1 g/L 10 g/L 100 g/L
Membrane (t = 0) No No No Yes* Yes*
Membrane (t = 12h) No No Yes* Yes Yes
Table 7.1. Presence of a membrane around the aqueous phase drop, immediately after adding the drops inside the
cyclohexane (t = 0) and 12 hours later (t = 12 h). “*” means that the membrane was not mechanically
resistant.
The drops were observed with naked eye in the cyclohexane, ﬁrst immediately after
introduction in the oil and after overnight incubation (12 hours). Results are summarized
in table 7.1.
With the 10 g/L and 100 g/L samples, an opalescence appearing immediately after im-
mersing the drop in the oil phase suggests that the membrane is rapidly formed. Reactions
times in the timescale of the minute were however not suﬃcient to create mechanically
resistant membranes, and contact with the side of a needle was suﬃcient to break the
ﬁlm at that stage of the reaction. Nothing happened in the same timescale with the other
samples. 12 hours later, no visible membrane was present around the 10mg/L and 100mg/L
drops. When two drops were put in contact, they immediately coalesced. The 1 g/L drop
was wrapped with a thin ﬁlm that did not resist to the lateral side of the needle. The ﬁlm
around the last two samples was resistant, and the capsules could be displaced with the
needle or a pipette without rupturing it.
The required concentration of HMDA to build resistant capsules – 10 g/L – is substantially
higher than the one reported in reference [194]. This may probably be explained by the
ability of the diisocyanate to react with water. At low concentration in HMDA, the side-
reaction between the isocyanate and the water can’t be neglected, and a polyurea matrix
is probably created, with inferior mechanical properties. For the next experiments, the
concentration of 10 g/L HMDA in the aqueous phase will be used.
Figure 7.4. Hydrolysis of one isocyanate function of TDI. This reaction leads to the formation of a primary
aromatic amine, which can in turn react with an isocyanate function. This will eventually lead to
the formation of a polyurea chain.
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cyclohexane
PBS (A) (B) (C) (D)
adding Tween 80
at the interface
Figure 7.5. Transfer of a millimeter-sized HMDA-based capsule. (A): PBS and cyclohexane are poured in a vial,
a small amount of Tween 80 is added at the water/oil interface. (B): The capsule is added in the oil
phase and (C) falls on the interface. Due to the presence of the surfactant at the interface and the
density of the capsule, the interface is crossed. (D): the capsule is ready for use in an aqueous phase.
7.1.3. Transfer into the aqueous phase
Transferring the capsules into water is a crucial step for further applications of these
systems in biological conditions. When the capsule was deposited with cyclohexane on
the surface of an aqueous medium, it remained at the oil/water interface. The addition of
surfactant in the aqueous phase – e.g. Tween 80, SDS or Triton X-100 – or in the oil phase –
Span 80 – did not ease the interface crossing. Pushing the capsule with a pipette or short
centrifugation cycles 2,000 rpm for 30 seconds) only led to the rupture of the membrane.
To successfully transfer the capsule in the water phase, 1) we increased the density of the
encapsulated aqueous phase, by adding either sodium chloride or sucrose (12 % w. in the
case of NaCl, 20 % w in the case of sucrose), and 2) we added a small amount of Tween 80 at
the PBS/oil interface, before introducing the capsule. The main disadvantage of this method
is the lack of control on the amount of surfactant deposited at the interface. In fact, when
“high” amounts were deposited, a gel appeared at the interface preventing the capsules to
cross it. Better control was ﬁnally achieved by adding a saturated solution of Tween 80 in
cyclohexane instead of pure Tween 80. The ﬁnal transfer procedure is shown in ﬁgure 7.5.
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7.2. PolyNIPAM-based capsules
Unless explicitly stated, polyNIPAM will refer to α,ω diamino-terminated polyNIPAM in this
section (7.2).
7.2.1. Synthesis of polyNIPAM-based capsules
Figure 7.6. Skeletal representation of α,ω diamino-terminated polyNIPAM. Polymer molecular weight:
4,600 g/mol.
To introduce polyNIPAM in the membrane we replaced the diamine by α,ω diamino-ter-
minated polyNIPAM1 (see ﬁgure 7.6 for the skeletal formula). As polyNIPAM is temperature
sensitive, the temperature of preparation needs to be controlled.
1. A gradient of TDI in cyclohexane is created by depositing TDI at the bottom of the
vial. Being denser than the oil, the TDI remains here and the concentration at the top
of the vial is too low to yield stable membrane.
2. The drop of aqueous phase is created in the oil at a temperature below the LCST of
polyNIPAM. This prevents the polymer to make macroscopic aggregates.
3. The temperature of the reaction vessel is then increased above the LCST, to precip-
itate polyNIPAM that goes partially to the interface; this gives birth to a primitive
membrane with poor mechanical properties.
4. The drop is released from the needle and plunge to the bottom of the vial, where the
primitive membrane is reinforced by formation of urea bonds between the polyNIPAM
chains via reaction with the TDI.
This preparation procedure is summarized on ﬁgure 7.7, and detailed in appendix F.1.1 Cap-
sule preparation, p. 215.
Concerning the transfer of the capsules in the water phase, the protocol used for HMDA
capsules can be reused. The only requirement is to keep the capsules at a temperature
above the LCST to prevent their destruction.
1This polymer was not commercially available. Commercial α,ω dicarboxy terminated polyNIPAM (Polymer
Source, CA) was converted to diamino terminated ones with a carbodiimide-mediated reaction with
ethylene diamine. For details on the reaction, refer to appendix C.2.2 α,ω diamino-terminated poly(NIPAM)
synthesis, p. 195.
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TDI / polyNIPAM
reaction
aqueous phase
(T below LCST)
polyNIPAM at the
water/oil interface
cyclohexane
(T above LCST)
TDI gradient
(A) (B) (C) (D)
Figure 7.7. Synthesis of the capsule in the oil phase. (A) a gradient of TDI concentration is created in cyclohexane,
at a temperature above the LCST. Under these conditions, the concentration in TDI at the top of
the cyclohexane is considered null. (B) a drop of the aqueous phase is introduced in the oil with a
microsyringe. The syringe and its content are at a temperature below the LCST, allowing the solution
to ﬂow through the needle. (C) as the oil is at a temperature above the LCST, the polyNIPAM inside
the drop precipitates and goes to the water/oil interface. As the drop was kept in the higher levels of
cyclohexane, where no TDI can be found, no reaction occurred yet. (D) the drop is made to fall at the
bottom of the cyclohexane, were the membrane is synthesized.
Eﬀect of the additives on the LCST of polyNIPAM
In the last section, sodium chloride or sucrose were used to increase the density of the
capsule, in order to ease the transfer from the cyclohexane to the aqueous phase. Both have
been reported to decrease the LCST of polyNIPAM, as shown in ﬁgures 7.8 and 7.9. The
concentration of sodium chloride and sucrose were respectively 2.22mol/L (12 % w.) and
0.63mol/L (20 % w.). This means that the LCST of polyNIPAM is expected to decrease to
≈ 29℃ with sucrose and ≈ 8℃ with sodium chloride.
Experimentally, a PBS solution containing 10 g/L in polyNIPAM and 20% w. sucrose is
opaque at room temperature (20–25℃), but becomes transparent when cooled below 15℃.
In presence of sucrose, it is thus possible to make the capsule at room temperature, with a
cooled syringe to process the polyNIPAM in its soluble form. A solution of polyNIPAM
containing sodium chloride at 2.22mol/L also appeared opaque at room temperature. The
polyNIPAM redissolved only when cooled below 5℃. An interesting consequence of these
conditions is that the polyNIPAM membrane will be in contact with two diﬀerent media:
the internal medium and the external one (PBS, in which the LCST of polyNIPAM is 32℃).
The release experiments will determined whether the polyNIPAM is aﬀected by the internal
medium, the external medium of both of them.
Results
The protocol of synthesis of millimeter sized capsules is detailed in appendix F.1.2 Evaluation
of the eﬀect of sucrose and NaCl on polyNIPAM capsules, p. 218, and compositions of the
aqueous core is reported in table 7.2.
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Figure 7.8. Evolution of non-reactive polyNIPAM
LCST in water, as a function of sucrose con-
centration. Polymer concentration: 1 g/L,
polymer molecular weight: 16 kg/mol.
Reprinted from reference [232] (ESI).
Figure 7.9. Evolution of non-reactive polyNIPAM
LCST as a function of the concentration of
sodium chloride and the molecular weight
of the polymer. Polymer concentration:
10 g/L. Reprinted from reference [233].
Sample name Buﬀer [polyNIPAM] (g/L) additive Cadditive
NaCl PBS 10 sodium chloride 2.22mol/L
Sucrose PBS 10 sucrose 0.63mol/L
Table 7.2. Aqueous phase compositions.
In both cases, we obtained capsule-like objects in oil. However, the capsules containing
sodium chloride did not tolerate the transfer in the aqueous phase: all the processed capsules
(≈ 12) burst either at the oil/water interface or within a few seconds in the water phase.
The ones made with sucrose were not as fragile and could be transferred into the aqueous
phase.
This diﬀerence of behavior can be tentatively attributed to the diﬀerence of the LCST in
both samples. With sugar, the LCST is just below the room temperature; at RT, the aqueous
phase looks like a suspension of ﬁne aggregates. With salt, the temperature is much lower.
Heating the aqueous phase at room temperature gives a coarse suspension, which may
explain why the capsules are fragile. Therefore, we only used sucrose-based samples in the
next experiments.
In addition, when capsules were based on longer chains – 22,000 g/mol polyNIPAM,
compared to experiments based on 4,200 g/mol one – neither sodium chloride nor sucrose-
containing capsules could resist mechanical stress during the transfer in PBS. When the
polymer length is increased, the number of amine functions per capsule is decreased, as
there is only two amine functions per chain. Increasing ratio between TDI and NIPAM
certainly contributes to better resistance due to the insolubility of the aromatic moieties
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in water. Finally as a control, we build the capsules from solutions of the commercial
dicarboxy-terminated polyNIPAM (4,200 g/mol). In this case, no membrane appeared, even
12 hours after pouring the drops in the cyclohexane + TDI mixture, and drops coalesced
when they were brought into contact. This observation conﬁrms that the amine functions
at the end of the polymer chains are required to build the capsules.
7.2.2. PolyNIPAM capsules: characterization
Pure polyNIPAM (4,200 g/mol) capsules once transferred into PBS at 45℃ (> LCST) appeared
mechanically resistant. To assess their permeabilization upon temperature shifts, two series
of experiments were performed. The ﬁrst set was to check visually the integrity of the
membrane as a function of the temperature. This was performed on a microscope with
a temperature-regulated plate, to determine the temperature of membrane breakage at
micrometer resolution.
Petri dish, filled with PBS
temperature probe
capsule
raised glass slide
Figure 7.10. Schematic representation of the microscope-based setup used to characterize the capsules. The
capsules is placed in the PBS ﬁlled Petri dish, whose temperature is controlled with a Peltier
microscope plate (not represented). If required, the capsule can be elevated with a glass slide, as
shown in the picture. The temperature was measured in the water phase, near (< 1mm distance) the
capsule with a temperature probe.
The second set of data assessed the permeability of the capsules to various molecules.
Capsules were loaded with ﬂuorescent-labeled molecules to estimate, by epiﬂuorescence
measurements, the amount of entrapped molecules. The procedure is described in details
in appendix F.1.1 Capsule characterization by microscopy, p. 217. The setup, at the exception
of the Peltier plate, is shown in ﬁgure 7.10. To ensure that the whole capsule was at the
same temperature as the PBS, it was deposited on an elevated glass slide. Especially this
prevented the capsule to be in contact with the bottom of the dish, whose temperature may
not be the same as the one of the PBS.
Integrity of the capsules as a function of the temperature
We prepared polyNIPAM (4,600 g/mol) capsules with sucrose 20% w. as reported before.
When cooled to ≈ 0℃ (ice bath), the capsules may remain apparently intact; however, gentle
stirring of the medium completely destroyed them, leading to a dispersion of ﬁne sheets.
The same process applied to capsules kept at 45℃ did not destroy them.
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200 µm
Figure 7.11. Phase contrast images of a polyNIPAM (10 g/L) + sucrose (20 % w.) capsule, upon a decreasing ramp
of temperature. Initially, the capsule appear homogeneous. Decreasing the temperature below 27℃
made the capsule to appear brighter while lacerations appeared in the membrane (orange arrows).
Pictures of the capsules were taken by phase contrast microscopy, every 5 seconds, along
a ramp of temperature, decreasing from 45℃ to 15℃ at 10℃/min; the temperature was kept
at 15℃ at the end of the ramp. Examples extracted from a complete pile of photographs is
shown ﬁgure 7.11. At the beginning of the ramp, the capsule looks homogeneous. When
the temperature decreased below 27℃, the membrane became spotted by brighter domains
and lacerations appeared. At this stage, any movement of the capsule, produced by moving
the microscope plate, achieved to disrupt the membrane.
Characterization of the membrane permeability as a function of the temperature
To characterize the release from these objects, various ﬂuorescent dyes were encapsulated
inside the capsules, ranging from small hydrophilic molecules (sulforhodamine 101) to
large antibodies. To this aim, the ﬂuorophores were dissolved in the aqueous phase used
to produce capsules. The dyes and their concentrations, in the micromolar range, are
reported in table 7.3. The detailed preparation and characterization procedures are reported
in appendix F.1.2 polyNIPAM capsules release tests, p. 219.
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Molecule Dye Cmolecule Cdye
Sulforhodamine 101 – 50 µmol/L 50 µmol/L
Dextran (3 kg/mol) Texas Red 50mg/L ≈ 10 µmol/L
Dextran (10 kg/mol) ﬂuorescein isothiocyanate 250mg/L ≈ 15 µmol/L
BSA (66 kg/mol) Texas Red 1 g/L ≈ 40 µmol/L
Netrin (68 kg/mol) ﬂuorescein isothiocyanate 60mg/L 1.9 µmol/L
Antibody (150 kg/mol) ﬂuorescein isothiocyanate 67mg/L 1 µmol/L
Table 7.3. Fluorescent probes entrapped in polyNIPAM capsules.
Sulforhodamine 101 Sulforhodamine 101 is a small (606.8 g/mol) hydrophilic molecule,
whose skeletal formula is shown in ﬁgure 7.12, best known for its sulfonyl chloride derivative
called Texas Red. This molecule has been selected because it is reported to bleach less easily
than other commonly used ﬂuorophores (e.g. ﬂuorescein isothiocyanate) and because its
ﬂuorescence does not depend on the temperature [234].
The temperature and ﬂuorescence intensity inside the capsules are reported on ﬁgure 7.13.
The ﬂuorescence intensity is quasi-constant at the beginning of the experiment, but de-
creases when the temperature crosses 36℃.This is characteristic of a release of the entrapped
dye. The release rate seems to be signiﬁcant below 34 ± 2℃. Approximatively 25 % of the ini-
tial ﬂuorescence intensity is lost 10 minutes after crossing the critical temperature (t = 300 s).
However waiting longer did not increase this value. 3 hours after, only 30 % leak is attained.
Two phenomena can explain this result:
1. A slow diﬀusion through the membrane (if the membrane becomes permeable, but
is not broken). In this case, the fast burst-like release shall presumably be due to
Figure 7.12.
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Figure 7.13. Fluorescence intensity of a polyNIPAM capsule loaded with sul-
forhodamine 101 (50 µmol/L).
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Figure 7.14. Fluorescence intensity proﬁle of a polyNIPAM capsule loaded with sulforhodamine 101, at high
temperature (t = 0 s) and low temperature (t = 1,230 s).
transient opening of large transmembrane pathways under the eﬀect of osmotic
pressure diﬀerence inside and outside the capsule.
2. The sulforhodamine is trapped inside the capsule and/or the membrane.
We saw that at low T the capsule is torn apart, thus an almost free diﬀusion of the
sulforhodamine outside the capsule is expected. The associated timescale (𝑡) can be evaluated
with 𝜏 ∼ 𝑙2/𝐷, where 𝑙 is the radius of the capsule (1mm) and 𝐷 is the diﬀusivity of
sulforhodamine (∼ 500 µm²/s). Evaluating this expression gives about ten minutes, which
likely explains the slow release of the entrapped dye.
The ﬂuorescence proﬁle of the capsule at the beginning and at the end of the temperature
ramp is shown in ﬁgure 7.14. The ﬂuorescence of a sphere projected on a plane, as viewed
by a microscope, has a spherical proﬁle. For a 0-centered sphere with a radius 𝑟, the
ﬂuorescence intensity proﬁle is given by the equation:
𝐼sphere = {
|𝑥| ≤ 𝑅, √𝑅2 − 𝑥2
|𝑥| > 𝑅, 0
(7.1)
where 𝑥 is the proﬁle abscissa (called distance in the proﬁle plots). If only the membrane of
the capsule is ﬂuorescent, the ﬂuorescence proﬁle becomes:
𝐼membrane =
⎧
⎪
⎨
⎪
⎩
|𝑥| ≤ 𝑅, √(𝑅 + 𝑒)2 − 𝑥2 −√𝑅2 − 𝑥2
𝑅 < |𝑥| ≤ 𝑅 + 𝑒, √(𝑅 + 𝑒)2 − 𝑥2
𝑅 + 𝑒 < |𝑥|, 0
(7.2)
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Figure 7.15. Theoretical ﬂuorescence proﬁle of an homogeneous sphere with a radius of 0.75mm and the one of
a membrane surrounding this sphere, with a thickness of 0.1mm. The concentration of dye is the
same in both compartments.
where 𝑅 is the radius of the inner capsule core and 𝑒 the thickness of the membrane. An
example is shown in ﬁgure 7.15. Lateral peaks, with in between a ﬂat ﬂuorescence proﬁle
are thus characteristic of a dye-stained membrane. The ﬂuorescence proﬁle at low T showed
typically such a shape. This means that sulforhodamine stained irreversibly the membrane
of the capsule, possibly due to hydrophobic binding. This result contradicts what is claimed
in references [199, 205], where sulforhodamine 101 is presented as a dye that do not alter
membrane composition, and was used to quantify the loading eﬃciency and the release
properties of capsules. Even if the systems are not strictly identical – in reference [199],
capsules are made from 1,6-hexane diol and in reference [205] from albumin – this raises
some doubts concerning the inactivity of sulforhodamine 101 towards the reaction and its
relevance for the characterization of the capsules.
Dextrans and proteins Dextran is a branched polysaccharide made from glucose mono-
mers, connected together with α-1,6 glycosidic linkages – branches emerge from α-1,3
linkages. These uncommon linkages are not hydrolyzed by endogenous enzymes, which
confers the polysaccharides an improved stability. Thanks to these properties, they are com-
monly used as hydrophilic macromolecular models. We used here 3 kg/mol and 10 kg/mol
dextrans, whose respective hydrodynamic radius are 1.2 nm and 2.3 nm. Finally, we used
also ﬂuorescently-labeled proteins. We report here bovine serum albumin labeled with
Texas Red (BSA-TR), an antibody labeled with FITC and netrin-1 labeled with FITC2.
2Netrin-1 labeled with FITC is not commercially available. The labelling protocol with ﬂuorescein isothio-
cyanate is reported in appendix C.2.1, page 194.
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In the case of dextran, a typical curve of release is shown in ﬁgure 7.17, here for dextran-
Texas Red. Fluorescence proﬁles of the capsules exhibit a spherical shape, as illustrated on
ﬁgure 7.16. This conﬁrms that ﬂuorescent dextran does not stain the membrane.
The ﬂuorescence intensity slightly decreased at high temperatures; this leak is constantly
seen with dextran-loaded capsules. This indicates that capsules are slightly permeable,
even at high temperature. Decreasing the temperature made the ﬂuorescence intensity
to decrease strongly when a critical temperature was reached. In contrast to the example
of sulforhodamine, long term experiments show an almost complete disappearance of
the ﬂuorescence inside the capsule. The amount of released dye has been estimated for
both dextrans, 10 minutes and 3 hours after crossing the critical temperature. The results
are summarized in table 7.4. Finally, dextran loaded capsules – even at a concentration
as low as 10mg/L – are more fragile than the previous ones, and are slightly permeable
even at 45℃. It may be caused by an interference of the dextran with TDI reaction during
formation of the membrane (e.g. reaction of hydrophilic dextran with TDI, competing with
the polyaddition of NIPAM chains).
Fluorescence intensity curves for BSA-TR and the antibody are shown respectively on
ﬁgure 7.18 and ﬁgure 7.19. The results are summarized in table 7.4.
Probe Critical temperature (°C) Released amount
10min 3h
Sulforhodamine 101 34 ± 2 25 % 30%
Dextran Texas Red 27 ± 1 19 % 84%
Dextran FITC 29 ± 2 24 % 88%
BSA-FITC 29 ± 1 30 % 40%
Netrin-FITC – 0% 0%
Netrin-FITC + BSA 29 ± 2 31 % 76%
Antibody-FITC 31 ± 1 13 % 25%
Table 7.4. Release of ﬂuorescent proteins from polyNIPAM capsules. Temperature of release, amount of dextran
released 10 minutes and 3 hours after crossing the critical temperature.
The amount of protein released 3 hours after crossing the critical temperature is rather
low: 25 % for the antibody and 40% for the BSA, and 0% for netrin-1. These proteins can
react with the diisocyanate and be integrated to the membrane. In fact, we show in the
bibliographical review that BSA can be used to create capsules, when reacted with the
toluene diisocyanate. To increase the released amount of these proteins from the capsules,
one could add a high concentration of BSA in the aqueous core of the capsule. This will
decrease the amount of the protein of interest entrapped in the membrane.
This has been tested successfully with netrin-1. BSA was added in large excess (32 times
the w. amount of netrin-1). The aqueous phase was therefore made of 60mg/L netrin-1 and
1.92 g/L unlabeled BSA. From 0% of release, we obtained the results shown in table 7.4. The
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Figure 7.16. Fluorescence proﬁle of a dextran-FITC
loaded capsule, at the beginning of the
experiment (t = 0 s) and at the end of the
temperature ramp (t = 800 s).
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Figure 7.17. Fluorescence intensity of a polyNIPAM
capsule loaded with dextran-Texas Red
(3,000 g/mol, 50mg/L), upon a decreasing
ramp of temperature.
 0.7
 0.75
 0.8
 0.85
 0.9
 0.95
 1
 1.05
 0  200  400  600  800  1000
 15
 20
 25
 30
 35
 40
 45
 50
 55
 60
F
lu
o
re
sc
en
ce
 i
n
te
n
si
ty
T
em
p
er
at
u
re
 (
℃
)
Time (s)
Fluorescence intensity
Temperature
Figure 7.18. Fluorescence intensity of a polyNIPAM
capsule loaded with BSA-Texas Red upon
a decreasing ramp of temperature.
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Figure 7.19. Fluorescence intensity of a polyNIPAM
capsule loaded with an antibody labeled
with FITC upon a decreasing ramp of tem-
perature.
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hypothesized eﬀect of BSA is veriﬁed, as 75 % of the entrapped netrin-1 are released within
3 hours.
Conclusion
The critical temperature and the release are summarized in 7.4. The temperature of release
is between 27℃ and 31℃, typically around 29℃, which is close to the LCST of regular
polyNIPAM in PBS. Of practical importance, the LCST refers here to critical temperature
measured in the outer buﬀer, not in the solution composition present inside capsules before
leakage. The critical temperature of the polyNIPAM+sucrose mixture (≈ 15℃) appears
clearly below permeabilization conditions.
Embedding the polymer into the membranes does not aﬀect much the dissolution tem-
perature compared to LCST in PBS. The hydrophobic ureas, formed upon attachment of
diisocyanate, can explain a slight decrease of critical temperature of release (29℃) compared
to polyNIPAM LCST (32℃).
Finally, we conﬁrmed that a high eﬃciency of release can be reached if the encapsulated
molecule does not interact with themembrane. Concerning the proteins, when encapsulated
alone the release was poor, presumably because of the reactivity of amine-containing amino-
acids. Indeed, proteins such as BSA can be used to form the shell of the capsule with TDI.
Adding an excess of unlabeled BSA increased the performances of the capsules as it competes
with the target protein (here netrin) for reaction and formation of the inner surface of the
shell.
7.3. Eﬀect of mixed membrane composition
In the last section we described temperature-sensitive capsules made of pure α,ω di-
amino-terminated polyNIPAM. In order to ﬁnely tune the encapsulation and release
properties of the capsules, we modulate the composition of the shell by using both HMDA
and polyNIPAM. To ﬁgure out whether homogeneous distribution of both HMDA and
NIPAM polymers can be obtained, the Hildebrand solubility parameters (δ, expressed in
cal1/2⋅cm−3/2) were estimated. When the diﬀerence between the solubility parameters is
higher than (e.g. more than one unit), polymers are considered to be not miscible. For
polyNIPAM, this value equals 10.0 cal1/2⋅cm−3/2; the value for the polyurea obtained from
HMDA+TDI is not available in the literature, but has been calculated to 18.8 cal1/2⋅cm−3/2
using the values given in reference [235]. The two polymers are thus not compatible:
depending on the concentration ratio of both compounds, we may observe domains of
one polymer entrapped in a matrix made of the other, as illustrated on ﬁgure 7.20. If
polyNIPAM domains are entrapped in an insoluble polyurea matrix, the LCST of these
plug-like domains should be essentially unaﬀected by the surrounding matrix. On the other
hand, more homogeneous mixing and copolymerization is expected to produce membrane
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T ↘
below LCST
insoluble polyurea matrix
polyNIPAM plugs
Figure 7.20. Illustration showing, on the left, a capsule made with an insoluble polyurea matrix (in green, made
from HMDA + TDI) entrapping plugs of polyNIPAM (in purple). Above the LCST of polyNIPAM,
the plugs are impermeable and stays in place. When the temperature is decreased below the LCST
– picture on the right – the plugs dissolve and the content of the capsules is released by the newly
created holes.
whose permeabilization occurs at decreasing temperature with increasing HMDA or that
are not responsive at all to temperature shifts.
In this section we describe capsules made frommixtures of HMDA and polyNIPAM. We as-
sessed the eﬀect of varying ratio between α,ω diamino-terminated polyNIPAM (4,600 g/mol)
and HMDA.
7.3.1. Reactive polyNIPAM and HMDA mixtures
The capsules were prepared as reported in the previous section, from α,ω diamino-termi-
nated polyNIPAM and HMDA mixtures. The total weight concentration of “monomers” –
i.e. polyNIPAM and HMDA – in the aqueous phase was kept constant and equals to 10 g/L.
Various composition of capsules were tried; their composition is reported in table 7.5 (the
detailed preparation and characterization procedures are reported in appendix F.1.2 Reactive
polyNIPAM+HMDA capsule release tests, p. 219).
Sample name 5 % 10% 25% 50%
CpolyNIPAM (g/L) 0.5 1.0 2.5 5.0
CHMDA (g/L) 9.5 9.0 7.5 5.0
Release No No Yes Yes
Glucose Yes Yes Yes No
Temperature (°C) – – 20 ± 1 30 ± 1
Table 7.5. Composition of the aqueous phase used to build capsules, release conditions (presence of glucose) and
temperature of release.
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The ﬁrst batch of capsules was loaded with dextran-Texas Red (3,000 g/mol, 50mg/L).
However, we were not able to transfer the capsules with a low amount of polyNIPAM
(5%, 10 % and 25%) in the aqueous phase. They all burst at the oil/water interface during
the dispersion process, regardless the presence of Tween 80 at the interface. Replacing
the dextran with sulforhodamine 101 (50 µmol/L) allowed to build capsules transferable
to water, but all burst within minutes in the aqueous phase after the transfer. This was
attributed to osmotic pressure. Therefore, we replaced both the transfer buﬀer and the one
used for the ﬂuorescence measurements with PBS supplemented with 11 % w. glucose. This
enabled to equals the concentration of sucrose in the capsules, while ensuring that the
density of the transfer buﬀer (1.04) remained lower than the one of the capsules (1.08). Due
to the presence of glucose, a decrease of the polyNIPAM LCST is expected. With 11% w.
glucose (≈ 0.63mol/L), the LCST is expected to decrease to 27℃ (see ﬁgure 7.21).
The samples 5 %, 10 % and 25% were processed with 11% w. glucose. The 50% capsules
were solid enough and have been processed without glucose. The ﬂuorescence intensity of
the ﬁrst three samples are reported on ﬁgure 7.22.
Samples 5 % and 10% did not release their content upon a temperature decrease. Con-
versely, the sample 25% gives a ﬂuorescence curve comparable to the ones obtained for
capsules made of 100 % polyNIPAM. The critical temperature of release is 20 ± 1℃, which is
below the expected LCST of polyNIPAM in presence of glucose (11 % w.). Increasing the
polyNIPAM/HMDA ratio led to more resistant capsules. At 50% polyNIPAM, a behavior
comparable to the one of the 100 % capsules was obtained (see ﬁgure 7.22). All the results
are summarized in table 7.5.
These results conﬁrm the possibility to build temperature-sensitive capsules from polyNI-
PAM/HMDA mixtures, though they appeared to be of lower mechanical stability than
pure polyNIPAM-based capsules. A minimum concentration ratio exists below which
the capsules are no longer temperature-sensitive, and it is located between 10% and 25%
polyNIPAM: when the concentration of HMDA is higher than 75%, the membrane made
mostly of insoluble polyurea matrix dominates.
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Figure 7.21. Evolution of polyNIPAM LCST in water, as a function of glucose concentration, and in presence
of various ions. Here, only the salt-free case is of interest (the red circles). Polymer concentration:
1 g/L, polymer molecular weight: 16 kg/mol. Reprinted from reference [232].
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Figure 7.22. Fluorescence intensity of capsules made from HMDA/α,ω diamino terminated polyNIPAM mix-
tures, ﬁlled with 50 µmol/L sulforhodamine 101, submitted to a decreasing ramp of temperature.
temperature, ﬂuorescence intensity.
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7.3.2. Unreactive polyNIPAM and HMDA mixtures
Finally, we prepared capsules from HMDA and non-reactive polyNIPAM mixtures. To
keep the length of polyNIPAM chain constant, the commercial precursor of the reactive
polyNIPAM was used, a α,ω dicarboxylic acid terminated polyNIPAM.
Samples were prepared as before, by adding the non-reactive polyNIPAM and HMDA
to the aqueous phase. The processed samples are reported in table 7.6 (the detailed prepa-
ration and characterization procedures are reported in appendix F.1.2 Unreactive polyNI-
PAM+HMDA capsule release tests, p. 220). The capsules were loaded with dextran-Texas Red
(50mg/L). The capsules obtained with this probe were resistant enough to be transferred
into the aqueous phase, even in the absence of glucose.
Sample name 5 % 10% 25% 80% 90% 95% 100%
[polyNIPAM] (g/L) 0.5 1.0 2.5 8.0 9.0 9.5 10.0
[HMDA] (g/L) 9.5 9.0 7.5 2.0 1.0 0.5 0.0
Solid capsule Yes Yes Yes Yes Yes No No
Temperature-sensitive No No No No Yes – –
Temperature of release – – – – 40 ± 1℃ – –
Table 7.6. Capsules made from amino-terminated polyNIPAM and HMDA, composition of the aqueous phase
and properties of the capsules.
In contrast to the results obtained with the reactive (amine-terminated) polyNIPAM, 25 %
and 50% polyNIPAM did not yield temperature-sensitive capsules with the non-reactive
polymer. This suggests that amino-terminated polyNIPAM was incorporated into the
membrane via its reaction with TDI. At higher polyNIPAM/HMDA ratio temperature-
sensitive objects were however formed, as reported in table 7.6. Three regions can be
extracted from this table. Below 80% polyNIPAM, capsules are not temperature-sensitive:
no release was detected when they were submitted to the decreasing temperature ramp.
Between 80% and 95%, fragile temperature-sensitive capsules are obtained. Above 95%,
the reaction did not lead to capsules, even after 12 hours reaction, and drops coalesced
rapidly in the oil or burst when transferred in the aqueous phase.
The responsive capsules diﬀer from the ones containing amino-reactive polyNIPAM by the
release temperature. Here, a clear rupture was observed at 40℃. The origin of this deviation
to the LCST of polyNIPAM has not been found yet. The LCST of the α,ω dicarboxylic acid
terminated polyNIPAM in PBS (3 g/L) is 32℃; the presence of two carboxylates in the chain
does not shift signiﬁcantly the LCST. Any eﬀect of the matrix should also be unlikely, as
capsules made from 50 % reactive polyNIPAM and 50 % HMDA release their content at 30℃
in PBS. Complementary experiments have to be performed to improve the statistics of
present data.
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Figure 7.23. Temperature-sensitivity of the capsules made from polyNIPAM, as a function of the relative amount
of polyNIPAM in the aqueous phase.
7.3.3. Conclusions
The range of composition compatible with formation of temperature-sensitive capsules
are illustrated on ﬁgure 7.23. When the polyNIPAM reacts with diisocyanate, and is
covalently attached at the interface and de facto integrated to the membrane, relatively
low [polyNIPAM]/[HMDA] ratios yield temperature-sensitive objects. On the contrary,
control experiments with non-reactive polyNIPAM show the lack of responses in most
cases. It is likely that the HMDA matrix pushes the polyNIPAM outside the membrane;
this is supported by the low miscibility of the two polymers. High concentrations of
polyNIPAM in water can nevertheless aﬀect the interface, because of adsorption of polymer
aggregates during membrane formation – the temperature is elevated above the LCST at
the beginning of the synthesis procedure. Adding just enough HMDA to get a resistant
membrane allowed to prepare temperature-sensitive objects without amine-ends in the
polyNIPAM. This observation supports the scheme drawn at the beginning of this section,
where the polyNIPAM would be entrapped in an insoluble polyurea matrix, and act as
soluble plugs.
Another interesting point observed with these capsules is their fragility. For the ones
made with reactive polyNIPAM and a high amount of HMDA, we added glucose to equi-
librate the osmotic pressures and prevent their burst. This fragility of the membrane is
rather surprising, because both polyNIPAM and HMDA are known individually to make
mechanically-resistant and impermeable capsules. However, they diﬀer by their ﬂexibility.
HMDA lead to ﬂexible membranes, easily deformed; polyNIPAM lead to stiﬀer membranes
(above LCST), not deformed with a similar strain. If the membrane is eﬀectively composed
of a continuous insoluble polyurea matrix with inclusions of polyNIPAM domains, this
means that stiﬀ domains are surrounded by ﬂexible ones. The capsule is submitted to
high shear stresses during the aqueous phase transfer protocol, which probably facilitate
breakage of heterogeneous membranes at the frontier between soft and rigid doamins. The
transfer protocol could probably be improved to reduce the shear stress.
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Besides the synthesis of thermoresponsive capsules, one of our long term objectives is to be
able to generate gradients of proteins inside culture gels. When encapsulated in a collagen
gel, macrocapsules won’t be able to freely diﬀuse inside the gel. Once their content has
been released in the medium, a second release is impossible as no ﬁlled capsules can reach
the zone. With that system, only pulses of concentration can be generated. To obtain a
gradient, a continuous source of protein is required. Therefore, a diﬀusion of the capsules is
necessary in order to reﬁll the zone that was stimulated with loaded objects. For capsules
freely diﬀusing inside the gel, the capsule size has to be smaller than the mesh size of the gel.
Objects of around 200 nm seem appealing for that application. This chapter thus focuses on
the synthesis and characterization of polyNIPAM-based nanometer-sized capsules.
This work is divided into two parts. The ﬁrst one deals with the synthesis of the nanocap-
sules and their re-dispersion in the aqueous phase. The last one focuses on the characteri-
zation of the capsules, including the determination of their diameter, their morphology and
their release properties.
8.1. Description of the synthesis of nanometer sized
capsules
8.1.1. Analysis of the synthesis procedure described in the
literature
The synthesis of nanocapsules by interfacial polyaddition has been described by the group
of K. Landfester (see section 4.3.2, page 62). This procedure of preparation of nanometer
sized capsules, shown on ﬁgure 8.1, involves two steps: the preparation of an ﬁne emulsion
followed by an interfacial polyaddition.
The size of the capsules derives from the size of the aqueous droplets involved in the
reaction with the diisocyanate. While a syringe was suﬃcient to create these drops to build
millimeter-sized capsules, a more complex method here is required. As we aim to build
200 nm capsules, the droplets must be in the same range. Emulsions with a droplet size in
the 20–200 nm range are called nano-emulsions1. To reach such a small size of droplets,
1As reported in reference [236], several names are given to 20–200 nm sized emulsion: nano-emulsion,
miniemulsions, ultraﬁne emulsions or submicron emulsion. Only the term nano-emulsion will be used
thereafter.
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(A)
Oil phase
Aqueous phase
Oil phase Oil phase
(C)
Aqueous phase
Figure 8.1. Schematic representation of the steps involved in the nanocapsules preparations. (A) the oil phase
and the aqueous phase are emulsiﬁed to yield a nanometeric scaled emulsion. The aqueous phase
initially contains one of the reactant, there a diamine-terminated polyNIPAM (red rectangles) and
the molecule to encapsulate, shown as orange stars. After emulsiﬁcation, the oil-soluble toluene
diisocyanate is added (green rectangles). (B) the diisocyanate reacts with the amine chain ends of
polyNIPAM at the water/oil interface, leading to the formation of capsules. (C) at the end of the
synthesis, the capsules are transferred to the oil phase.
high energy ultrasounds are often applied to the system [236]. However, we have to keep
in mind that these high energy ultrasounds can have a negative impact on the activity
of the protein. Fortunately, low-energy methods yielding water-in-oil nano-emulsions
have emerged recently [237]. For more details on the nano-emulsions, one may refer to
reviews [236–239].
Choice of the surfactant
In this study, only the ultrasound technique was used to prepare the water-in-oil emulsion.
However, we are conscious that this step may have deleterious eﬀects on encapsulated
proteins. Therefore, we decided to give priority to surfactants that have also been used in
low energy methods. The surfactant can be chosen from one of the following classes:
• anionic molecule, like SDS, potassium oleate,
• cationic molecule, like oleylammonium chloride, oleylamine,
• non-ionic one, like the PEG based CxEy, Tween or Span.
As the surfactant will enter the aqueous phase, ionic ones must be avoided to prevent the
denaturation of the encapsulated protein.
Conversely, the Tween and Span family is often proposed to prepare nano emulsions,
as the diversity of available surfactants enable to match the HLB required to emulsify a
speciﬁc aqueous phase in a speciﬁc oil.
Associated in pairs, i.e. one Tween and one Span, a broad range of HLB can be cov-
ered, depending on the relative amount of each surfactant. They are thus been used to
prepared water-in-oil and oil-in-water emulsions [240–242], and as well as oil-in-water
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Figure 8.2. Skeletal representation of Span 80 and Tween 80, two biocompatible non-ionic surfactants. Tween 80:
𝑥 + 𝑦 + 𝑧 + 𝑡 = 20, HLB = 15. Span 80: HLB 4.3.
nano-emulsion [243] and water-in-oil nano-emulsion [244–247]. Moreover, these surfactant
are biocompatible – Tween 80 and Span 80, two members of this family shown on ﬁgure 8.2,
have already been approved as drug and food additives.
Transferring the capsules from the oil phase to an aqueous phase
The interfacial polyaddition-based synthesis has been conducted in cyclohexane as this
solvent was reported to be well suited for the synthesis of nanocapsules [194, 196–200, 231,
248].
As it was the case with the millimeter-sized capsules, the newly synthesized objects
must be transferred from the oil to the aqueous buﬀer. Several methods have already
been discussed in the bibliographical review, section 4.3.2 page 62. Brieﬂy, the oil phase
containing the suspended capsules is emulsiﬁed in an aqueous buﬀer, with the aid of a
surfactant, and then the oil is evaporated, either by heating the emulsion or by stirring
for some time at room temperature. Concentrated SDS solutions (≈ 1 g/L) and high power
ultrasounds are reported [194]. We decided to exploit this technique to explore the feasibility
of synthesizing capsules in oil and transferring them in an aqueous phase, despite the fact
that it may be deleterious for encapsulated proteins.
8.1.2. Synthesis of HMDA based nanocapsules
The ﬁrst set of experiment aimed at verifying the possibility to replace the surfactants used
in the literature by the Span/Tween mixture. Two things needed to be veriﬁed: the stability
of the obtained emulsions and the possibility to prepare capsules from HMDA and toluene
diisocyanate.
Emulsions studies
The key point of this study is to ﬁnd the correct mixture between Span 80 and Tween
80 which lead to stable nano-emulsions of the required size. The aqueous phase contains
HMDA at 100 g/L and ﬂuorescein at 1mmol/L in PBS. The aim of ﬂuorescein was not to
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follow the system by ﬂuorescence, but rather to localize the aqueous phase, as this dye is
not soluble in cyclohexane. This helped to see with naked eyes whether the system demixed
or not. As mentioned before, the HLB of Tween 80 and Span 80 strongly diﬀer, being
respectively 15 and 4.3. HLB, the hydrophilic-lipophilic balance, is an empiric value used to
quantify the hydrophilic or hydrophobic degree of a surfactant. This value is used to predict
whether a surfactant will lead to direct (oil-in-water) emulsions or inverse (water-in-oil)
emulsions. HLBs in the 9–15 range tend to make oil-in-water emulsions, while water-in-oil
ones are obtained with lower values, in the 3–6 range. For the mixtures of surfactants, one
may estimate the HLB of the mixture by the formula HLBmixture = HLBA ⋅ 𝑤A + HLBB ⋅ 𝑤B,
where A and B are the two considered surfactants, and 𝑤A, 𝑤B their respective weight
fractions.
Span:Tween vol.
ratio
HLB Initial aspect of the emulsion Aspect 12 h
later
100:0 4.3 Yellow, trouble, homogeneous Idem
90:10 5.4 Yellow, trouble, homogeneous Idem
80:20 6.6 Yellow, trouble, homogeneous Idem
70:30 7.7 Yellow, almost transparent,
homogeneous
Idem
60:40 8.8 Yellow, translucent, homogeneous Idem
50:50 9.8 Yellow, translucent, homogeneous Demixing
40:60 10.9 Aqueous phase gelation —
30:70 11.9 Aqueous phase gelation —
Table 8.1. Emulsion aspect of the obtained emulsion, unaided eye observation. Idem means that no evolution
could be detected. HLB estimated with the formula HLBmixture = HLBA ⋅ 𝑤A + HLBB ⋅ 𝑤B.
We prepared emulsions from the diﬀerent Span to Tween ratio, as reported in table 8.1.
The details of the experimental procedure are given in appendix C.3.1 Characterization
of nano-emulsions prepared from Tween 80/Span 80 mixtures page 197. Depending on the
surfactant mixture, yellowish transparent, translucent or opaque emulsions are obtained.
Stable emulsions are obtained for the highest ratios of Span 80. For 50 % vol. Span (HLB
= 9.8) the emulsion demixed after 12 hours. This is not surprising, as the HLB of the
surfactant mixture is outside the water-in-oil HLB range. For the lowest ratios of Span, the
preparation of the emulsions was even hindered by the gelation of the aqueous phase. This
can be attributed to the high amount of Tween used. Being only partly soluble in the oil, it
concentrates in the aqueous phase thereby inducing the transition to a gel state. The aspect
of the other emulsions can be explained by the size of the droplets.
Each sample was characterized by dynamic light scattering at t = 0 and t = 12 h, without
dilution. The results – the diameter and the associated polydispersity – are summarized in
table 8.2. As expected, emulsions prepared with the highest ratio of Span exhibited small
droplets sizes and high stability. With lower values, typically the Span:Tween 70:30 vol.
ratio, the diameter decreased with time after preparation while no demixing was observed.
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Span:Tween t = 0 t = 12h
vol. ratio Dh (nm) Disp. Dh (nm) Disp.
100:0 198 0.22 200 0.10
90:10 201 0.18 221 0.12
80:20 197 0.18 215 0.29
70:30 185 0.21 115 0.25
60:40 199 0.20 276 0.25
50:50 222 0.20 – –
Table 8.2. Diameter of the emulsiﬁed droplets, as measured by dynamic light scattering. The measurements
were conducted on emulsions without dilution, immediately after preparation and 12 hours later.
This suggests that we were close to the micro-emulsion domain, where the emulsions
are thermodynamically stable. Decreasing the Span:Tween ratio further lead to unstable
emulsions, as seen with the increasing diameter of the 60:40 sample and the demixing of
the last one.
Capsule synthesis
All the previously detailed emulsions with a Span ratio comprised 100 % and 50 %were mixed
with toluene diisocyanate. A polyurea shell should be formed from the reaction between
TDI and HMDA. All the samples in the range 100–50 % vol. Span reported in table 8.2 were
processed. After this reaction step, the samples were transferred into aqueous phase, by
emulsifying the oil suspension in a solution of sodium dodecyl sulfate and evaporating the
cyclohexane at 70℃ for 30 minutes under magnetic stirring. The aqueous samples were
ﬁltered on 1.2 µm cellulose acetate prior DLS measurements. The protocol is detailed in
appendix F.2.1, p. 222. The diameter of the synthesized objects both in cyclohexane and in
water, after ﬁltration, are summarized in table 8.3.
Span:Tween In cyclohexane In SDS, ﬁltered
vol. ratio Dh (nm) Disp. Dh (nm) Disp. kcps
100:0 5,190 0.32 208 0.16 17
90:10 10,700 0.42 206 0.23 5
80:20 1,980 0.40 218 0.11 19
70:30 633 0.29 204 0.19 10
60:40 344 0.22 218 0.17 27
50:50 322 0.22 217 0.17 52
Table 8.3. Diameter of the capsules in cyclohexane (after synthesis) and in SDS solution obtained by dynamic
light scattering.
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In cyclohexane, high amounts of Span lead to aggregated samples, as shown by the high
diameter and polydispersities. Conversely, with 60:40 and 50:50 Span:Tween vol. ratios, the
diameters of the capsules are close to the diameter of the droplets in the initial emulsion.
After dispersion in the aqueous phase, all sample exhibited a diameter close to 200 nm,
which suggests some aggregation in the oil phase. However, the intensity of scattered light
diﬀers strongly from one sample to the other. Low intensities are obtained with Span 80
concentration in the 100–70 % range, which means there is only a few objects remaining in
the aqueous phase. The aggregates visible in the oil phase were probably stuck in the ﬁlter.
Conversely, high intensities were measured for the two samples obtained with 60 and 50 %
vol. Span. These values are highly encouraging. Therefore, the samples prepared in the next
parts will be synthesized in the presence of 60:40 and 50:50 Span 80:Tween 80 mixtures.
8.1.3. Application to the synthesis of polyNIPAM nano-capsules
In this part, HMDA has been replaced by the diamine-terminated polyNIPAM used in the
previous chapter, whose structure is reminded ﬁgure 8.3. In the case of polyNIPAM, the
preparation procedure has to be adapted to the temperature sensitivity of the polymer.
Figure 8.3. Skeletal structure of the α,ω diamino terminated poly(N-isopropyl acrylamide).
In the last chapter, we demonstrated that replacing a fraction of polyNIPAM with HMDA
did not aﬀect the responsiveness of the membrane. Therefore, two series of capsules
were synthesized, one with 100 % diamino-terminated polyNIPAM and another one with a
50 %/50 % polyNIPAM/HMDA mixture. As explained in the previous chapter, polyNIPAM
solutions needs to be processed at low temperature. Here, the high concentration of
polyNIPAM causes the LCST to decrease, even if no salt nor sucrose were added. Unless
speciﬁed, all the next steps performed at 10℃. The detailed preparation procedure is
available appendix F.2.2, p. 223.
The size of the obtained droplets has been assessed at 25℃ after emulsiﬁcation and prior
adding the TDI. The capsules obtained after the reaction with TDI were characterized at
40℃ both in oil and in the ﬁnal aqueous phase. The DLS measurements are reported in
table 8.4.
The diameter of the emulsions obtained in the presence of polyNIPAM is slightly higher.
Indeed, polyNIPAM may increase the viscosity of the dispersed phase, thus reducing the
eﬃciency of ultrasounds. As before, the capsules in oil tend to aggregate, which makes the
measurements unreliable, and gives diameter in the micrometer range. When transferred to
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Composition
Emulsion Capsules in oil Capsules in SDS (40 °C)
Dh (nm) Disp. Dh (nm) Disp. Dh (nm) Disp. kcps
pNIPAM 100 % 359 0.20 760 0.25 176 0.09 120
pNIPAM 50 %/HMDA 50 % 315 0.22 3,260 0.25 171 0.22 89
Table 8.4. Diameter of the emulsion and the capsule suspension, measured by dynamic light scattering. SDS
samples were ﬁltered on cellulose acetate (1.2 µm) prior to measurement.
the aqueous phase, objects with a diameter in the expected range are obtained. The factor
of two between the diameters of the emulsion and the capsules in the aqueous phase may
be the sign that capsules are, at least, partly broken in the process.
These preliminary experiments conﬁrmed the possibility to build objects with a diam-
eter close to 200 nm using a mixture of Span/Tween. This opens the way to low-energy
emulsiﬁcation procedures, compatible with the encapsulation of fragile molecules.
8.2. PolyNIPAM nanocapsules characterization
8.2.1. Temperature eﬀect on the hydrodynamic radius
PolyNIPAM capsules were prepared from 100 % diamino-terminated polyNIPAM, according
to the previously exposed protocol. After being transferred in the aqueous phase, the
resulting suspension was characterized by DLS. We measured the hydrodynamic diameter
and the intensity of scattered light, above the LCST (50℃), and below the LCST (20℃)
immediately after decreasing the temperature, as well as 24 hours and 8 days later. These
results are summarized in table 8.5.
Time Temperature (°C) Dh (nm) kcps
0 50 218 57
≈ 15min 20 413 65
24 h 20 562 64
8 d 20 440 69
Table 8.5. Hydrodynamic diameter and intensity of scattered light of a suspension of polyNIPAM capsules.
When the temperature is decreased below the LCST of polyNIPAM, the diameter of the
objects increases from 218 nm to 413 nm; this might correspond to the swelling of the
polymer. Long term measurements show no signiﬁcant evolution of the hydrodynamic
diameter or of the intensity of scattered light. We do not observe the dissolution of the
whole capsule. This is compatible with the observations made on millimeter size capsules,
where the capsule did not dissolve either, but was rather torn into pieces.
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8.2.2. Temperature-induced release
For the millimeter-sized capsules, it was possible to follow the ﬂuorescence intensity directly
inside the capsule as their size permits it. The dye concentration inside the capsule could
be directly linked to the intensity of ﬂuorescence inside it. However, it is not possible to
follow nanometer-sized objects by this technique. The main obstacles here are the Brownian
motion, causing a continuous movement of the capsule, and the diﬀraction of light, which
make the observation of a single capsule rather diﬃcult.
With the vesicles, this issue was addressed by using a speciﬁc ﬂuorophore or combination
of molecules, whose ﬂuorescence is quenched inside the capsules and reappeared when
released. Amongst the diﬀerent possibilities, we choose to focus on calcein and cobalt(II)
complexes. As reported in references [249–252], calcein and cobalt(II) ions form non-
ﬂuorescent complexes. Adding EDTA to the outer buﬀer make the ﬂuorescence reappear
when the complex leak out of the capsule, as EDTA is a stronger ligand for cobalt than the
calcein. While one calcein is able to complex one cobalt ion, they are encapsulated at a
1:2mol. calcein:cobalt ratio.
Figure 8.4. Skeletal representation of calcein, in its ionized form. The four carboxylates complex cobalt(II) ions.
The concentrations we choose to encapsulate were 250 µmol/L calcein – two order of
magnitude lower than the concentration used for self-quenching – and 600 µmol/L cobalt(II),
introduced as CoCl₂.
In order to check the validity of the technique, we recorded the emission spectra of
calcein (3.2 µmol/L)+ cobalt(II) chloride (7.7 µmol/L), with and without 10mmol/L EDTA, in
PBS. The excitation wavelength was 495 nm; the obtained spectra are shown on ﬁgure 8.5.
Adding EDTA caused a strong increase of the ﬂuorescence intensity. At the maximum
emission wavelength (525 nm), the intensity ratio with and without EDTA is 280.
Based on the these observations, we encapsulated the calcein/cobalt(II) complex in polyNI-
PAM/HMDA capsules. Several polyNIPAM:HMDA w. ratios have been tested: 100/0, 90/10
and 80/20. The detailed protocol is reported in appendix F.2.3, p. 224.
We were not able to reproducibly synthesize capsules made of 100 % polyNIPAM capsules,
as irreversible macroscopic aggregates formed either in the oil phase or after their transfer
in the aqueous phase. Therefore, we did not characterize the release from these objects,
but rather focused capsules containing mixtures of HMDA and polyNIPAM. Conversely,
the ﬂuorescence intensity dependence on the temperature of the 90/10 and 80/20 samples
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Figure 8.5. Left: ﬂuorescence intensity of a solution containing 3.2 µmol/L calcein sodium salt and 7.7 µmol/L
CoCl₂ in PBS, without and with 10mmol/L EDTA.
Right: ﬂuorescence intensity of polyNIPAM/HMDA 80/20 capsules, encapsulating calcein/cobalt
complex, suspended in 10mmol/L EDTA in PBS. The suspension is submitted to a decreasing temper-
ature ramp. The temperature dependence of the ﬂuorescence intensity has been corrected. Excitation
wavelength: 488 nm. Emission wavelength: 526 nm.
was recorded. An example of the curves obtained from these experiments is shown on
ﬁgure 8.5, and is representative of the ones obtained for both samples.
The ﬂuorescence intensity was found to slightly increase when the temperature is de-
creased; no slope discontinuity is observed. In particular, crossing the LCST of the polyNI-
PAM (32℃) does not alter the shape of the ﬂuorescence intensity curve. This means that
either the capsules are not made leaky with the decrease of temperature, or that they were
already empty before this experiment. The initial raw value of ﬂuorescence, 53,580 for
the 80/20 sample and 17,000 for the 90/10 one, is in the range of what is expected for a
complete release, which conﬁrms that all the encapsulated content was already released at
the beginning of the experiment.
8.2.3. Morphology of the capsules imaged by electron microscopy
We showed in the previous paragraph that calcein is completely released even before
decreasing the temperature. This suggests that either the membrane synthesis leads to
leaky shells, or that capsules are destroyed in any of the following steps. We tried therefore
to analyze the shape of the obtained capsules by cryoTEM. To this aim, we prepared capsules
with the compositions reported in table 8.6. The capsules were prepared as reported before,
without any dye. After their transfer in the aqueous phase, the SDS in the buﬀer was
removed by gel permeation chromatography conducted at 50℃. This additional step was
required, as SDS micelles appears on cryoTEM pictures, adding unwanted noise. The
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Sample number 1 2 3
HMDA (g/L) 100 50 20
diamino-terminated polyNIPAM (g/L) 0 50 80
Table 8.6. Composition in diamine terminated monomers of the aqueous phases used to prepared the capsules
for the transmission electron microscopy.
A B
Figure 8.6. Suspensions of capsules viewed by cryoTEM. A: capsules made of 50 g/L HMDA/50 g/L polyNIPAM,
3200×. Scale bar size: 500 nm. B: capsules made of 100 g/L HMDA, 11000×. Scale bar size: 200 nm.
protocol is detailed in appendix F.2.3, p. 224. Pictures obtained for samples 1 and 2 are
shown on ﬁgure 8.6.
On picture A is shown the suspension of capsules made from 50% polyNIPAM/50%
HMDA – pictures obtained for the 80% polyNIPAM were similar. The sample seems to
consist mainly of aggregates of spherical objects; no tight capsules could be seen on this
picture. We note also the presence of a black network on the whole sample. Picture B
shows objects made from 100% HMDA. They are spherical, and their diameter is in the
expected range of 200 nm. They seem also to be made of aggregates of small spheres or
patches. In this case, no network is observed, but we can see ﬁlaments emerging from the
200 nm objects.
Conversely, 100 % HMDA capsules prepared in reference [231] are shown on ﬁgure 8.7.
The capsules looks partly collapsed, as the samples are not frozen prior imaging in this
case. However, they seem to be made from a homogeneous and continuous membrane.
The only diﬀerence between this reference and our experiment is the surfactant used to
stabilize the emulsion. In our case, we used Span 80/Tween 80 mixtures, while they used a
polyisobutene-succinimide pentamine (Lubrizol U).
Span 80 and Tween 80 contains both 3 alcohols functions susceptible to react with the
diisocyanate. The high functionality of these molecules will lead to the formation of a
cross-linked network, which explains the black mesh on the electron microscopy pictures.
This issue is not observed with Lubrizol, as it only carries one amine function. In our
system, we have both primary amine functions, at the end of our “monomers” – polyNIPAM
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Figure 8.7. TEM picture of capsules made from HMDA+TDI, from reference [231].
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Figure 8.8. Tween 80 and Span 80 contains both three functions thaymay react with an isocyanate, while Lubrizol
U contains only one. These functions are highlighted in green, and are alcohols for Tween/Span, and
a primary amine for Lubrizol.
or HMDA – and alcohols on the surfactants. We expected that the diisocyanate would
mostly react with the amines, as both were introduced in almost quantitative proportions.
Furthermore, amines are more reactive than alcohols. However, this seems not be the case.
Span 80 is not soluble in water, and is probably mostly present in the oil phase, even after
the emulsiﬁcation. Span 80 and the disocyanate are thus in the same phase making their
reaction easier, thus creating the network.
Conclusion & perspectives
Transposition of the synthesis procedure of nanocapsules described in the literature to
polyNIPAM based systems was a priori a simple question of adjusting emulsiﬁcation
conditions. We choose the couple Span 80/Tween 80 to emulsify the system because they
enable to form water-in-oil emulsions by a low energy emulsiﬁcation strategy.
In the published articles, no mention is made of the importance of the nature of surfactant
in the synthesis of the capsules, but our attempts to use Tween/Span mixtures proved
that it matters. Calcein/cobalt assay and morphology of capsules shown in transmission
electron microscopy images suggest ill-deﬁned surfaces. In practice, only leaky objects were
obtained. Interfacial reactivity was certainly be aﬀected by surfactants. The presence of
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alcohols in the surfactant molecules may lead to side reactions; this work should be pursued
by a systematic evaluation of the surfactants that could be used to stabilize the emulsion,
for instance the Brij family. As Tween/Span, they can be used to prepare nanoemulsions
by low energy processes, at constant temperature [247], and are also biocompatible (see
ﬁgure 8.9).
Figure 8.9. General formula of a Brij surfactant. This molecule is made of an alkyl chain and a PEG tail; the
alkyl chain may be unsaturated.
Finally, the procedure to redisperse the capsules in an aqueous phase has to be optimized.
Indeed, the ultrasounds step might be too violent both for the capsules and their load.
Centrifugation may be an alternative, and it has already been used to make water droplets
crossing the oil/water interface, as shown section 2.4.3, page 36, for the preparation of
liposomes by the reverse emulsion method. We may also consider to replace progressively
the oil with solvents of increasing polarity, e.g. by cycles of gentle centrifugation and
redispersion of the capsules in polar solvents, like alcohols of decreasing chain length,
while avoiding the dissolution of the polyNIPAM shell.
142
9. UCST polymer-based
millimeter-sized capsules
Figure 9.1. Common skeletal formula of the UCST polymers. Molecular weight: ∼ 15 kg/mol. The UCST of the
polymer depends on the acrylamide/acrylonitrile ratio. Polymer 35℃: α = 67.9 %, β = 32.1 %. Polymer
43℃: α = 66.1 %, β = 33.9 %. Polymer 47℃: α = 65.8 %, β = 34.2 %.
This chapter presents the use of UCST polymers to build temperature sensitive capsules.
Asmentioned in the review chapter, UCST polymers are appealing for biological applications
as an increase of temperature will induce their dissolution and thus the destabilization
of the capsule shell and the release of the encapsulated content. The work reported here
mainly focuses on three of the polymers provided by Y. Zhao, whose general structure is
shown back in ﬁgure 9.1. The UCST of these polymers was 35℃, 43℃ and 47℃ in PBS,
and they will be referred later by these values.
Like the commercial polyNIPAM derivative we used in the last chapter, the UCST polymer
chains are end-functionalized by carboxylic acid functions. We planned to incorporate
these polymers in the same way we incorporated the polyNIPAM. Due to lack of time,
the conversion of the polymers to “reactive” amine-terminated chains was however not
accomplished. A ﬁrst preliminary study was carried out to assess the preparation of capsules
from non-reactive precursors.
9.1. Characterization of the UCST polymer
TheUCST of polymers is sensitive to the composition of the aqueous phase, but these eﬀects
were not characterized when this work was launched. As we use sucrose or NaCl to increase
the density of the inner aqueous phase during capsule preparation, it was important to
measure the impact of these osmolytes, and of other alternative additives used to increase
capsule density – including glucose and heavy water – have been characterized.
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9.1.1. Solute eﬀects on the UCST
Eﬀect of sucrose, NaCl and HMDA on the UCST of the polymers
We studied the eﬀect on various solutes – HMDA, sodium chloride and sucrose – on
the UCST of the 35℃ polymer, as a function of the solute concentration. We ﬁrst de-
termined the cloud point of solution of polymers by stepwise decrease of temperature
(steps of 1℃), and observation of emerging turbidity; the detailed protocol is reported in
appendix C.3.5 Evaluation of UCST as a function of solute concentration, p. 200. The results
are shown in ﬁgure 9.2.
With all the solutes, the UCST decreased almost linearly with increasing concentration
of solute. This enabled us to extrapolate the UCST for the concentrations required in the
capsules. For sucrose at 0.63mol/L, the expected UCST is 13℃ (< RT); for sodium chloride
at 2.22mol/L, − 44℃…1 Thus the impact of the two osmolytes, sucrose or sodium chloride,
is high and would decrease the UCST below the temperature of experiments.
Whereas all UCST polymers quickly dissolved in water with sucrose or NaCl above a
threshold temperature, their mixtures with HMDA turned into translucent gels within
minutes or hours, even at high temperature. Cooling the mixtures below the UCST (ice
bath) did not induce to precipitate, which was surprising. When they are dissolved in water
or PBS, the diamine and the polymer are of opposite charges, which may explain that gel
were formed by coulombic associations. To alleviate this eﬀect, we added two equivalents
1Those concentrations are the ones used for the synthesis of HMDA or polyNIPAM-based millimeter-sized
capsules.
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Figure 9.3. Evolution of polyNIPAM LCST as a func-
tion of the concentration of sodium chloride
and the molecular weight of the polymer.
Polymer concentration: 10 g/L. Reprinted
from reference [233].
Figure 9.4. Reprinted from reference [253]. Relation-
ship between ΔT (LCST with sugar − LCST
in water) and concentration of sugars: fruc-
tose (◆), xylose (◇), glucose (○), sucrose
(▲) and maltose (□), for a polyNIPAM
crosslinked hydrogel.
of HCl per HMDA, turning the solution to slightly acidic before adding the polymer under
its acid form.
We can compare the eﬀect of the solutes on the polyNIPAM and on the UCST polymer.
The evolution of polyNIPAM LCST in presence of sodium chloride is shown in ﬁgure 9.3.
The slope of the curve is approximatively − 10℃/mol, one third of the value obtained with
the UCST polymer, which means that the eﬀect of NaCl is much higher in the case of UCST
polymers. Sucrose also decreases the LCST of polyNIPAM, as shown in ﬁgure 9.4. The
slope is also in the range of − 10℃/mol.
To achieve the reverse response to additives, we ﬁnally used heavy water.
Eﬀect of heavy water on the UCST
TheUCST of the polymers in D₂O was assessed by following the absorbance of polymer solu-
tions by UV-visible spectroscopy upon decreasing temperature. Details on the experimental
setup and conditions are available in appendix C.3.2, page 198.
Reference spectra for polymers at 5 g/L in PBS were provided by Y. Zhao, and are reprinted
on ﬁgure 9.5. The spectra obtained in heavy water are shown in ﬁgure 9.6. The UCSTs
are deﬁned here as the temperature when the transmittance is decreased by 50%. The
values are summarized in table 9.1. For all three polymers, the UCST in heavy water was
≈ 10℃ above the one obtained in PBS. The UCST temperature of polymer 1 is 45℃ in heavy
water, which means that capsule loaded with high density solutions can be prepared while
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Polymer 1 (35 °C) 2 (43 °C) 3 (47 °C)
UCST in PBS (°C) 34 43 47
UCST in D₂O (°C) 45 52 58
ΔT (°C) 11 9 11
Table 9.1. UCST of the three polymers, in PBS and in heavy water.
preserving the response to a temperature jump above RT (or above 37℃ if application in
biological environments are sought). If the processing temperature of 50℃ is too high (e.g.
induce the degradation of the protein encapsulated), addition of sucrose or sodium chloride
could be used to decrease the UCST.
9.2. Adaptation of the capsule preparation procedure to
the UCST polymers
To build capsules with UCST polymers, we had to replace HMDA by another reactant that
do not form gels with the polymer. In reference [194], various “monomers” are reported to
lead to the formation of capsules in conjunction with TDI: starch, dextran and 1,6-hexane
diol. We tried to build capsules from 1,6-hexane diol, using an aqueous phase made of
10 g/L 1,6-hexane diol and 20% w. sucrose in PBS. However, this did not lead to capsules;
even after 12 hours of reaction, the aqueous drops were not covered with a mechanically
resistant membrane. The other monomers reported by K. Landfester’s team are proteins,
bovine serum albumin and ovalbumin (OVA) [205]. 170–190 nm capsules were prepared
from an aqueous phase made of protein (BSA or ovalbumin), of deionized water and sodium
chloride. The weight concentration of “monomer” is the same here as the one reported
for the capsules made from HMDA. We decided to adapt this strategy to build capsules
in the presence of UCST polymers. As for polyNIPAM, we mixed the UCST polymer and
ovalbumin while keeping their total weight constant – 100 g/L.
The ﬁnal synthesis procedure – aqueous phase transfer excepted – is represented on
ﬁgure 9.7. The aqueous phase – containing the ovalbumin, heavy water and the UCST
polymer – must be processed at a temperature where the polymer is soluble, that is above
the UCST in presence of heavy water. Conversely, the cyclohexane:TDI mixture must be
added below the UCST to react on interfaces that contain polymers. For all polymers, we
worked at room temperature (20℃), as their UCST is above 34℃.
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TDI / albumin
reaction
aqueous phase
(T above UCST)
UCST polymer at the
water/oil interface
cyclohexane
T at room temperature
(below UCST)
TDI gradient
(A) (B) (C) (D)
Figure 9.7. Synthesis of the capsule in the oil phase. (A) a gradient of TDI concentration is created in cyclohexane,
at room temperature (below UCST). Under these conditions, the concentration in TDI at the top of
the cyclohexane is considered null. (B) a drop of the aqueous phase is introduced in the oil with a
microsyringe. The syringe and its content were heated above UCST, allowing the solution to ﬂow
through the needle. (C) the UCST polymer inside the drop precipitates and goes to the water/oil
interface. As the drop was kept in the higher levels of cyclohexane, where no TDI can be found,
no reaction occurred yet. (D) the drop is made to fall at the bottom of the cyclohexane, were the
membrane is synthesized.
Results
The experiments performed in this section have been done in parallel of the characterization of
the UCST polymers. Thus, the density of the aqueous phase was increased with sucrose for the
capsules made with 10 g/L of proteins, and with heavy water for the 100 g/L ones. The detailed
procedure is available in appendix F.1.2 Determination of the working UCST+albumin
composition, p. 220.
Four sets of aqueous phases were prepared, with BSA or ovalbumin with a concentration
of 10 g/L or 100 g/L. Dextran TexasRed was used as the ﬂuorescent probe. The composition
of these phases are reported in table 9.2. Due to some experimental constraints – mainly
the concentration of ﬂuorescent probes in stock solutions – the concentration of heavy
water used was 71.7 % vol.
All the aqueous phases lead to mechanically resistant capsules transferable to PBS. Fluo-
rescent proﬁles for all samples are shown in ﬁgure 9.8.
Albumin Calbumin Additive Cadditive Fluorescent probe Cprobe
Ovalbumin 10 g/L Sucrose 20 % w. Dextran Texas Red 100mg/L
Ovalbumin 100 g/L D₂O 71.7 % vol. Dextran Texas Red 10mg/L
BSA 10 g/L Sucrose 20 % w. Dextran Texas Red 100mg/L
BSA 100 g/L D₂O 71.7 % vol. Dextran Texas Red 10mg/L
Table 9.2. Composition of the aqueous phases used to build model capsules from albumin. The solvent of all the
phases is PBS. The ﬂuorescent probe here is Texas Red labeled dextran (3,000 g/mol).
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Figure 9.8. Capsules made from albumin and ﬁlled with dextran-TexasRed. Left: epiﬂuorescence picture. Right:
ﬂuorescence proﬁle.
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Capsules made from low protein concentration (10 g/L) show almost ﬂat ﬂuorescence
proﬁles, which suggest that the TexasRed labeled dextran is partially entrapped in the
membrane. This is probably due to a reaction between the diisocyanate and the dextran.
The reactivity of the dextran compared towards the diisocyanate has even been exploited
to build nanocapsules from it, as reported in references [194, 197].
For BSA (≈ 65 kg/mol), 10 g/L corresponds to 0.154 µmol/L. BSA probably reacts with the
isocyanates by its primary amine functions, brought by the lysine residues. The number of
lysine residues in BSA is evaluated to 12 [254]. This increases the concentration of reactive
functions to 1.85 µmol/L. For dextran (162.14 g/mol per monomer), 0.1 g/L corresponds to
a concentration of 0.617 µmol/L. As each dextran monomer bears three alcohol functions,
this leads to a concentration of 1.85 µmol/L reactive species. The same calculation has been
performed for ovalbumin; all the results are summarized in table 9.3.
Reactant BSA Ovalbumin Dextran
Mw (monomer) 65 kg/mol 43 kg/mol 162.14 g/mol
Reactive functions/monomer 12 (lysine) 20 (lysine) 3 (alcohol)
Concentration 10 g/L 10 g/L 0.1 g/L
Reactive functions concentration 1.85 µmol/L 9.30 µmol/L 1.85 µmol/L
Concentration 100 g/L 100 g/L 10mg/L
Reactive functions concentration 18.5 µmol/L 93.0 µmol/L 0.185 µmol/L
Table 9.3. Reactant concentrations in 10 g/L capsules (loaded with 100mg/L dextran Texas Red) and 100 g/L
capsules (loaded with 10mg/L dextran Rexas Red). Data for ovalbumin were extracted from Protein
Data Bank, reference 1OVA.
The concentration of reactive functions for dextran and the proteins is close, which may
explain the integration of dextran in the membrane, as explained in section 7.2.2 Sulforho-
damine 101, p. 121. Even if amines are reported to be more reactive than alcohols, their
number is probably overestimated. All the lysines have been taken into account, regardless
of their position in the protein – some of them must be less accessible to the isocyanate,
thus less reactive.
To overcome this competition between dextran and the albumin, we choose both to
decrease the concentration of ﬂuorescent-labeled dextran to 10mg/L and to increase the
concentration in albumin (100 g/L). The new concentrations in reactive functions are shown
in table 9.3. The ratio albumin-functions:dextran-functions is now 100 for BSA (1 before)
and ≈ 500 for ovalbumin (5 before). The corresponding ﬂuorescence proﬁles are shown
in ﬁgure 9.8. For BSA, the proﬁle plot has the shape of a reverse sphere (convex curve),
which is characteristic of a ﬂuorescent membrane (cf. section 7.2.2 page 121). The dextran
is still incorporated in the membrane, even with optimized conditions. A diﬀerent proﬁle is
obtained with ovalbumin, though. Its concave shape conﬁrms that dextran is less integrated
in the membrane in this case.
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These results show that the synthesis of UCST polymer based macrocapsules is possible.
In reference [205], where nanometer-sized capsules from albumin are described, it is shown
that ovalbumin lead to capsules with higher performances than their BSA-based counter-
parts. They report a higher loading eﬃciency of sulforhodamine 101. The morphology of
the capsules also diﬀers (see ﬁgure 9.9). Ovalbumin capsules seemed more deﬁned than the
BSA ones.
Figure 9.9. Reprinted from reference [205]. Capsules made from albumin by the reverse emulsion emulsion
method, viewed by scanning electron microscopy. A: capsules made from bovine serum albumin
(BSA). B: capsules made from ovalbumin.
These observations, together with our results, allowed us to conclude that capsules made
from ovalbumin should be preferred, because encapsulated molecules are less susceptible
to react with the diisocyanate, and because the performance of nanometer-sized capsules
built from ovalbumin are higher.
9.3. Characterization of capsules made from UCST
polymers and ovalbumin
This section focuses on the characterization of the thermal properties of capsules made
from UCST polymer and ovalbumin. The experiments were conducted mainly on the 43℃
polymer. Due to a lack of time, only a limited set of measurements has been done with the
35℃ polymer. We decided not to use the 47℃ one as its UCST in heavy water is 58℃, and
experimentally, its mixture with protein was accompanied by gelation likely due to protein
denaturation at high temperature – at this temperature, the denaturation rate of ovalbumin
is in the range of 100 minutes [255]. For the other two UCST polymers, we explored the
inﬂuence of the composition of the shell on release properties.
9.3.1. Choice of the encapsulated fluorophore
In order to determine the best ﬂuorophore to study the thermal properties of the UCST
polymer-based capsules, we prepared capsules from aqueous solutions containing OVA,
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UCST polymers and 3 diﬀerent ﬂuorophores. The composition of the aqueous phases
is reported in table 9.4. The experimental procedure is detailed in appendix F.1.2 UCST
polymer-based capsules: choice of the ﬂuorophore, p. 221.
Dye Cdye Covalbumin (g/L) CUCST polymer (43 °C) (g/L)
BSA-FITC 167mg/L 80 20
Calcein 10 µmol/L 80 20
Dextran-TexasRed 10mg/L 100 10
Table 9.4. Composition of the aqueous phase used to made ﬂuorophore-ﬁlled capsules. All contained also 71.7 %
vol. D₂O and were buﬀered with PBS.
BSA-FITC loaded capsules looked initially (i.e. at RT) homogeneous. Bright spots (likely
aggregates) appeared upon temperature increase. The size and brightness of these aggre-
gates increased with increasing the temperature (see ﬁgure 9.10), while the background
became darker which suggests that some BSA-FITC is associated with the aggregates.
Aggregation may be either due to the increase of temperature or a co–precipitation of the
BSA with the polymer.
The mean ﬂuorescence intensity over the all volume of the capsule was plotted as a
function of the temperature (see ﬁgure 9.10). It has been shown to increase with the
temperature, with a 300 seconds lag time. The origin of this unexpected increase is possibly
rooted in BSA aggregation and/or denaturation.
Similar experiment conducted with calcein as the ﬂuorophore preserved the homogeneous
appearance of membrane ﬂuorescence, even when heated to 51℃ (see ﬁgure 9.10). In the
example shown, the total ﬂuorescence inside the capsule increased with the temperature,
ﬂuorescence intensity and temperature curves being remarkably superimposed, which
suggests the absence of leakage and the eﬀect of T on the ﬂuorescence of this ﬂuorophore.
Calcein and FITC belong to the same class of ﬂuorophores. FITC being known to have a
T-dependant quantum yield, this speaks for a strong inﬂuence of the temperature on calcein
too.
Finally, dextran-TexasRed loaded capsules looked homogeneous in ﬂuorescence, inde-
pendently of the temperature. The ﬂuorescence of Texas Red is almost constant with
temperature [234]. Increasing the temperature made the ﬂuorescence intensity decrease
(see ﬁgure 9.10). The magnitude of the decrease – 25 % over 55℃ – was however low.
As a control experiment, we evaluated the behavior of non encapsulated TexasRed in
an aqueous solution of similar composition as the inner phase of the capsule – 100 g/L
OVA and 100mg/L Dextran TexasRed. The ﬂuorescence intensity recorded as a function
of temperature, as shown on ﬁgure 9.11, display a clear increase when the temperature
decreased, and variations were essentially reversed by reversing temperature shifts. The
amplitude of the variation was of the same order of magnitude as the variation measured
in the capsules, which suggest that capsules were impermeable.
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Figure 9.10. Capsules made from ovalbumin and UCST polymer, ﬁlled with ﬂuorescent probes and submitted to
an increasing ramp of temperature. Left: epiﬂuorescence pictures. Right: ﬂuorescence intensity of
the capsule and temperature as a function of time.
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In practice, we nevertheless observed release (of internal aggregates or microscopic
heterogeneities) because it was accompanied by their burst out of the capsule, visible on the
pictures recorded with the epiﬂuorescence microscope. An example of this burst is shown
on ﬁgure 9.12, where a capsule made from 80 g/L UCST polymer (43℃) and 20 g/L ovalbumin
is heated from 15℃ to 55℃. We deﬁned the temperature of release as the temperature of
capsule burst.
9.3.2. Influence of the membrane composition on the
temperature-sensitivity of the capsules
To assess the inﬂuence of membrane composition (varied by variation of the inner aqueous
phase during membrane formation) on temperature sensitivity, capsules were prepared
from a solution of ovalbumin, UCST polymer (43℃) and heavy water in PBS. Capsules were
tested within 24 h after their preparation. The composition of the processed aqueous phases
is reported in table 9.5 (the detailed protocol is reported in appendix F.1.2 Temperature-
sensitivity of UCST:ovalbumin capsules, p. 221).
Sample name 0 % 10% 20% 30% 50% 70% 80% 90% 100%
CUCST polymer 43 °C (g/L) 0 10 20 30 50 70 80 90 100
COvalbumin (g/L) 100 90 80 70 50 30 20 10 0
Solid membrane Yes Yes Yes Yes Yes Yes Yes Yes No
Ruptured capsules (/2) 0 1 0 0 0 0 2 2 –
Table 9.5. The aqueous phases were prepared from heavy water 71.7 % vol. and 10 µmol/L calcein in PBS, alongside
the compounds shown in the table above.
Capsules were submitted to a temperature ramp, while controlling the integrity of the
capsule by ﬂuorescence microscopy. The results are reported in table 9.5. Except the 100 %
sample containing only UCST polymer, all the aqueous phases used lead to mechanically
resistant capsules, transferable to PBS. Capsules made from less than 80 % UCST polymer
were not temperature-sensitive. The capsules made from 80% and 90 % UCST polymer were
found to burst when the temperature was increased.
These results are comparable to the ones obtained for capsules made from polyNIPAM
and HMDA. A low polyNIPAM:HMDA ratio lead to non-permeable capsules, insensitive to
the temperature, while high ratios did not lead to capsules at all. The temperature-sensitive
capsules were found in a narrow window of concentrations, comparable to the one obtained
with polyNIPAM. The existence domains of these capsules are reported on ﬁgure 9.13.
To determine the temperature of burst , and possible statistical ﬂuctuations from capsule to
capsule, series of similar preparations have been studied: two with the 43℃ UCST polymer
and one with the 35℃UCST polymer, subjected to an increasing sweep of temperature (from
15℃ to 50℃, ≈ 7℃/min; the detailed protocol is reported in appendix F.1.2 Determination of
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Figure 9.11. Fluorescence intensity of a solution composed of 100 g/L ovalbumine, 100mg/L Dextran TexasRed
in PBS. Viewed on a microscope; the solution was sealed between two glass slides. Sample thickness:
120 µm.
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Figure 9.12. Example of capsule explosion, viewed on an epiﬂuorescence microscope. The capsule here is made
of 80 g/L UCST polymer (43℃), 20 g/L ovalbumin and 71.1 % vol. D₂O.
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Figure 9.13. Temperature-sensitivity of the capsules made from UCST polymer (43℃), as a function of the
relative amount of polymer in the aqueous phase.
the burst temperature of UCST:ovalbumin capsules, p. 221). An example of a “burst” seen by
epiﬂuorescence microscopy has been shown in ﬁgure 9.12, p. 155.
90% 43℃ UCST polymer – 10% ovalbumine capsules
We prepared 17 capsules from an aqueous phase composed of 43℃ UCST polymer and
ovalbumine, at a 90:10w. ratio. The buﬀer composed of PBS containing 71.7 % vol. heavy
water. 14 of them exploded during the increasing ramp of temperature (82 %). 13 “bursting”
temperatures have been determined (cf. table 9.6); the leakage from the 14th one was not
sharp enough to allow the extraction of one temperature.
Sample 1 2 3 4 5 6 7 8
Burst temperature (°C) 35.9 48.0 40.3 31.3 44.6 48.0 42.7 34.6
Sample 9 10 11 12 13 avg stddev
Burst temperature (°C) 40.6 45.5 41.5 36.7 33.0 40.2 5.6
Table 9.6. Burst temperature of capsules made from 90 % 43℃ UCST polymer. avg and stddev stand respectively
for average temperature and standard deviation.
The mean temperature at which the release occurs is 40 ± 6℃. This is close to the UCST
of the polymer in PBS, 43℃. This is similar to what we observed with polyNIPAM: thermal
behavior of the mixed capsules can be achieved near the critical solution temperature of
the polymer “physically” adsorbed in the membranes.
80% 43℃ UCST polymer – 20% ovalbumine capsules
Preliminary data of capsules prepared from a mixture of 43℃ UCST polymer and ovalbumin
at a 80:20w. ratio (same buﬀer as above: PBS at 71.7 % vol. heavy water) are reported in the
table 9.7.
The average burst temperature seems lower than the previous one, but the standard
deviation suggest that variability between capsules has a marked impact. The statistic is
not suﬃcient to draw clear conclusion in this case.
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Sample 1 2 3 avg stddev
Burst temperature (°C) 25.7 36.5 40.5 37.5 9.0
Table 9.7. Burst temperature of capsules made from 80% 43℃ UCST polymer.
90% 35℃ UCST polymer – 10% ovalbumine capsules
Finally, a series of capsules was prepared from an aqueous phase, composed of 35℃ UCST
polymer and ovalbumine, at a 90:10w. ratio. The buﬀer was composed of PBS (71.7 % vol.
heavy water). BSA-Texas Red was used as the ﬂuorescent reporter. The results are shown
in table 9.8.
Sample 1 2 3 avg stddev
Burst temperature (°C) 22.4 25.0 20.8 22.7 2.1
Table 9.8. Burst temperature of capsules made from 90% 35℃ UCST polymer.
Themean temperature is signiﬁcantly lower in this case, compared to capsules containing
the 43℃ UCST polymer. Considering the poor statistic, no quantitative relationship can
be established between UCST and temperature capsules breakage. Nevertheless, the T of
response is here again lower than UCST. Changing the polymer aﬀects burst temperature.
Conclusion
Kindly provided by Y. Zhao’s team (Sherbrooke University, Canada), the UCST polymer
used were end-functionalized by carboxylic acid functions and thus could not be chemically
attached into the capsule membranes. Using proteins, serum albumin or ovalbumin as
monomers reacting on TDI, capsules were shown to incorporate UCST polymers and form
thermosensitive membranes in a narrow range of composition. Ovalbumin gave the best
results, which is consistent with the results reported by the group of K. Landfester [205].
Results are promising, as capsules were found to burst at a temperature close to the UCST
of the polymer. In addition, the limited range of eﬃcient compositions is comparable to the
results obtained with non-reactive polyNIPAM. This suggests that signiﬁcant improvement
should be reached by making the UCST polymer end-reactive for covalent attachment to
the capsules.
The use of NaCl, sucrose and D₂Omodulate the UCST of the polymers that can accordingly
be chosen well below or above the room temperature. As mentioned in the review part,
UCST polymer based capsules are very appealing for biological applications as an increase
of temperature can be induced locally to trigger the release. This study has established the
proof a concept that such capsules can be prepared.
157

Conclusions & perspectives
159

Conclusions & perspectives
The present work aimed to identify promising routes for the design of molecular tools that
are capable to improve controlled chemical activation of cells. A need for non-invasive and
local activation was identiﬁed in the context of academic biological studies, in particular
studies of the early stages of cell growth, migration or polarization. To maximize the chance
for successful encapsulation and fast on-demand delivery of fragile proteins or peptides,
several functional assemblies were evaluated from literature. The speciﬁc constraints of
biological environments and the need for a robust spatio-temporal control on responses
primarily limits the candidates to 1) light-responsiveness – the milder and most versatile
stimulus – with the alternative of temperature-responsiveness coupled to exposure to light,
2) systems compatible with mild encapsulation in aqueous core(s).
None of the systems currently used can reach all the requirements exposed below.
• Release and control on timescales faster than the biological responses to study.
Typically, fast subcellular reorganization of the cytoskeleton is observable in the
timescale of seconds, but minutes and hours are also of interest.
• Localized activation.
If the release must occur in a limited region of space, or generate gradients to activate
subcellular levels (∼ µm), it should be faster than diﬀusion of the released agents.
Capsules have ideally to become permeable at subsecond timescales.
• Manipulation of fragile molecules, such as proteins, in conditions ensuring the preser-
vation of their activity.
• Finally, toxicity of capsules or of the stimulus may be issues that deserve to be
assessed.
In the present thesis, experimental investigations were focused on promising candidates
that may fulﬁll the above requirements once optimized: liposomes and polymer capsules
with an aqueous core, primarily because breakage of a thin membrane upon exposure to
stimuli is likely to provide the fastest release. Although light can provide harmless stimula-
tion and excellent spatial control, we also considered temperature-responsive systems as
models. They represent the ﬁrst step in the development of visible or infrared-sensitive sys-
tems – both can be implemented from the temperature-sensitive ones via the encapsulation
of dyes or nanoparticles.
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Liposomes
Liposomes have been found to be “easily” turned into light-sensitive vehicles. Despite
permeabilization to small molecules was extensively reported and sounded as promising
basis, diﬀerent principles are involved for the controlled release of proteins. To release
quickly a high molecular-weight molecule, the membrane must indeed be disrupted or pores
larger than several nanometers must be opened. Our model, light-sensitive liposomes, was
based on the incorporation of azobenzene in the lipid bilayers, under the form of surfactants
or polymers. The azobenzene-containing surfactant (azoTAB) proved eﬃcient to solubilize
liposomes, and solubilization was light-triggerable. A switch from UV-adapted cis-azoTAB
to blue-adapted trans isomer triggers dissolution. However, the kinetics of dissolution was
highly sensitive to the amount and distribution of azobenzene surfactant in the leaﬂets. Low
amounts, or more surprisingly absence of surfactant in one of the two leaﬂets at the time
of exposure under blue light markedly slowed down the kinetics. The timescale of hours
emerged, thus indicating that such systems are not robust to dilution or to any competitive
partition of the surfactants between other membranes (e.g. cell membranes). The reversible
and fast responses (seconds) observed in mixed solutions of lipid and azobenzene surfactants
near CMC showed however that reorganization and membrane dissolution can be rapid in
conditions that distribute evenly the molecular partners.
To maintain azobenzene moieties in permanent proximity with the membranes, we used
amphiphilic polymer “anchors”. Previous studies performed in our laboratory showed
that this polymer triggers the formation of pores in the membrane of giant vesicles, when
irradiated with blue light. Our application to smaller liposomes indicates similar eﬃciency,
and a fast release time of the order of tens of seconds. Detailed studies based on ﬂuorescence
were however hampered by the irradiation time during which no measurement was possible,
and by complicated quenching eﬀects in the liposomes.
Finally, two points deserve future studies that were out of the scope of the present work.
1. The absence of conditions that can aﬀord full (100 %) release of encapsulated ﬂuo-
rophores is not understood. Assessment of the leakage of azobenzene surfactants
and/or polymer-containing liposomes complicated by the high quenching eﬃciency
of azobenzene may be carried out by an alternative method, based on FRAP and
diﬀerences in the diﬀusion coeﬃcients of encapsulated and released molecules. This
method has been optimized during this thesis and will be considered in future experi-
ments.
2. The literature reports on the kinetics of liposome dissolution by surfactants are scarce
– which contrast with the extensive reports on phase diagrams at equilibrium – and
mostly rely on DLS analysis. A more precise analysis of transition from micelles
to vesicles in liposome/surfactant interaction is certainly required. It is planned to
resume the study initiated in the present work by the analysis of the transitions by
time-resolved small angle X-ray scattering.
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Polymer capsules
As an alternative to liposomes we considered polymer capsules. They were reported in the
literature to be versatile objects, able to encapsulate molecules with a high yield and to
release their content by the disruption of the membrane. In 2012, the date at which this work
started, no particularly successful results on light-sensitive polymer membranes were avail-
able in the literature, and most responsive systems did not enable simple encapsulation of
fragile molecules. We choose to build capsules based on interfacial polyaddition approaches
(aromatic diisocyanate + polyamines) known at the time to yield non-responsive systems,
but to facilitate encapsulation in mild conditions. Adjustment of membrane composition
was anticipated to enable responsiveness by integration of polymers that dissolves upon
a temperature shift. Because of its vast potential for chemical adjustments and extensive
reports existing in literature, the model of polyNIPAM was considered as representative of
polymer chains with LCST. On the other hand, studies of a more original system, based on
UCST of neutral chains in water, were initiated in collaboration with the group of Y. Zhao
(Sherbrooke Univ.).
Preparation of macrocapsules with a diameter of the order of the millimeter was an
important preliminary step, because this conﬁguration enabled direct observations and
identiﬁcation of artifactual phenomena, due to adsorption or covalent attachment of ﬂu-
orophore probes in the capsule membranes. Based on these model macrocapsules, it is
possible to conclude that membranes can be made by covalent attachment between aggre-
gates of polyNIPAM. In addition, mechanically resistant mixed membranes can be made by
the addition of short amines with hydrophobic isocyanates in the presence of polyNIPAM
or of the UCST polymer. They were found to be easily processed and impermeable to small
hydrophilic molecules when kept respectively above the LCST or below the UCST.
Amine-terminated polyNIPAM formed temperature-responsive membranes in a broad
range of composition – copolymerization with non-responsive hydrophobic amines, in
the window of 25% to 100% w. Variation of composition provided a tuning parameter
to modulate the membrane rigidity and hydrophobicity. The window of compositions
yielding temperature-responsive capsules was in comparison relatively narrow when the
temperature-responsive chains are not covalently bound. This result came from a control
experiment showing that in the main part of the composition range, covalent attachment
was required. But it may in practice speak in favor of preparation of capsules from any
commercially available polymer showing a transition of solubility. In the absence of a tight
attachment of the responsive chains, variability may however emerge in the temperature
of responses, as revealed by the standard deviation of several degrees of the temperature
of breakage (capsules containing UCST polymers). One shall prefer to introduce reactive
(amine) end groups in the chain and to form the membrane by copolymerization with
short amines, which in our hands (with polyNIPAM) yielded well controlled temperature of
permeabilization, close to LCST of the responsive polymer in the outer medium of capsules.
Finally, to achieve obvious responses to temperature, and high degree of release of
encapsulated probes (including proteins), it is critical to control the conditions of addition.
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In practice, it has been diﬃcult to alleviate cross-interaction with additives, including
surfactants, osmolytes (sucrose, NaCl), and side reaction of isocyanates with hydroxyl
and/or amine groups that were present on proteins. Thismay be a practical issue Preparation
of capsules based on the reaction of a protein (ovalbumin, BSA) added in excess improved
clearly the system, by preserving the protein of interest (in this work ﬂuorescent probes)
from being irreversibly bound to the membranes. It was also forming apparently more
homogeneous membranes than with the polyamine:TDI precipitates.
In general, we highlight that the adaptation of the protocol and in particular the nature of
molecules present in internal compartment of droplet at the stage of capsule polymerization
has a critical impact on capsule functionality. Ourwork identiﬁed important parameters, and
contribute to progress toward the rational design of robust and biocompatible responsive
systems, which is a demanding task becoming now within our reach.
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A. Role of molecular gradients on
biological systems
Whether it is a single isolated cell or a whole organism, biological system activity is regulated
by several external signals of various nature. Both chemical and physical cues have been
reported in literature.
Chemical signal family is very heterogeneous in term of cue and of target. It includes
ions (Ca²⁺, Mg²⁺), dissolved gases (O₂, N₂O), small organic molecules (ionized or neutral, like
acetylcholine), peptides and proteins of various sizes. The targets of these molecules can be
either intracellular or extracellular. Magnesium ions have been reported to regulate gene
expression in Humans, by interacting directly with enzymes and nucleic acid [256]. This is
also the case for lactose; this sugar is normally not metabolized by enteric bacteria, like
escherichia coli. However, its presence is suﬃcient to trigger on several bacteria strains the
expression of several genes, which will lead to the production of proteins involved in the
transport and the metabolism of lactose. As for external stimuli, numerous examples are
reported. Neurotransmitters, hormones, growth factors are examples of molecules targeting
receptors located on the cell membrane.
Cells are also sensitive to physical stimuli. Neurons or ﬁbroblasts are known to discrimi-
nate their culture substrate by its stiﬀness [257, 258]. In the human body, some cells are
even specialized to the transduction of physical signaling, like the photoreceptor cells for
light, the lamellar corpuscle cells for pressure or the thermoreceptors for temperature.
Electrical ﬁelds are used to propagate information along nerve ﬁbers in most multicellular
animals, but they are also reported to inﬂuence cell migration in wound repair or tumor
genesis [25, 259].
Sensibility to signals can diﬀer strongly from one cell type to another. Some react to
the instantaneous concentration of the signaling molecule. This is the case for β-cell in
the pancreas for example: they adapt their insulin secretion as a function of the glucose
concentration. At the opposite, some cells are sensitive to the temporal and spatial distri-
bution of a signaling molecule, and as often referred to as gradients. These gradients of
chemical cues has been reported to play a role during the embryogenesis of vertebrates,
to aﬀect cells of the immune system or even play a role in the development of cancers. In
many articles, the gradient is expressed by its relative slope on a characteristic length. The
relative slope, noted 𝑠, is calculated as 𝑠 (in %) = 100 ⋅ Δ𝐶/𝐶, where Δ𝐶 is the diﬀerence of
concentration between the two ends of the cell (or the ends of the studied part of the cell)
and C is the mean value of the concentration along the cell. The characteristic length is the
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length between these two ends, which is in the range of 10 µm, and often assumed to be
exactly 10 µm (see ﬁgure A.1).
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Figure A.1. A cell in a gradient of a molecule of interest. The relative gradient steepness, 𝑠 in percentage, is
deﬁned as 𝑠 = 100 ⋅ Δ𝐶/𝐶, where 𝐶 is the mean concentration on the cell level [22].
A.1. Gradients role during embryogenesis
Embryogenesis is a good example of chemical cue sensitivity, as the gradients aﬀects
the whole embryo, and are responsible for its evolution from a symmetric cell heap to a
non-symmetric organism with diﬀerentiated cells. For reference, the anatomic axes of a
diﬀerentiated mouse embryo are shown on ﬁgure A.2.
A.1.1. From the symmetric embryo to gastrulation
The embryo begins as a symmetrical unicellular fertilized egg. In the early stages of
development, the embryo morphology stays the same. The only evolution is owed to cell
division, which increase the cell number. In the case of the mouse embryo, this process
goes along with cell diﬀerentiation, from stage E3.5 onwards. As shown on ﬁgure A.3, the
symmetric cell heap is replaced by the blastocyst, which consists in two diﬀerentiated cells.
The trophectoderm cells are located on the periphery of the embryo, while the inner cell
mass constitutes the inside of the blastocyst.
The symmetry of the embryo is broken shortly after its implantation, which occurs
between stage E4.5 and E5.5. The embryo elongates along the proximal-distal axes to
gain an egg shape. This elongation is accompanied by the localized expression of proteins
from the TGFβ, Wnt and FGF families. The nodal protein from TGFβ family is expressed
in the vicinity of the extraembryonic/embryonic visceral endoderm by the embryonic
visceral endoderm cells (see ﬁgure A.3, the frontier between the pink and blue regions
on the E5.5 stage). Nodal secretion is regulated by several mechanisms involving the
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Dorso-ventral axis
Right-le axis
Anteroposterior axis
(rostro-caudal axis)
Figure A.2. Mouse embryo, 14.5 days old. The three axes (anteroposterior, dorso-ventral and left-right) are
represented by arrows.
extraembryonic cells, leading to the formation of a proximal-distal nodal gradient. This
gradient is responsible for the cell diﬀerentiation and organization along the proximal/distal
axis [9].
The anteroposterior axis (see ﬁgure A.2) is deﬁned by the gradient of Wnt [8–10], not only
in the mouse but in most animals (see ﬁgure A.3, on the inferior part of the pink region). In
mammals, Wnt is expressed in the posterior region, while a Wnt inhibitor is secreted in the
anterior region, establishing a gradient of both proteins.
Nodal and Wnt are not the only two proteins involved during embryogenesis, and they
are certainly not the only ones to be secreted as a gradient. Serotonin, inversin, polaris and
various other proteins have been proteins have been reported [260].
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Figure A.3. Early stages of mouse embryo development, from day 2.5 (E2.5) to day 4.5 (E4.5). The initial symmetry
is broken at E3.5 when the blastocyst is formed by the segregation of the inner cell mass (ICM) and
the trophectoderm cells (TE). Gradients of Nodal develops in the medial part of the embryo, below
the extraembryonic (in blue) and embryonic (in pink) visceral endoderms. This give the direction
of the proximal/distal axis. Wnt gradient develops at the distal extremity of the embryo which
contributes to the development of the anterio-posterior axis. Adapted from [9].
Soma Axon Growth
cone
Filopodia
Lamellipodia
Figure A.4. Schematics of a migrating neuron. The
dynamic part, sensitive to netrin-1 is the
growth cone.
A
B
Figure A.5. Precerebellar neurons migrate from the
rhombic lip (A, in red) to the ventralre-
gions of the ventral hindbrain regions (B,
blue and yellow). Adapted from [261].
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A.1.2. Tissue and cell scale
On a smaller scale, protein gradients are also responsible for the constitution of tissues
during embryogenesis. The nervous system undergoes massive changes during this pe-
riod, which involves neurogenesis, neuron migration and axon development. Precerebellar
neurons (see ﬁgure A.5) are known to migrate from the rhombic lip to the ventral hind-
brain [261]. This process is driven by a protein from a laminin related protein called netrin-1,
also involved in neuron survival [13]. Neurons are attracted by increasing concentrations
of this protein and are very sensitive to it. It has been reported that 5 molecules of netrin-1
are suﬃcient to trigger a morphologic response from the cell [44]. However, the relation
between biological response and netrin-1 concentration is not obvious. While low doses
are suﬃcient to trigger a response, its activity can be modulated by other proteins. Above
a critical concentration, the Slit protein is able to annihilate netrin-1 activity. Without
netrin-1, Slit is reported only as slightly repulsive. On Xenopus, it has also been found that
a small fragment of laminin-1, a constituent of the extracellular matrix, is able to reverse
the netrin-1 activity which becomes repulsive [262]. An interesting result, even more when
remembering netrin-1 belongs to the laminin related-protein family.
Other protein gradients are also reported. FGF (ﬁbroblast growth factor) family is involved
in the development of neocortex, in particular in the development of its rostro-caudal axis
and in its area patterning [263] (see ﬁgure A.6). TGFβ proteins are also found, along the
bone morphogenetic protein (BMP), to be involved in spinal cord proliferation [264]. NGF
(nerve growth factor) is a chemoattracting protein for neurons from rat superior cervical
ganglion. It has been reported that the cell response is also dependent on the gradient
steepness [2].
Caudal
Rostral
Olfactory bulb
Motor area lll
Motor area ll
Motor area l
Somatosensory area l
Somatosensory area ll
Associative area
Auditory area
Retrospenial cortex
Visual area ll
Visual area l
Temporal cortex area ll Area 29d
Precentral cortex, putative motor area
Figure A.6. Areas of mouse neocortex, dorsal view. Reprinted from [263].
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A.2. Immune system
Gradients of molecules cue plays also a role after the embryogenesis. Some families of
cells are known to migrate in the direction of the increasing concentration of a particular
molecule. This phenomenon is called chemotaxis. A part of the immune system response
against a pathogen is based on chemotaxis. Macrophages are cells from the innate immune
system specialized in phagocytosis. They are present in most tissues and represent the front-
line of host defense against pathogens. Diverse receptors are expressed on its membrane
to detect various antigens generally expressed on the surface of pathogens, like bacteria.
When a pathogen is encountered and recognized by the macrophage, a phagocytic process is
engaged, leading to the destruction of the foreign body. This process is accompanied by the
secretion of several cytokines, including chemokines, like interleukine-1 (IL-1), IL-2, IL-8 or
the tumor necrosis factor α (TNFα). These molecules will diﬀuse around the macrophage
and eventually reach the blood ﬂow. The surrounding tissue will also aﬀect the surrounding
tissues, leading to the inﬂammation.
Two kinds of cells will be recruited from the blood stream by the cytokines, the neu-
trophiles and the monocytes. Both are leukocytes which are normally present only in the
blood ﬂow. In particular, they are not found in healthy tissues. The ﬁnal role is the same, to
destroy the pathogen with a phagocytic process. While neutrophiles are directly able to
ﬁght, monocytes are not potent cells. They are only macrophage precursors and need to
diﬀerentiate themselves, which only occurs after leaving the blood stream [265]. Figure A.7
summarizes this process.
Inflammatory cells migrate into
tissue, releasing inflammatory
mediators that cause pain
monocyte
neutrophil
Vasodilatation and increase
vascular premability cause
redness, heat and swelling
proteins
fluids
Bacteria trigger
macrophages to release
cytokines and chemokines
macrophage
cytokines
chemokines
Figure A.7. Some bacteria are detected by a macrophage. Neutrophiles and monocytes are recruited to the site
of infection by the secretion of chemokines and other chytokines. Red cells represents erythrocytes.
Adapted from [265].
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Neutrophils are highly sensitive cells: a gradient steepness lower than 1% is suﬃcient
to polarize the cells. This has been reported for N -formylmethionylmethionylmethione
(fMMM), N -formylmethionylleucylphenylalanine (fMLP) [31] and IL-8 [32]. They also
respond to a broad range of cytokines, as mentioned before. Due to these properties,
neutrophils have become a widespread model to study chemotaxis [266]. Some pathways
implicated in the chemotactic processes have described. The cytokine detection almost
always involves the binding to a heterotrimeric G protein. If it seems simple outside the cell,
the complexity increases drastically inside. Various intracellular signaling pathways have
been identiﬁed: they involve phospholipases β2/3, phosphatidylinositide 3 γ, ion channels,
adenylyl cyclases… This complex signaling pathways has numerous consequences, and
amongst them is probably the non-linear response to cytokine concentration [267].
Several speciﬁc equipments have been developed to study the neutrophil chemotaxis.
They range from simple chambers with a ﬁxed uni-dimensional concentration gradient
allowing 2D culture [31, 33] to more complex chambers allowing real time observation
of cell polarisation in 3D collagen gel [268, 269]. Attempts to study the cells under a
time-dependent gradient have also been reported [41].
A.3. Cancer development
Chemotactic molecules are also reported to play a major role in cancer development and
metastasis. Understanding the role of each molecule and the associated signaling pathways
are considered to be a key to developments of new treatments. Targeting precise molecules
or signaling pathways should lead to more eﬃcient and speciﬁc treatments [270]. The task
is far from being easy: the cancerous cells are sensitive to a large range of cytokines. It is
even worse as the eﬀect of one molecule varies from one cancerous cell type to the other.
Cancerous cells are called metastatic when they are able to leave their original tumor
to spread to other organs. To achieve this, these cells must cross several barriers. The
ﬁrst is the tumor itself; the second one is the extra-cellular matrix of the surrounding
tissues. The blood ﬂow is reached by a process called the intravasation, which leads to
a dissemination of the cells in the whole body. The cells will get out of the blood vessel
by an extravasation process, which can be related to the leukocyte tissue invasion. It has
been shown for several types of cancerous cells that the migration process is attributed to
cytokine gradients. In the case of mesothelioma cells, a rare type of cancer which aﬀects the
mesothelium, several growth factors have been found to trigger a migration of cells. IGF-I
and IGF-II are reported to both trigger the migration of the cells and direct their migration.
To illustrate the complexity of the studied systems, the authors underline that these cells
does not respond to aFGF, bFGF, GM-CSF and IL-6, while these molecules are known to
stimulate the movement of carcinoma and sarcoma cells [271].
The stroma cell-derived factor-1 (CXCL12) involved in leukocyte migration has also been
found to play a role in metastasis for several cancers: the breast cancer [39], the non-small
cell lung cancer [38] or glioblastoma [272].
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B.1. Diﬀusion-based gradient generators
These gradient generators are based only on passive diﬀusion of the molecule of interest,
either in solution or in a 3D hydrogel.
B.1.1. Coculture based assays
This technique is probably the ﬁrst used to study the response from developing cells to
gradients of chemotactic molecules. Its principle is simple: two populations of cells are
cultured in a hydrogel. One is the studied population; the other one is secreting the
chemotactic factors. Both populations are organized as clusters, facing themselves in the
hydrogel [37]. The cluster of secreting cells acts as a localized source of molecules, as shown
on ﬁgure B.1.
Culture gel
Studied cells Secretring cells
L
d
Figure B.1. 1D gradient generated in a culture gel with the coculture method. The gradient is represented in
purple, and is established around the cluster of generated cells. The typical distance between the
studied cells and the secreting cells 𝐿 is 1mm; the size of both clusters 𝑑 is in the 100 µm – 1mm
range. Collagen is often used as the culture medium, at a concentration of 2–3 g/L [12, 13].
The earliest reported assay was focused on the study of ganglion neurons from chicken
embryos [37]. A gradient of NGF was supposedly generated by tissues taken from diﬀerent
organs (heart, kidney, colon). The cells from the ganglia responded by migrating towards
the source of NGF. However, the secreting cells were not specialized in NGF secretion,
which suggests that the NGF gradient was superimposed with gradients of other unknown
molecules.
This issue was conﬁrmed later by Lumsden et al. [273]. Neuron ganglions from mouse
embryos were submitted to the gradient of NGF secreted by neuronal tissues. As in the
previously mentioned experiment, the neurons were attracted by the NGF source, but a
NGF inhibitor was not suﬃcient to repress this attraction. This observation suggests that
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at least one more molecule secreted by the neuronal tissues has an attracting eﬀect on
neurons. The same conclusion has been done with laminin [274].
Using tissues known for secreting themolecule of interest enabled to show the chemotactic
abilities of neurons. However, due to the various secreted molecules at the same time, it
is impossible to determine the role of each molecule separately. Thanks to the progresses
made in genetic engineering, it became possible to design cells specialized in the expression
of the molecule of interest. This method has been applied to various chemotactic factors.
Fibroblast growth factor (FGF-1) were eﬃciently secreted by transfection of NIH 3T3 cells
to study neurons from rat spinal ganglia [275]. Several molecules from the semaphorin
family (Sema III, E, IV) were also produced by this method and applied on neurons from
superior ganglia of rats [276]. Other molecules, like netrin-1, have also been reported [13,
277].
This method, while having the advantage of being simple, suﬀers from several draw-
backs. The gradient is not established immediately after the cells are put in the gel. The
characteristic diﬀusion time can be estimated with the following formula: 𝜏 ∼ 𝐿2/𝐷,
where 𝜏 is the characteristic diﬀusion time, 𝐿 is the characteristic diﬀusion length and 𝐷
the diﬀusivity of the studied molecules. For a protein which has no interaction with the
culture gel, its diﬀusivity is in the range of 100 µm²/s. Under such conditions, we have
𝜏 ∼ 𝐿2/𝐷 = (10−3)2/100 ⋅ 10−15 = 104 s. The gradient is established in approximatively 3
hours on the 1mm separating the clusters. This kind of experiment is therefore limited to
long-term studies, on large length scales. While it is suﬃcient to study neurons, it may
not be suﬃcient for other cells. In fact, no other kinds of cells are reported. The other
main limitation of this technique is the absence of control on the gradient. The molecule is
secreted continuously, and there is no convenient way to quantify the concentration, either
during the experiment or after. Gradients of proteins have been predicted using diﬀusion
based models [278], but not conﬁrmed by immunoﬂuorescence due to an insuﬃcient sensi-
tivity of this technique. It is also reported that the steepness of the gradient and the mean
value of the molecule concentration is mainly dependent of the distance between the two
clusters [22]. The gradient is therefore not easily reproducible from on experiment to the
other.
B.1.2. Pipette based assays
The other commonly used technique used to create gradients from a punctual source use
micropipettes, as shown on ﬁgure B.2. In the typical experiment, the point of the pipette is
located at 100 µm from the studied part of the cell. The pipette body is commonly placed at
45° from an imaginary line drawn between the cell and the pipette tip [3]. The molecule is
released most of the time on a pulsed regime using a pressure generator, although diﬀusion-
based only processes are also reported [26]. Compared to a constant ﬂux, the pulsed release
prevents the ﬂow to reach the cells, which may trigger an undesirable response. This
system has been applied on various kinds of cells, ranging from neurons cultured in 3D
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Cell (neuron)
~ 10 µm
Growth cone
45°
~ 100 µm
Pipee filled with the 
molecule of interest
Figure B.2. A pipette is used to create a local source of a molecule of interest in a culture medium. The gradient
is represented in purple. The scale of the targeted cell (leukocyte) or part of cell (the growth cone of a
neuron) is typically 10 µm. The pipette is located 100 µm away from the cell. The concentration of
the molecule is assumed to be 1/1000 of the one in the pipette.
collagen gel [2] to leukocytes [26] or cancerous cells [27] in 2D culture conditions. The same
diversity is found for the released molecules, ranging from proteins [2, 28] to peptides [26].
The advantage of this technique compared to the previous one the possibility to control
precisely the ejected amount of molecules in space and time. Reproducible gradients of
high steepness can be reached by this method, in the range of 10–30 % [4, 11, 25]. The mean
value of the molecule concentration around the cell can be controlled by the concentration
of the molecule in the pipette. The time required for the gradient establishment is in the
range of 10 minutes [4], but is considered table for longer periods, allowing to study cells
on long timescales, in the range of one hour [23, 24]. However, the gradient range is in the
100 µm range, which can be reached by cells during the experiment. To maintain the cell
in a gradient of deﬁned concentration and range, it may be required to move the pipette
during the experiment [279].
However, most of the cited publications in the last paragraph are based on a single article
by Lohof et al. [3], where the characterization of the system is made. Authors often derive
the concentration and the gradient slope from it without further characterization. This has
been the subject of several discussions and criticisms [4–6]. A theoretical analysis of the
pipette-based gradient generator and its experimental has been performed by Pujic et al [4].
The assumed linear relationship between the released molecule from the pipette and the
pulse duration and frequency is not always true. The gradient is also often considered 2D,
neglecting the vertical component. This is not veriﬁed experimentally by confocal imaging,
which shows an heterogeneous of a labeled dextran along the vertical axis. These two
observations turn the pipette-based in a qualitative-only assay, as the prediction of the local
concentration of the released molecule is unreliable.
Unfortunately, this technique suﬀers from others drawbacks, independent from the
characterization of the gradient. Only one cell can be studied at a time; to study N cells
181
B. Currently used gradient generators
in parallel, one should possess N micropipette devices, and probably N microscopes too if
the observation is to be made live. To study the eﬀect of more than one molecule, several
pipettes should be used. It could be circumvented by mixing the molecules altogether, at
the expense of having a ﬁxed gradient of these molecules, which is somewhat limiting.
Eventually, it should be noted that most of the experiments has been conducted with 2D
cells cultures. The experiment has been conducted in 3D cultured cells (collagen gel) in
only one of the cited references [2].
B.1.3. Diﬀusion in culture chambers
Speciﬁcally designed culture chambers have been proposed to study the cells. Compared
to the two previously cited systems, they produce a known an reproducible gradient,
and due to their size, several cells can be studied at the same time, which make them an
high-throughput system.
The Boyden chamber
The ﬁrst reported chamber is the Boyden chamber [280], which is shown on ﬁgure B.3. The
cells are studied in suspension, and are separated from a solution of the studied molecule by
a classical ﬁlter membrane, in which the gradient is established. The chemotactic property
of the molecule was assessed by counting the leukocytes trapped inside the membrane.
The system is simple, but suﬀers also from several drawbacks. It is not possible to track the
cells in real time: the system must be emptied to isolate the ﬁlter. The gradient established
near the ﬁlter is also not predicted, and is known to vary with time [6]. And ﬁnally, the
cells are studied in suspension, which is not representative of the in vivo conditions.
This system is however used widely as a cell invasion model, as it occurs during cancer
metastasis or during immune cell migration [281–283]. The ﬁlter is replaced by various
membranes, ranging from simple collagen gels of various densities to more complex gels
mimicking the extra-cellular matrix. To my knowledge, this system has not been applied to
neuron migration.
A microﬂuidic version of this chamber has also been developed, enabling live-imaging of
the migration and invasion process [284].
The Zigmond chamber
The Zigmond chamber can be viewed as an enhancement of the previous chamber. The
chamber is made of two compartments linked by a small bridge (1mm wide) where the
gradient develops. The whole cell is made of glass, which allows to record the cell migration
in live. The gradient was characterized using ﬂuorescein isothiocyanate, and was found to
be the steepest from 15 minutes to 90 minutes after ﬁlling the wells, and was considered
to be steep and stable from 30 minutes to 90 minutes. No other characterization of the
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C
Figure B.3. A side view of the Boyden chamber. A
suspension of cells is placed in the com-
partment labeled B, and a solution of the
studied molecule is placed in compartment
A. The two compartments are isolated by a
porous membrane, located in C. Adapted
from [280].
Figure B.4. The original Zigmond chamber. The two
wells act as sink and source, while the gra-
dient is established in the bridge. Cells are
cultured on the coverslip used to close the
chamber. Reprinted from [31].
gradient was done. The chemotaxis of human leukocytes to various peptides, like fMLP, is
reported [31].
The Dunn chamber
The Zigmond chamber is not sealed, which is problematic on long term experiments, as the
culture medium is allowed to evaporate. The Dunn chamber is presented as an evolution of
the previous chamber, overcoming the evaporation problem. Like the Zigmond chamber,
the gradient is established in a small region linking two wells, acting as source and sink
(see ﬁgure B.5) [33]. The gradient shape and time evolution has been described with a
Figure B.5. Schematic view of the Dunn chamber, reprinted from [29].
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numerical model and assessed experimentally with ﬂuorescent molecules. A linear gradient
of rhodamine labeled dextran is established in approximatively 20 minutes, and is sustained
for several days. The slope of the gradient is in this case the highest one can expect
from a linear gradient. This chamber has been used to study the chemotaxis properties
of peptides on leukocytes [33] and proteins (macrophage colony stimulation factor) on
macrophages [285], on long term experiments (90 minutes to 3 hours).
B.1.4. Diﬀusion in hydrogels
Gel printing
Collagen gel
Printed lines of increasing doplet density
Collagen gel, upper view
1 mm
1 m
m
Figure B.6. Generation of a molecule gradient inside a collagen by printing lines of increasing droplet density on
its surface. The molecule of interest is represented in purple. The gradient is established by diﬀusion
from the lines to the gel.
Gradients inside a collagen gel have been generated by depositing the studied molecule on
its top. The system described in ref [34] is shown on ﬁgure B.6; the theoretical analysis and
experimental validation of this system is shown in ref [35]. Lines of increasing concentration
in NGF have been printed on the top of a 1mm-thick collagen gel containing the studied
cells, which were neuron explants from rat embryos in this case. The same solution is
deposited on each line; the increasing concentration pattern is achieved by increasing the
droplet density from one line to the other. A linear gradient is established within 1 hours;
before, its proﬁle shows oscillations, due to the discrete pattern from which the gradient
comes from. The gradient is established on a long range, 1 cm, and can persist more than
12 hours with a constant slope and mean concentration on almost 0.5 cm. However, these
good performances are counterbalanced by several issues. The steepness of the generated
gradient is rather low: gradients up to 0.4 % have been generated. It has been used to prove
that neurons are sensitive to slope as low as 0.1 % with a mean concentration of 1 nmol/L,
but all cells are not as sensitive. A dedicated equipment, specialized in dispensing drop of
1 nL on top of the collagen gel, is required, which proves expensive. These drawbacks may
explain that only a few chemotaxis experiments are based on this technique [2].
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This technique was not met with a great success: only a few chemotaxis experiments
have been reported [2]. One way to make this technique more accessible may be to use
desktop inkjet printers, as they have been successfully modiﬁed to allow cell printing, and
are used in tissue engineering [286].
Diﬀusion in a collagen bridge
PDMS chamber
Collagen source Collagen sink
Source Sink
Gradient zone (1 mm)
Figure B.7. A gradient of molecules is established in the collagen junction between two chambers ﬁlled with
collagen. One of the chambers contains the molecule and acts as a source, while the other one does
not contain the molecule initially, and acts as a sink.
Gradients have also been generated in systems as simple as the one shown on ﬁg-
ure B.7 [36]. The system consists into two chambers isolated by a PDMS bridge 1mm
thick. Filled with collagen, the two chambers are connected by collagen bridge 1mm thick
and 200 µm high. One of the chamber is ﬁlled with collagen containing the studied molecule
and acts as a source, while the other one acts a sink. A linear gradient is established within
one hour in the collagen bridge, but evolves with time. The highest gradient steepness, 1.2 %,
is reached in 6 hours, as reported by 40 kg/mol dextran labeled with tetramethyl rhodamine.
Its value stays around 1% for the next 18 hours. This system has been successfully used
to study the chemotaxis properties of NGF and Slit2 against neurons from rat embryos.
This device is probably by far the cheapest, and is sold by its creators as such. The most
expensive part is the reusable mold used to make the PMDS chambers, with a price of $100.
This chamber can prove to be very useful for long-term experiments requiring steady-states
gradients. They can’t however be used to study the cell response to a fast-established
gradient, in the timescale of the second.
Some variations of this system are also reported. The collagen bridge can be replaced by
a membrane [269].
Towards the generation of gradients in 3D gels with microfluidic devices
A variation of this system using an inverse conﬁguration, with reﬁllable sink and sources,
is shown on ﬁgure B.8 [30]. The 1D gradient is established in a millimeter-sized channel
ﬁlled with an agarose gel, with either a linear shape or an exponential shape. The gradient
is established initially within 7 hours, which is slow. The advantage in this resides in the
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Figure B.8. Gradient generated in channel ﬁlled with collagen gel. The channels two wells, which acts either as
the source or the sink. Reprinted from [30].
possibility to empty and ﬁll again the sink and the source. If done regularly, at a frequency
determined by a theoretical analysis of the system, it is possible to maintain the gradient
for at least 10 days, in the case of the linear gradient. The theoretical results have been
assessed with Alexa 488, a small hydrophilic ﬂuorescent dye (Mw ∼ 400 g/mol). They also
used their chamber to study the chemotaxis of leukocytes in a collagen matrix against a
gradient of fMLP.
Figure B.9. A diﬀusion-based gradient generator, implemented in microﬂuidic device. The inner chamber (in
pink) is ﬁlled with a hydrogel containing the studied cells. The side channels (blue and green) acts
as the source and the sink. Reprinted from [287].
An automated version of this system has been implemented in microﬂuidic devices,
as shown on ﬁgure B.9 [287]. As the dimensions of the diﬀusion chamber are also of
millimeter scale, performances comparable with the previous system should be expected.
No precise characterization of these systems was performed on a long time range, but
a linear gradient is expected within 24 hours, as shown by their numerical predictions.
Nevertheless, those systems were used to study the migration of human ﬁbroblasts against
a gradient platelet-derived growth factor or TGFβ.
B.2. Flow-based systems: microfluidic devices
Microﬂuidic based devices has also reported to generate gradients of molecules in culture
of cells. The simplest device is able to create a deﬁned linear gradient in a liquid culture
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medium, which has already been addressed by the various chamber-based systems shown
above. The main diﬀerence between the two system is the possibility to create dynamic
gradients in a microﬂuidic device, which was not possible in the steady-state chambers.
Some systems speciﬁcally designed for biological applications are reviewed in various
references [5, 6, 288–292].
In microﬂuidic devices, two phenomena are responsible for the creation of the gradi-
ent: the convection and the diﬀusion. Péclet number can be used to determine which
phenomenon prevail above the other [292]. Its expression follows:
Pé =
𝑈𝐿
𝐷
(B.1)
where 𝑈 is the ﬂuid velocity, 𝐿 the characteristic length of the microﬂuidic channel and 𝐷
the diﬀusivity of the considered molecule. At high Péclet regimes (Pé ≫ 1) convection is
the dominant mass transport mode, while at low Péclet regimes (Pé ≪ 1), diﬀusion is the
dominant mode.
B.2.1. Cells in the flow of the microfluidic device
A
B
A
B
(1) (2)
Inlets Outlet
Figure B.10. Y-shaped microﬂuidic device, as described in reference [293]. (1) a gradient of a molecule (in
red) is obtained in the microﬂuidic channel. (2) same systems, with two molecules (the red one is
introduced in A, the yellow one in B); two opposite gradients are obtained.
Themost simple device of this category is made of T- or Y-shaped microﬂuidic channels, as
shown on ﬁgure B.10 [293, 294]. In such systems, the gradient is created by injecting a ﬂuid
containing the studied molecule and the buﬀer in two diﬀerent outlets. A 1D gradient is
created, but its slope depends on the position along the ﬂow; steepest gradient are obtained
near the source, while the lowest one are obtained downstream. The shape of the gradient
can be predicted, and the accurateness of the results was conﬁrmed with gradients of
ﬂuorescent dextran. The continuous ﬂow allows maintaining the same gradient indeﬁnitely,
at the expense of using large volumes of the studies molecules. The typical ﬂow rate for
these experiments is 1 µL/min, which leads to almost 300 µL for a one-day experiment [6].
Such devices have been used to study the chemotaxis properties of leukocytes in a gradient
of IL-8 [294] and T-lymphocytes in gradients of CXCL12 or CCL19 [293].
A diﬀerent device using a set of premixing channels has been proposed by Dertinger
et al. [295]. The chamber shown on ﬁgure B.11 allowed to generated 1D gradients of
various shapes, ranging from linear one to parabolic (concave, convex). Evolutions of this
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Figure B.11. Microﬂuidic device designed by Dertinger and Whiteside for cell culture. A linear gradient in
generated in the right part of the device (downstream), by a series of premixing channels. Reprinted
from [295].
microﬂuidic device relying on the multiplication of the input channels allowed creating
more complex gradients, but always restrained to one dimension. Shapes like 3rd order
polynomials or saw teeth with high slopes were obtained. Superimposition of two diﬀerent
gradients is also possible with this system. The characteristic length of the gradient ranges
from 1 to 2 millimeters (channel width), and can persist for several millimeters along the
ﬂow.
The two previously developed devices work at high Péclet regime, meaning that convec-
tion is responsible for establishing the gradient. The gradient generation characteristic
time is in the range of the second [292]. This, associated with the possibility to precisely
predict the shape of the gradient, made this system interesting for cell studies on biological
timescales, as far as 1D gradients in a liquid medium is suﬃcient. Thus, they have been
used to study neutrophil chemotaxis, cancer cells chemotaxis, bacteria chemotaxis, stem
cell diﬀerentiation, axon guidance, endothelial cell migration, and even prokaryotic cells,
like yeast [289].
Dynamic gradients have been generated using these systems. The characteristic time asso-
ciated with gradient modulation, in a pulsed regime, is in the timescale of the minute [296];
this can be determined by the relation 𝑡𝑐 = 𝐿𝑐/𝑈 at high Péclet, where 𝑡𝑐 is the charac-
teristic time, 𝐿𝑐 the characteristic dimension of the channel and 𝑈 the ﬂow velocity. The
microsecond timescale can be reached using a in-situ mixer [297]. This mixer is made of
a bubble trapped inside the microﬂuidic channel, and forced to vibrate with an external
piezoelectric transducer operating at the bubble resonance frequency (70.1 kHz). The only
restriction of this system is that the mixing device can only be used to turn a linear steep
gradient to an homogeneous one. We may also wonder what are the eﬀects of the acoustic
vibrations on the studied cells.
Most of the developed systems generate linear gradients or even complex gradient along
only one direction. More complex gradients, 2D in particular, can be developed at the
expense of complex microﬂuidic devices [298].
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B.2.2. Cells in low shear-stress channels
The culture and study of cells directly in the microﬂuidic ﬂow has several advantages. The
systems remains simple, as the gradient generated in the ﬂow is directly applied to the
cells. Fast gradient modulation in time is possible, and is only limited by the ﬂow when
mixing does not rely on diﬀusion. However, the shear stress induced to the cells in those
conditions has been reported to alter their behavior [14, 15]; the observed eﬀects ranged
from a modiﬁcation of the cell skeleton to a collapse of the growth cone. The ﬂow is even
able to detach cells from the culture plate. To address this problem, several improvements
relying on the isolation of the cell culture channel have been proposed.
1D-shaped gradients
One of the proposed methods relies on isolating the cell with a porous membrane. Two
conﬁgurations have been proposed. The ﬁrst one is made of a chamber ﬁlled with a hydrogel,
with several microﬂuidic channels around it to establish the gradient. These devices have
already been developed in part B.1.4, page 185. The second one is based on the same ﬂow-
based gradient generators shown before, the upper or the lower side of the microﬂuidic
device is replaced by a membrane, upon or above which the cells are placed (see ﬁgure B.12).
A steep gradient is obtained, and can be considered linear in a zone of 200 µm. Steady
state was reached within 10 seconds for small molecules (GABA, 101 kg/mol) but it took 15
minutes for larger proteins (netrin-1, 75 kg/mol). This high time can be explained by the
change of gradient-establishing process, which is diﬀusion based in this case, and depends
on the diﬀusivity of the studied molecule.
Figure B.12. Cell culture above a microﬂuidic chamber, separated from it with a porous membrane, which allow
th diﬀusion of the studied molecule. Reprinted from [17].
The other proposed system is based on an isolation of the cells using walls with holes in
it (see ﬁgure B.13). Depending of the size of the holes, their position and the thickness of
the wall, the ﬂow can be reduced to the point the cells do not sense it. In a device developed
in reference [18], a quasi-linear gradient is obtained in a channel 200 µm wide, in 2 minutes
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for 70 kg/mol dextran. The steepness of the gradient, and its position in the channel at
the same time, depends on the pressure applied in the side channels. Similar devices are
shown in other references, where they have been used to study neuron chemotaxis to netrin
gradients [19] and the eﬀect of Wnt3a on melanoma cells [20].
Figure B.13. Amicroﬂuidic device to create 1D linear gradients for cell culture. This device is speciﬁcally designed
for the study of neurons on glass slide, as the ﬂow is almost zero near the neurons. Reprinted
from [19].
2D-shaped gradients
Figure B.14. A microﬂuid/diﬀusion-based hybrid gradient generator. (A, B) a 1D gradient is created in a square
hydrogel with two reservoirs, one ﬁlled with the molecule, the other one serving as a sink. The
original shape of the gradient is modiﬁed with microﬂuidic channels under the gel. The shape of
the channel impose the shape of the resulting gradient. (C) The shape of the concentration gradient
along the channel. Reprinted from [299].
2D gradients have been implemented in an hybrid of microﬂuidic and diﬀusion based
device, as shown on ﬁgure B.14 [299]. A “steady-state” gradient is established in a square
hydrogel 100 µm thick, with two reservoirs at opposite end of the gel. One plays the role of
the source and the other one the sink. The almost-linear obtained gradient is modulated by
microﬂuidic channels in contact with the lower side of the gel. This allows to create various
shapes of gradients, which depend on the shape of the microﬂuidic channel. However, as
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the 2D gradient depends on the shape of the channels tapped in the PDMS block, it is not
possible to make this shape evolve with time. The time required to establish the linear
gradient in the gel is long, due to its large size, and is estimated to be 10 hours for a small
protein. The price of the arbitrary shaped gradient is high in term of system response speed.
Creating time-modulated gradient may be possible with this system, by changing the
shape of the channel in real time. A laser-beam can be used to “draw” the channels in real
time, as reported in references [300, 301].
Dynamic gradients
Figure B.15. Dynamic gradient generation in a cell culture medium using a microﬂuidic device. Reprinted
from [21].
Dynamic gradients have also been implemented in these devices [21], as shown on
ﬁgure B.15. However, even if the authors claims that the gradient is established quickly, it
is in still in the timescale of the minute (45 seconds exactly). It is still out of the range of
the biological timescale.
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C. Materials & Methods
All the experimental procedures related to liposomes and millimeter-sized capsules are described
in dedicated appendices. See respectively appendix E, Preparation and characterization of
liposomes (p. 209) and appendix F, Preparation and characterization of polymer capsules
(p. 215).
C.1. Materials
C.1.1. Chemical and biological materials
Deionised water was obtained from a MilliQ Millipore system. α,ω dicarboxy terminated
polyNIPAM (Mw = 4,600 g/mol or Mw = 22,000 g/mol) were purchased from Polymer Source
Inc. Butan-1-ol, bovine serum albumin, Brij C2, Brij C20, chloroform (HPLC grade, stabi-
lized with ethanol), cholesterol, cyclohexane (anhydrous), dimethyl sulfoxide (anhydrous),
ethylene diamine, FITC-labeled dextran (10,000 g/mol), ﬂuorescein isothiocyanate (iso-
mer mixture), ﬂuorescein sodium salt, heavy water (except for NMR), hexane-1,6-diamine,
hexane-1,6-diol, methanol (spectrophotometric grade), nile red, ovalbumin, phosphate
buﬀered saline 10× concentrate, rhodamine B (laser grade), Sephacryl 300-HR, Sephacryl
400-HR, Sephacryl 500-HR, sodium chloride, sodium carbonate, sodium dihydrogenophos-
phate, sodium dodecyl sulfate (SDS), sodium tetraborate (borax), sucrose, trypan blue, 2,4-
diisocyanato-1-methylbenzene (also known as toluene diisocyanate, TDI) were purchased
from Sigma-Aldrich. 1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC) was purchased
from Avanti Polar Lipids, Inc. Calcein (acidic form), Texas Red-labeled bovine serum albu-
min, Texas Red-labeled neutral dextran (3,000 g/mol) were purchased from life technologies.
D-glucose was purchased from Merck KGaA. Hydrochloric acid (0.1mol/L and 1mol/L) and
sodium hydroxide solution (1mol/L) were purchased fromMerckMillipore. Sulforhodamine
101 (laser grade) was purchased from Acros organics. UCST polymers were provided by
Yue Zhao (Université de Sherbrooke, Québec, Canada). Diethyl ether, hydrochloric acid
(37 %), sodium hydroxide solution (9.3mol/L) and sodium iodide were purchased from VWR.
Black hole quencher (BHQ-1) was purchased from Biosearch Technologies. Molecular sieve
(4 Å) was purchased from Fisher Scientiﬁc France. Deuterated solvents for NMR (DMSO-d₆,
D₂O) were purchased from Euriso-top.
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C.1.2. Specific laboratory furnitures
Teﬂon spacers (Grace Bio-Labs SecureSeal, 1 well, diam. × thickness 9mm × 0.12mm) were
purchased from Sigma-Aldrich. Glass slides for microscopy and dialysis cassettes (Slide-
A-Lyser, 100 µL – 500 µL and 0.5 – 3mL, MWCO 3,500 g/mol) were purchased from Fisher
Scientiﬁc France. Syringe ﬁlters (PVDF, 0.22 µm, low protein binding) were purchased from
Merck-Millipore. Syringe ﬁlters (Whatman, cellulose acetate, 1.2 µm) were purchased from
VWR. Polystyrene culture dishes with glass bottom, suitable for ﬂuorescence microscopy
(35×10mm, aperture 22mm) were purchased from Willco Wells.
C.2. Sample preparation procedures
C.2.1. Fluorescein isothiocyanate netrin-1 labeling
Procedure adapted from [302]. A carbonate buﬀer (pH 9.5, 0.5mol/L) is prepared by dissolving
14.0 g of anhydrous sodium hydrogenocarbonate and 11.0 g anhydrous sodium carbonate
in 500mL deionized water. 65 µL of a netrin-1 solution in PBS at 1 g/L (0.942 nmol, 1 eq.)
was dialyzed against the carbonate buﬀer for 2 hours at 5℃. 0.65 µL of a FITC solution
at 5 g/L in anhydrous DMSO (18.8 nmol, 9 eq.) were added to the netrin-1 solution. The
reaction mixture was kept 2 hours at room temperature under gentle stirring, protected
from light, then dialyzed for one day against PBS at 5℃. As the protein solution volume
was too small, the gel permeation chromatography step described in the cited reference
was not performed.
The concentration of the protein and its degree of labeling was measured by UV-visible
spectroscopy. The concentration of the protein was obtained according to the following
formula, which eliminates the FITC contribution to the absorbance at 280 nm:
CNetrin-1 =
A280 − 0.31 ⋅ A495
𝜀280
(C.1)
where A280, A495 are the absorbances of the labeled-protein solution at 280 nm and 495 nm
respectively, 𝜀280 is the attenuation coeﬃcient of the protein at 280 nm. 0.31 corresponds to
the attenuation coeﬃcient ratio of FITC at 280 nm and 495 nm. As no mention of netrin-1
attenuation coeﬃcient was found in the literature, 𝜀280 has been evaluated using a numerical
method. Netrin-1 PDB was retrieved from RCSB Protein Databank (ref. 4OVE)1. The amino-
acid list was fed to ExPASy ProtParam tool [303, 304] to give 𝜀280 = 46,475 L/mol/cm. This
value assumes that all cysteins form disulﬁde bonds, which has been conﬁrmed using
Pymol2 on the PDB ﬁle. For mole to mass conversion, the computed molecular weight of
netrin-1 was used (48,918.1 g/mol).
1http://www.rcsb.org/pdb/explore/explore.do?structureId=4OVE
2version 1.7.6.0, retrieved from http://www.pymol.org
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The degree of labeling has been calculated using the relationship:
degree of labeling =
A495
𝜀495(FITC)
×
1
CNetrin-1
(C.2)
where 𝜀495(FITC) is the attenuation coeﬃcient of FITC at 495 nm (69,000 L/mol/cm).
C.2.2. α,ω diamino-terminated poly(NIPAM) synthesis
α,ω di-NHS terminated poly(NIPAM) synthesis
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Figure C.1. poly(NIPAM)-NHS₂, Mw = 4,794 g/mol.
Prepared according to [305]. 200mg of α,ω dicarboxy-teminated poly(NIPAM) (4,600 g/mol,
43.5 µmol, 1 eq.), 15.0mg of N -hydroxysuccinimide (130 µmol, 3 eq.) and 26.9mg of N,
N’-dicyclohexyl carbodiimide (130 µmol, 3 eq.) were dissolved in 2mL of anhydrous di-
chloromethane on ice bath under magnetic stirring. After complete dissolution of the
reactants, the ice bath was removed and the stirring was pursued overnight to yield a white
suspension. The suspension was poured in dry diethyl ether under magnetic stirring to
give a white precipitate isolated by centrifugation. This precipitate was redissolved in
anhydrous dichloromethane and precipitated once more in dry diethylether, isolated by
centrifugation and dried in vacuo for at least 6 hours. α,ω di-NHS terminated poly(NIPAM)
was obtained as a white brittle solid (170mg, yield 81.6 %). NMR (DMSO-d₆): δ=1.07 ppm
6.3H, (5), δ=1.5 ppm 2.3H (1), δ=2.0 ppm 1.1H (2), δ=2.8 ppm 0.17H (6), δ=3.9 ppm 1.0H (4),
δ=7.2 ppm 1.0H (3).
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α,ω di-amino terminated poly(NIPAM) synthesis
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Figure C.2. poly(NIPAM)-(NH₂)₂, Mw = 4,684 g/mol.
Prepared according to [306]. 28 µl of ethylene diamine (418 µmol, 10 eq.) were added to 5mL
of 50mmol/L borax buﬀer. 100mg of α,ω diamino-terminated poly(NIPAM) (4,794 g/mol,
41.72 µmol in chain ends, 1 eq.) were dissolved in 1mL of anhydrous DMSO to give an
homogeneous colorless solution. This solution was added dropwise to the previous one
under magnetic stirring. The reaction was allowed to proceed for two days at room tem-
perature. The obtained solution was dialyzed (Slide-a-Lyser, 0.5-3mL, MWCO 3500 g/mol)
against MilliQ water for 2 days and ice-dried to give a white ﬂuﬀy solid (78.9mg, yield
80.8 %). NMR (DMSO-d₆): δ=1.05 ppm 6.17H (5), δ=1.48 ppm 1.84H (1), δ=1.99 ppm 1.02H
(2), δ=3.87 ppm 1.00H (4), δ=7.21 ppm 0.97H (3)+(6). (7), (8) and (9) can’t be distinguished
from the other signals.
C.3. Sample characterization
C.3.1. Dynamic and static light scattering
All light scattering-based experiments were conducted on the same device: a BI-200SM
Goniometer System (Brookhaven Instruments Corporation) equipped with a 637 nm LED
laser with a variable power output (0 – 30mW) and a BI-CROSS CORR dual-photomultiplier
as the detector. The temperatures of the decaline and the sample were ﬁxed arbitrarily
between 10 and 50℃ with a regulated circulating bath (PolyScience). Before any set of
measurement, the intensity of light scattered by a sample of ﬁltered decaline was recorded
as the reference.
General purpose hydrodynamic radii measurements
Correlation functions were acquired at 25℃, at a ﬁxed angle of 90°, using the BIC Dynamic
Light Scattering software. The diaphragm openingwas set to 100 µm. Sampleswere analyzed
directly or were diluted in the case of high concentrations to avoid multiple diﬀusions.
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The hydrodynamic radius was extracted from the correlograms by the software using the
cumulants, biexponential, CONTIN or NNLS algorithms. The intensity of scattered light
was also returned by the software (as a function of time and its mean value).
Characterization of nano-emulsions prepared from Tween 80/Span 80 mixtures
We study here the stability of emulsions made of aqueous phase + Span 80/Tween 80 +
cyclohexane. The aqueous phase is made of HMDA 100 g/L and ﬂuorescein 1mmol/L in PBS.
The ﬁnal composition of each sample is 50 µL of the aqueous phase, 50 µL of surfactants and
9.8mL cyclohexane. First, surfactants are added to the cyclohexane and are emulsiﬁed with
a vortex mixer for 30 seconds. Then, the aqueous phase is added to the obtained solution,
and pre-emulsiﬁed for 2 minutes with the vortex mixer. The obtained rough emulsion is
submitted to ultra-sounds for 3 minutes, with 20 s on/10 s oﬀ cycles, on a water bath kept
at 10℃. The ultra-sounds are generated with a Vibracell VCX750 Ultrasonic Cell Disrupter
equipped with the microtip; the power was set to 40 % of the maximal available one.
Immediately after preparation and one day later, the size of the droplets obtained after the
ultra-sound emulsiﬁcation step was assessed by dynamic light scattering. As the emulsions
are highly diﬀusive, an optical density with a value of 1 was introduced in the optical path
of the laser before hitting the sample, to reduce the intensity of scattered light and enable
the measurement. The obtained correlograms were ﬁtted by the second-order cumulants
method. The average diameter, the polydispersity and the intensity of scattered light were
extracted.
C.3.2. UV-visible spectroscopy
General-purpose spectrum acquisition
Spectra were recorded either on a single-cell ThermoScientiﬁc Evolution array spectropho-
tomoter, equipped with a Peltier temperature-regulated cell holder or a dual-cell Agilent
Cary 300 UV-Visible spectrophotometer, equipped with a Peltier temperature-regulated cell
holder (TC 1, Quantum Northwest).
Spectra of UV (365 nm) or blue light (470 nm) irradiated samples were recorded on the
ThermoScientiﬁc Evolution spectrophotometer. The sample was irradiated directly in the
spectrophotometer, using a CoolLED light source (PE-2, Roper Scientiﬁc). The light was
shone from a light guide to the sample through the top of the quartz cuvette holding
the sample. The irradiances reached with this system were 35mW/cm² with UVs and
92mW/cm².
Measurement of azoTAB relaxation time by UV-Visible spectroscopy
Data acquisition A solution of azoTAB at 34mg/L in deionized water was prepared by
the dilution of a concentrated solution, obtained by dissolving the dry surfactant in deionized
water. The thermal relaxation experiment was performed on a UV-visible spectrophotometer
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(Evolution array, ThermoScientiﬁc). The solution was poured into a 3mL quartz cell and
kept at 25℃ in a thermostated cell holder, protected from light, during all the experiment.
The initial absorbance of the sample at 370 nmwas recorded prior illumination, as a all-trans
reference. UV light (365 nm, CoolLED PE-2, Roper scientiﬁc) was shone on the top of the cell
for 3 hours at an irradiance of 35mW/cm² to convert the surfactant into a predominantly
cis population (which was validated by the near zero absorbance at 375-380 nm). Spectra
were acquired by 30ms exposure of the cell to the spectrophotometer beam, at a sampling
rate of one spectrum every 20 minutes, for 2 days.
Data processing The absorbance at 370 nm was plotted as a function of time. To extract
the characteristic relaxation time, the relaxation processes was assumed to be of the ﬁrst
order. Its value (𝜏) was inferred from the initial slop of the curve (𝑆0), the initial absorbance
(𝐴0) and the all-trans absorbance (𝐴∞) which is the state reached at inﬁnite times. These
values are linked together by the following expression:
𝜏 =
𝐴∞ − 𝐴0
𝑆0
(C.3)
Determination of the UCST by UV-visible spectroscopy
UV-visible spectroscopy has been used to characterize the turbidity of polymer solutions as a
function of the temperature. From the temperature vs. transmittance curve was extracted the
UCST.
A polymer solution at 3 g/L in the studied solvent was prepared at a temperature 𝑇, above
the UCST; in practice, the solution was heated ≈ 10℃ above the temperature at which the
polymer dissolves. This solution was poured in a quartz cell (500 µL), held in the Peltier
cell-holder of a ThermoScientiﬁc Evolution array spectrophotometer heated at the same
temperature 𝑇. Spectra were recorded every 5 minutes, while the sample temperature
was decreased at 1℃ per 5 minutes. The turbidity of the sample was inferred from the
transmittance of the sample between 650 nm and 700 nm. The UCST was deﬁned as the
temperature reached by the sample when its initial transmittance was reduced by a factor
of 2.
C.3.3. Fluorescence intensity measurements
Emission spectra and time-based ﬂuorescence intensity recordings at ﬁxed wavelengths
were recorded on a on a Photon Technology International QuantaMaster QM-1 spectroﬂuo-
rimeter (PTI, Monmouth Junction, NJ) equipped with a Peltier cell-holder (TLC50,Quantum
Northwest, Shoreline, WA). Unless speciﬁcally speciﬁed, the bandwidth of irradiation and
excitation slits was set to 2 nm and the Peltier cell holder was set to 20℃. To prevent local
photobleaching during long-term acquisitions, the sample was homogenized by magnetic
stirring. All acquired data were corrected by the intensity of excitation light.
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The ﬂuorimeter has been slightly modiﬁed to allow the irradiation of the samples directly
inside it. The end of the CoolLED (PE-2, RoperScientiﬁc) liquid guide was placed at 1.5 cm
of the cuvette on its left side.
Time-resolved data acquisitionwas performed using the timebased mode of the acquisition
software (Felix GX).
Calcein fluorescence in presence of the azo-polymer
2mL of a 200 nmol/L calcein solution was poured in a 3mL quartz cell. The ﬂuorescence
intensity of this solutionwas recorded (excitationwavelength: 495 nm, emissionwavelength:
515 nm, acquisition frequency: 1Hz). To this solution were added 20 µL of a 0.1 g/L UV
irradiated (cis) polymer solution, yielding a solution at 198 nmol/L calcein and 0.99mg/L
polymer. The ﬂuorescence intensity of the solution was recorded again. Then, blue light or
UV light was shone alternatively on the sample through the light guide for 1 or 5 minutes,
and then the ﬂuorescence intensity was recorded for 5 minutes.
C.3.4. Maximum bubble pressure tensiometer
Maximum bubble pressure measurements were conducted on a BPA-1S tensiometer (SIN-
TERFACE, Germany).
Quantification of the SDS concentration in capsules suspensions
The maximum bubble pressure tensiometer can be used to quantify the surfactant concen-
tration in a given solution. This relies on establishing a calibration curve from solutions of
known concentrations. The general principle of the technique, as well as a short example
are reported in appendix D.1, p. D.1.
Calibration curves Reference solutions of SDS in PBS were prepared in the 20 µmol/L
– 20mmol/L range. The surface tension of each sample was acquired for bubble lifetimes
ranging from 10ms to 100 s. Each surface tension vs. lifetime curves has been ﬁtted by the
following equation:
𝛾 (𝑡) = 𝛾0 − 𝐾√𝑡 (C.4)
where 𝛾 (𝑡) is the surface tension for a lifetime of 𝑡, 𝛾0 is the surface tension of the pure buﬀer
and 𝐾 a factor proportional to the surfactant concentration. Plotting 𝐾 vs. the surfactant
concentration leads to the calibration curve.
Concentration determination To determine the residual concentration of SDS in the
capsule suspension, 5mL of this suspension were introduced in the tensiometer. The surface
tension was acquired for bubble lifetimes ranging from 10ms to 100 s. The surface tension
vs. lifetime curve was ﬁtted by equation (C.4), to extract the value of𝐾. The concentration of
SDS in the sample was inferred from 𝐾, using the calibration curve established beforehand.
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C.3.5. Other characterizations
Evaluation of UCST as a function of solute concentration
500 µL of a solution of the 35℃ UCST polymer at 3 g/L in deionized water were introduced in
a glass test tube. The temperature of the tube was regulated with a water bath (refrigerated
thermostat, polystat 26, Fisher Scientiﬁc) and controlled continuously in the sample using
a digital thermometer (Traceable 4000, VWR). A deﬁned volume of a concentrated aqueous
solution of the studied solute (sucrose 1.38mol/L, HMDA,HCl 1.72mol/L or sodium chloride
4.45mol/L) was added to the solution. After homogenization, the temperature of the sample
was decreased degree by degree, until the apparition of a precipitate (assessed with unaided
eyes). This temperature was noted, and the sample was heated again (≈ +5℃). When the
polymer was dissolved, the concentrated solution was added again to the sample, and this
process was repeated again. The concentration in polymer at the end of the process was
1.5 g/L. N.B.: each solute was processed separately, on freshly prepared polymer solutions.
The volumes added at each step (for each solutes) are summarized in table C.1.
Vconcentrated solute (µL) 0 26.3 31.0 36.5 43.0 50.9 60.4 71.8 85.8
Csucrose (mol/L) 0 0.07 0.08 0.09 0.11 0.13 0.15 0.17 0.20
CHMDA (mol/L) 0 0.09 0.10 0.12 0.14 0.16 0.19 0.22 0.25
CNaCl (mol/L) 0 0.22 0.26 0.30 0.35 0.41 0.48 0.56 0.65
Vconcentrated solute (µL) 103 124 151 185 230 291 375 500
Csucrose (mol/L) 0.23 0.27 0.32 0.37 0.43 0.51 0.59 0.69
CHMDA (mol/L) 0.29 0.34 0.40 0.47 0.54 0.63 0.74 0.86
CNaCl (mol/L) 0.76 0.89 1.03 1.20 1.40 1.64 1.91 2.23
Table C.1. Volumes of concentrated solute solutions (total) added to the polymer solutions, and solute concentra-
tion in the whole sample. In the ﬁrst line of the table is shown the total volume of solute in a given
step.
C.4. Various calculations
C.4.1. Evaluation of the encapsulated volume fraction in a
liposome suspension
For this evaluation, we will consider a liposome made of a lipid bilayer, as shown on
ﬁgure C.3. The three dimensions are linked together by the relation 𝐷 = 𝑑 + 2 ⋅ 𝑙. The area
per lipid in the bilayer is noted 𝐴. The number of lipids per vesicle𝑁ves can be expressed
as:
𝑁ves =
𝜋
𝐴 (
𝐷2 + (𝐷 − 2𝑙)2) (C.5)
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Figure C.3. Schematics of a liposome. 𝐷 is the diameter of the liposome, 𝑑 its inner diameter and 𝑙 the thickness
of the lipid bilayer.
For a suspension of lipid at 𝐶 g/L, the amount of lipid𝑁lip in a volume 𝑉susp is equal to:
𝑁lip =
𝐶𝒩𝐴𝑉susp
𝑀𝑤
(C.6)
where 𝑀𝑤 is the molar weight of the lipid. The number of vesicles 𝑛 in a given volume
𝑉susp is equal to 𝑛 = 𝑁lip/𝑁ves. The inner volume 𝑉 of one vesicle is equal to:
𝑉 =
4
3
𝜋(
𝑑
2)
3
=
4
3
𝜋(
𝐷 − 2𝑙
2 )
3
(C.7)
The volume fraction 𝜑 is therefore given by:
𝜑 =
𝑛𝑉
𝑉susp
=
𝐶𝒩𝐴𝐴(𝐷 − 2 ⋅ 𝑙)
3
6𝑀𝑤 (𝐷2 + (𝐷 − 2 ⋅ 𝑙)2)
(C.8)
and is proportional to 𝐶.
For a DOPC bilayer,𝐴 ≈ 70Å², 𝑙 ≈ 40Å [307],𝑀𝑤 = 786 g/mol. For 200 nm sized liposomes,
with a lipid at 10 g/L, the volume fraction equals to 8 %.
C.4.2. Evaluation of the characteristic time of release from a
porous liposome
These calculations are adapted from reference [228], pages 183–184. A liposome (see
ﬁgure C.4) is ﬁlled with a solution containing molecule whose diﬀusion coeﬃcient is 𝐷.
The radius of the liposome is 𝑅 and the thickness of its bilayer 𝑙; the inner radius will be
assimilated to 𝑅. The concentration of the molecule of interest inside the vesicle is noted 𝐶.
Fick’s ﬁrst law allows to write the following equation:
𝐣 (𝐱, 𝑡) = −𝐷 ∇𝐶 (𝐱, 𝑡) (C.9)
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Figure C.4. Schematics of a liposome and a pore in its membrane bilayer. 𝑅 is the liposome radius, 𝑟 its inner
radius, 𝑙 the thickness of the membrane and 𝑟𝑝 the radius of pore.
which can be rewritten as
𝐣 (𝑡) ∼ −
𝐶 (𝑡)
2 ⋅ 𝑟𝑝
(C.10)
assuming that the largest contribution to the gradient is given by the pore itself, and that
the concentration outside the vesicle can be neglected. By deﬁnition,
d𝑁
d 𝑡
(𝑡) = 𝑉
d𝐶
d 𝑡
(𝑡) = −4𝜋 ̃𝑟 𝐣 (𝑡) (C.11)
where𝑁 is the amount of molecules inside the vesicle, 𝑉 = 4
3
𝜋𝑅3 the vesicle volume and ̃𝑟
the apparent radius of the pore; ̃𝑟 = 𝑟𝑝 − 𝑒, where 𝑒 is the radius of the entrapped molecule.
From equations (C.10) and (C.11), we obtain the following diﬀerential equation:
d𝐶
d 𝑡
(𝑡) +
3𝐷 ̃𝑟2
𝑙𝑅3
𝐶 (𝑡) = 0 (C.12)
whose solution is exponential, associated with the characteristic decay time 𝜏 = 𝑙𝑅
3
3𝐷 ̃𝑟2
=
𝑙𝑅3
3𝐷(𝑟𝑝−𝑒)
.
For a protein, the associated radius (in nanometers) is given by 𝑒 = 0.066
3
√𝑀, where𝑀 is
its molar weight in g/mol (see reference [157]). Its diﬀusivity is given by the Stokes-Einstein
law:
𝐷 =
𝑘𝐵 𝑇
6𝜋𝜂𝑒
(C.13)
with 𝑇 = 310K, 𝜂 = 0.7⋅10⁻³ Pa⋅s. A 50 kg/mol protein has a radius of 2.4 nm, which corre-
sponds to a diﬀusion coeﬃcient of 135 µm²/s. We also consider DOPC vesicles, where 𝑙 =
40Å.
The associated characteristic time for a 10 µm vesicle is 21 s, and decrease to 1.4ms for a
200 nm sized one.
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D.1. Maximum bubble pressure tensiometer
The maximum bubble pressure method allows to measure the dynamic surface tension on
the air/liquid interface. It is based on the pressure measurement inside a bubble growing in
the studied liquid at the extremity of a capillary. This method has been implemented in
speciﬁc equipments by several companies (Krüss, SInterface, Launda-Brinkmann…) and is
used both in the industrial ﬁeld [308] and in the research ﬁeld [309, 310] to study various
liquids, from fuel mixtures to biological samples.
Maximum bubble pressure is widely used to determine the eﬀect of surfactants on the
dynamic surface tension [311, 312]. This technique has been extended to determine the
concentration of surfactant in liquids.
D.1.1. Principle
Air is ﬂowed through a capillary to create bubbles, as depicted on ﬁgure D.1. The pressure
is recorded as a function of time; as the bubble “grows” (points A & B), its radius diminishes
and the pressure increases to reach a maximum (point C). At this point, the radius of the
bubble is at its minimum and equals the one of the capillary; the shape of the bubble is a
half-sphere. After this point, the radius of the bubble increases and the pressure diminishes
until the bubble detaches from the capillary (point E), to give way to another bubble.
The pressure in the bubble is linked to its radius by the Laplace equation:
𝛾 =
𝑃𝐶 𝑅𝐶
2
(D.1)
where 𝛾 is the surface tension at the maximum bubble pressure (point C), 𝑃𝐶 is the pressure
at this point, 𝑅𝐶 is the radius of the capillary. However, the value returned by commercial
apparatus, like the SInterface BPA-1S maximum bubble pressure tensiometer, is corrected
by several factors, taking into account the eﬀect of the capillary size on the surface tension,
the eﬀect of the hydrodynamic pressure on the bubble formation, the eﬀect of the liquid
viscosity…
Eﬀect of surfactants on the dynamic surface tension
Due to their amphiphilic properties, surfactants are known to take interfaces over, which
leads to a decrease of the surface tension. The equilibrium state is not reached immediately
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Figure D.1. Upper ﬁgure: schematic representing the bubbling process. One cycle is represented (A to E). As the
air ﬂows, the volume of the bubble grows. The bubble radius increase up to point C, then decrease
until bubble detachment. Lower ﬁgure: graph representing the evolution of the pressure in the
capillary as a function of time.
as the molecules, initially dispersed in one phase, need to migrate to the interface. The
time evolution of the surface tension can be used to determine the kinetics of surfactant
migration/adsorption on the interface. Several models have been proposed to describe the
surfactant migration and/or adsorption on the interface [312]. Mechanisms restricted to
diﬀusion can be described by the Ward and Tordai equation:
Γ (𝑡) = 2√
𝐷
𝜋 (
𝑐0√𝑡 −∫
√𝑡
0
𝑐 (𝜏) d (𝑡 − 𝜏)
)
(D.2)
where Γ is the surface excess, 𝑐0 is the bulk surfactant concentration, 𝐷 is the diﬀusion
coeﬃcient of the monomeric surfactant, and 𝑐 is the surfactant concentration near the
interface. This equation takes into account the diﬀusion towards the interface, but also the
reverse process, when the interface becomes highly populated. The surface excess is linked
to the surface tension by the Gibbs equation:
Γ = −
1
𝑛𝑅𝑇
d𝛾
d ln 𝑐0
(D.3)
where 𝑅 is the gas constant, 𝑇 the temperature and 𝑛 represents the number of species per
surfactant molecule: 𝑛 = 1 for neutral surfactants, 𝑛 = 2 for ionic 1:1 surfactants.
204
D.1. Maximum bubble pressure tensiometer
Ward and Tordai equation solution
Ward and Tordai equation (D.2) can’t be solved analytically. However, two limit cases can
be considered. At short timescales (𝑡 → 0), diﬀusion originating from the surface can be
neglected. The solution to this equation in term of surface tension is:
𝛾 (𝑡)𝑡→0 = 𝛾0 − 2𝑛𝑅𝑇𝑐0√
𝐷𝑡
𝜋
(D.4)
where 𝛾0 is the surface tension of the solvent. The surface tension is linked to the square
root of the time by the bulk surfactant concentration 𝑐0. This technique can therefore be
used to quantify the surfactant concentration in a sample.
Equation (D.2) can also be solved at long time (𝑡 → ∞):
𝛾 (𝑡)𝑡→∞ = 𝛾eq +
𝑛𝑅𝑇 Γ2eq
𝑐0 √
𝜋
4𝐷𝑡
(D.5)
where 𝛾eq is the equilibrium surface tension and Γeq is the equilibrium surface excess. The
surface tension is linked to the inverse square root of time by the inverse of the bulk
surfactant concentration 𝑐0. This approximation also leads to a method to determine the
surfactant concentration.
D.1.2. Determination of surfactant concentration
As mentioned in reference [311], knowing 𝛾(𝑡) should be suﬃcient to determine the sur-
factant concentration 𝑐0. The relation between 𝑐0 and 𝛾(𝑡) depends only on an apparatus
constant characteristic the considered tensiometer. The determination of this constant
relies on a video analysis of the bubbling process, which has not been done for our device.
Another technique proposed in [308], which relies on a non-linear calibration curve (𝑐0,
𝛾(𝑡)) for a given 𝑡. This empirical method does not allow to quantify the surfactant in a wide
range of concentrations; the absence of a model to ﬁt the data reduce the robustness of the
method.
Here, we use equation (D.4) to draw a linear calibration curve. To illustrate the method,
we will focus on SDS solutions in PBS1 (see table D.1). The dynamic surface tension is
measured for each solution using the maximum bubble pressure tensiometer (BPA-1S,
SINTERFACE, Germany). The (𝑡, 𝛾(𝑡)) plot is shown on ﬁgure D.2.
The low-concentration curves (up to 0.502mmol/L) have been ﬁtted by the following
equation:
𝛾 (𝑡) = 𝛾0 − 𝐾√𝑡 (D.6)
with 𝐾 = 2𝑛𝑅𝑇𝑐0√𝐷/𝜋. The ﬁtted curves are shown on ﬁgure D.3. For the highest
concentrations, only the beginning or the curves have been ﬁtted. Fit results are summarised
in table D.2.
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Sample 1 2 3 4 5
SDS (mmol/L) 0.0200 0.0320 0.0502 0.0796 0.126
Sample 6 7 8 9 10
SDS (mmol/L) 0.200 0.317 0.502 0.796 1.26
Sample 11 12 13 14 15 16
SDS (mmol/L) 2.00 3.17 5.02 7.96 12.6 20.0
Table D.1. SDS concentration in calibration samples
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Figure D.2. (bubble lifetime, surface tension) for SDS samples. Its concentration is in the [0.02, 20]mmol/L range.
The calibration curve is obtained by plotting 𝐾 as a function of 𝑐0. The model implies a
linear relationship between these two values. The dataset has been ﬁtted accordingly with
the equation 𝐾 = 𝐴 ⋅ 𝑐0, as shown on ﬁgure D.4.
To determine the concentration of SDS in an unknown solution, it is only needed to
measure the dynamic pressure on the same time range and to ﬁt the beginning of the curve
by equation (D.6). 𝑐0 can then be extracted from 𝐾 and the previously determined 𝐴 by the
relation 𝑐0 = 𝐾/𝐴. As SDS is sensitive to ionic strength, the buﬀer should be the same for
the calibration and the measurement.
1Another example is shown with Tween 80 in the Material and Methods, section C.3.4, page 199.
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Figure D.3. Dynamic surface tension of SDS solutions ﬁtted by equation (D.6).
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Figure D.4. SDS calibration curve. The points are ﬁtted by the equation 𝐾 = 𝐴 ⋅ 𝑐0 with 𝐴 as the ﬁt parameter.
𝐴 = (23.8 ± 1.0) L⋅mN/m/√s/mmol.
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SDS conc (mmol/L) K stddev(K) 𝛾0 stddev(𝛾0)
0.02 0.530 0.016 77.150 0.084
0.032 0.866 0.023 76.279 0.089
0.0502 1.175 0.017 76.744 0.058
0.0796 1.538 0.037 76.13 0.12
0.126 2.972 0.028 76.385 0.049
0.2 5.48 0.23 75.66 0.22
0.317 11.06 0.32 76.00 0.17
0.502 19.1 1.2 74.33 0.49
Table D.2. Fit parameters of surface tension curves by equation 𝐾 = 𝐴𝑐0.
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E. Preparation and characterization of
liposomes
E.1. Sample preparation procedures
E.1.1. Liposome suspensions preparation
Liposomes were prepared according to literature by the ﬁlm hydration/extrusion method [106].
The procedure exposed below in a general one. Lipid stands for any kind of lipid or polymer used
to build the vesicles. In this work, combinations of DOPC, cholesterol, azoTAB or azobenzene-
grafted polymer have been used.
A ﬁlm of lipids (750 µg) was prepared in a glass crystallizer by evaporating a solution
of these lipids in chloroform/methanol under a ﬂux of nitrogen. Film drying was pursued
under vacuum for at least 4 hours. The dried ﬁlm was hydrated with the aqueous medium
(750 µL) and suspended roughly in the aqueous medium with the ﬂow of a plastic pipette.
The hydration was pursed under sonication for 10 minutes, to yield a suspension at 1 g/L
in lipids. This mixture was submitted to three cycles of freeze/thaw (freezing in liquid
nitrogen followed by melting in a water bath at 50℃) and was ﬁnally extruded by ﬁltering
it three times on a syringe ﬁlter (PVDF, 0.22 µm, Millipore).
E.1.2. Liposome purification by GPC
The bottom of a 3mL plastic syringe was stuﬀed with hydrophilic cotton and ﬁlled with
about 2mL of Sephacryl 500-HR. The gel was allowed to sediment for a few minutes
and was washed with 40mL of the aqueous medium (PBS, unless speciﬁcally stated). The
dead volume of the column was evaluated by following the elution of 100 µL of a dextran
blue solution (Mw = 2,000 kg/mol). 200 µL of the vesicle suspension were deposited on the
column and eluted with the aqueous medium. 100 µL fractions were collected. The presence
of liposomes in the fractions can’t be determined with unaided eyes and has been inferred from
systematic DLS measurements, cf. section E.2.1 below.
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E.2. Sample characterizations
E.2.1. Systematic size and concentration characterization
The concentration and the size of the vesicles were measured by DLS. The general procedure
is presented section C.3.1, page 196. Samples were analyzed as-is, without dilution or further
preparation.
E.2.2. AzoTAB-mediated dissolution of liposomes
“Low lipid concentration” protocol
Vesicles were prepared as described above in section E.1.1 Liposome suspensions preparation,
on 750 µg DOPC and with 750 µL deionized water as the aqueous medium. After extrusion,
the suspension was centrifuged for 10 minutes at 14,000 g; the pellet was eliminated to
yield a suspension of vesicles at approximately 1 g/L.
Trans azoTAB stock solutions were prepared from dry powder and deionized water, at
10 g/L and 1 g/L. A fraction of both solutions was submitted to UV light irradiation (365 nm,
35mW/cm²) for 4 hours to yield cis-azoTAB stock solutions.
The samples made of azoTAB and liposomes were prepared as follows. In a DLS quartz cell
were added deionized water and 50 µL of the liposome suspension. After homogeneization,
a deﬁned volume of the cis or trans azoTAB stock solution was added ; the sample was
homogeneized again and immediately characterized by DLS to extract the scattered light
intensity and their hydrodynamic diameter (cf. appendix C.3.1, p. 196). The samples were
allowed to incubate at room temperature for 24 hours, then they were processed again by
DLS. The volumes of deionized water and of stock azoTAB solutions used to prepare the
samples are reported in table E.1.
Final azoTAB concentration
(g/L)
0.0 0.2 0.4 0.6 0.8 1.0 2.0 4.0
azoTAB stock solution – 1 g/L 1 g/L 1 g/L 1 g/L 10 g/L 10 g/L 10 g/L
VazoTAB stock solution (µL) – 100 200 300 400 50 100 200
VDeionized water (µL) 450 350 250 150 50 400 350 250
Table E.1. Sample composition.
“High lipid concentration” protocol
A ﬁlm of DOPC was prepared in a glass crystallizer by evaporating a solution of these lipids
in chloroform/methanol under a ﬂux of nitrogen. Film drying was pursued under vacuum
for at least 4 hours. The dried ﬁlm was hydrated with a 20 g/L trans azoTAB solution and
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sonicated for ∼ 10min. The samples were allowed to rest for 24 hours at room temperature
before use.
The samples were characterized by DLS (cf. C.3.1, p. 196). Light was shone on the sample
from the top of the DLS cell, through a light guide. This enabled to irradiate the sample
with blue light (470 nm, 91mW/cm²) or UV light (365 nm, 35mW/cm²).
Determination of azoTAB-mediated liposome dissolution kinetics
Vesicles were prepared as described above in section E.1.1 Liposome suspensions preparation,
on 300 µg DOPC and with 300 µL deionized water or 300 µL NaCl 150mM as the aqueous
medium. After extrusion, the suspension was centrifuged for 10 minutes at 14,000 g; the
pellet was eliminated to yield a suspension of vesicles at approximately 1 g/L. A solution of
cis azoTAB (8.4 g/L, deionized water), was obtained by irradiating a 8.4 g/L azoTAB solution
under UV light (365 nm, 35mW/cm²) for several hours.
The samples “without NaCl” were obtained from mixing 15 µL of the liposome suspension
(ﬁlm hydrated with deionized water), deionized water and the cis-azoTAB solution (in this
order) The samples “150mmol/L NaCl” were obtained from mixing deionized water, 8.8 µL
NaCl 4mM, the cis-azoTAB solution and 15 µL of the liposome suspension (ﬁlm hydrated
with 150mM NaCl solution). The volumes of cis-azoTAB solution and deionized water are
reported table E.2.
Buﬀer Deionized water 150 mmol/L NaCl
Final azoTAB concentration (g/L) 0.34 0.50 1.26 0.34 0.50 1.26
Vcis-azoTAB 8.4 g/L (µL) 10.0 15.0 37.5 10.0 15.0 37.5
Deionized water 225 220 198 216 211 189
Table E.2. Sample compositions.
Immediately after mixing, 200 µL of the samples were transferred into a DLS quartz
cell. The hydrodynamic diameter and the intensity of scattered light were measured by
DLS (cf. C.3.1, p. 196). The sample was then shone continuously with blue light (470 nm,
92mW/cm²), from the top of the DLS cell, using a CoolLED (PE-2, Roper Scientiﬁc) light
source. The hydrodynamic diameter and the intensity of scattered light were measured
every 5 minutes for 14 hours.
Light-sensitivity assessment of azoTAB-loaded liposomes
Liposomes were prepared as reported above in section E.1.1, on 250 µg DOPC. The lipid ﬁlm
was hydrated with 250 µL of a cis-azoTAB solution, at 1.0 g/L, 1.5 g/L, 2.0 g/L or 5.0 g/L. The
cis-azoTAB solutions were obtained by irradiating the trans ones with UV light (365 nm,
35mW/cm²) for at least 15 minutes. The presence of liposomes in each samples was inferred
from DLS measurements on raw samples.
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The samples containing liposomes were puriﬁed by GPC to remove unbound surfactant
molecules (cf. section E.1.2). The fraction with the highest concentration in ≈ 200 nm vesicles
was determined by DLS.
These fractions were then poured in a DLS quartz cell ; the hydrodynamic diameter
and the intensity of scattered light was recorded. The studied sample was then shone
continuously with blue light (470 nm, 92mW/cm²), from the top of the DLS cell, using a
CoolLED (PE-2, Roper Scientiﬁc) light source. The hydrodynamic diameter and the intensity
of scattered light were measured every 5 minutes for 14 hours.
E.2.3. Characterization of the release from azo polymer-sensitized
liposomes
Preparation of calcein-loaded and azo polymer-sensitized liposomes
A ﬁlm of lipids (DOPC, azo polymer and possibly cholesterol, 750 µg total) was prepared in
a glass crystallizer by evaporating a solution of these lipids in chloroform/methanol under a
ﬂux of nitrogen. Film drying was pursued under vacuum for at least 4 hours. The dried ﬁlm
was hydrated with 750 µL of a 25mmol/L calcein solution in PBS, and suspended roughly
in it with the ﬂow of a micropipette. The hydration was pursed under sonication for 10
minutes, to yield a suspension at 1 g/L in lipids. This mixture was submitted to three cycles
of freeze/thaw (freezing in liquid nitrogen followed by melting in a water bath at 40℃) and
was ﬁnally extruded by ﬁltering it three times on a syringe ﬁlter (PVDF, 0.22 µm, Millipore).
The lipid+polymer suspension was placed in a watchglass and precisely weighed. To
convert the azobenzene into a predominant cis conﬁguration, the suspension was placed
under UV light (365 nm, 10mW/cm², CoolLED, PE-2, Roper Scientiﬁc) for 1 hour. The
sample was weighed again and the evaporated water was replaced. The liposomes were
then puriﬁed by GPC, to remove the outer calcein, as shown in section E.1.2 below.
N.B.: To prevent the thermal relaxation of the cis azobenzenes, the fractions obtained after
puriﬁcation were kept in a dark room and placed periodically under UV light.
Sample selection
After puriﬁcation, the fractions were analyzed by DLS to assess the presence of liposomes
as reported below. The presence of loaded calcein was characterized by forcing the release
with Triton X-100. This procedure is explained below. The samples selected for the release
study were those with a correct hydrodynamic diameter (≈ 200 nm) and the highest increase
of ﬂuorescence during the forced release test.
Forced release test
A 3mL quartz cuvette was ﬁlled with 2mL of the elution buﬀer and 20 µL of the studied
liposome suspension (at ≈ 1 g/L in lipids). The ﬂuorescence intensity of the sample was
recorded for about 60 seconds, at a frequency of 1Hz. The excitation wavelength was set
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to 495 nm and the emission one to 515 nm. The complete description of the ﬂuorimeter
used is reported in appendix C.3.3, p. 198. The recording was stopped and 20 µL of a Triton
X-100 solution in deionized water (100 g/L, 160mmol/L) were introduced in the cuvette. The
ﬂuorescence intensity recording was resumed after sample homogenization, and pursued
for 60 seconds.
Remark: Triton X-100 is able to dissolve almost instantaneously the membrane of the
liposomes [218], as soon as there is more Triton X-100 molecules than lipids in the sample. In
this assay, its ﬁnal concentration is 1.6mmol/L. The concentration in lipids is roughly 10mg/L
(≈ 13 µmol/L of DOPC). The Triton X-100:lipid ratio is ≈ 120, which ensures that all the vesicles
are dissolved.
Release experiment
The ﬂuorescence intensity was recorded with the device described in appendix C.3.3, p. 198.
The excitation wavelength was set to 495 nm, the emission one to 515 nm, the acquisition
frequency to 1Hz. To prevent a local photobleaching of the sample by the excitation source,
the sample was continuously homogeneized by magnetic stirring.
The studied was prepared as follows: a 3mL quartz cuvette was ﬁlled with 2mL of the
sample buﬀer and 20 µL of the studied sample. The ﬂuorescence of this sample was recorded
for about 1 minute. To prevent any damages caused to the detector by the high intensity
irradiation, the emission shutter was closed and the recording was paused. The sample
was irradiated at 470 nm (14mW/cm²) through the liquid guide, for the given time (1 or
5 minutes). Immediately after shutting down the light source, the emission shutter was
reopened and the recording resumed for at least 30 minutes. At the end of the experiment,
the recording was paused again, and 20 µL of a Triton X-100 solution at 100 g/L in water
was added to the sample. The sample was let to homogeneize for several seconds and the
recording was resumed for 30–60 seconds.
Data processing
Fluorescence intensity vs. time plots were analyzed as is, without pre-processing.
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F. Preparation and characterization of
polymer capsules
F.1. Millimeter-sized capsules
F.1.1. General procedures
The preparation procedure is mostly the same for the capsules made from polyNIPAM or UCST
polymers. The only diﬀerence resides in the temperatures of all the phases. The temperature of
the aqueous phase – from which the capsules are made – will be noted 𝑇aq, the temperature of
the oil phase 𝑇oil and the temperature of the redispersion medium 𝑇redisp. When the capsule is
submitted to a temperature ramp, the temperature at the beginning of the ramp is noted 𝑇start,
the one at the end of the ramp 𝑇end.
Capsule preparation
The exact composition of the aqueous phase depends on the considered sample. It will be
referred only to the aqueous phase below, its composition will be exposed on an assay-basis,
in the next section.
The aqueous phase is brought to temperature 𝑇aq and introduced in a microsyringe
(Hamilton, 25 µL) kept at the same temperature. 20mL dry cyclohexane (molecular sieve
dried) are poured in a clean and dry glass vial, and brought to 𝑇oil with a water bath. 71 µL
TDI (340 µmol) are added cautiously on the bottom of the vial, to ensure that the TDI
concentration is almost zero in the upper layers of the cyclohexane. A 1 µL drop is created
with the microsyringe and quickly immersed in the upper layer of the cyclohexane. The
drop is kept that way 2–5 seconds, then the microsyringe is removed from the cyclohexane.
The drop does not cross the oil/air interface and falls at the bottom of the vial. ≈ 12 drop are
created per vial this way. This system is kept at 𝑇oil overnight. This preparation procedure
is summarized in ﬁgure F.1 (polyNIPAM example).
The capsules are then transferred to the redispersion medium (PBS, unless speciﬁcally
stated). A glass tube is ﬁlled with 1mL of the redispersion aqueous medium and 500 µL
cyclohexane. Two drops of a Tween 80-saturated cyclohexane solution are then added. The
capsules – still in the reaction vial – and this tube are brought to 𝑇redisp. One capsule is
transferred from the reaction vial to the cyclohexane layer in the glass tube with a glass
pipette. The capsule spontaneously falls to the bottom of the aqueous phase. If the capsule is
stuck at the oil/water interface, two drops of the Tween 80-saturated cyclohexane solution
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TDI / polyNIPAM
reaction
aqueous phase
(T below LCST)
polyNIPAM at the
water/oil interface
cyclohexane
(T above LCST)
TDI gradient
(A) (B) (C) (D)
Figure F.1. Synthesis of the capsule in the oil phase. (A) a gradient of TDI concentration is created in cyclohexane,
at a temperature above the LCST. Under these conditions, the concentration in TDI at the top of
the cyclohexane is considered null. (B) a drop of the aqueous phase is introduced in the oil with a
microsyringe. The syringe and its content are at a temperature below the LCST, allowing the solution
to ﬂow through the needle. (C) as the oil is at a temperature above the LCST, the polyNIPAM inside
the drop precipitates and goes to the water/oil interface. As the drop was kept in the higher levels of
cyclohexane, where no TDI can be found, no reaction occurred yet. (D) the drop is made to fall at the
bottom of the cyclohexane, were the membrane is synthesized.
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Figure F.2. Capsule transfer from oil phase to aqueous phase. (a) a glass tube ﬁlled with PBS and cyclohexane +
2 drop of Tween 80-saturated cyclohexane. (b) the capsule is transferred into the tube with a glass
pipette. (c) due to its high density the capsule falls towards the cyclohexane/PBS interface, (d), (e)
and crosses it spontaneously due to the Tween 80 added in the oil phase. (f) after removing the
cyclohexane, the capsule can be transferred elsewhere with a glass pipette.
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can be added to ease the crossing. Each capsule is processed the same way in a freshly
prepared glass tube. This procedure is shown in ﬁgure F.2.
Capsule characterization by microscopy
Experimental device The experimental device used to characterize the capsules is com-
posed of an inverted microscope (Leica DM-IRE2), capable of epiﬂuorescence and phase
contrast illuminations. Pictures were recorded with a µEye UI-3250CP (IDS, Stemmer
Imaging). The temperature of the sample was regulated using a Peltier microscope stage
(Linkam 100-LI3 Peltier stage, Linkam PE-94 controller). On this plate was mounted a
ﬂuorescence-grade Petri dish (glass bottom, 35mm diam.), modiﬁed with a raised glass
slide (25mm diam.), as shown on ﬁgure F.3. The temperature in the Petri dish – near the
studied sample – is recorded using a probed thermometer (Traceable 4000, VWR). Prior
to the introduction of the capsule, this Petri dish is ﬁlled with ≈ 5mL of the redispersion
medium and heated to ∼ 𝑇start with the Peltier plate.
Petri dish, filled with PBS
temperature probe
capsule
raised glass slide
Figure F.3. Schematic representation of the microscope-based setup used to characterize the capsules. The capsules
is placed in the PBS ﬁlled Petri dish, whose temperature is controlled with a Peltier microscope plate
(not represented). If required, the capsule can be elevated with a glass slide, as shown in the picture.
The temperature near the capsule was measured with a temperature probe.
One capsule is studied at a time. The capsule is transferred the Petri dish, on the raised slide,
with a glass pipette. Unless speciﬁcally stated, the capsule is submitted to a temperature
ramp, from 𝑇start to 𝑇end. The heating or cooling rate was set to 10℃/min. N.B.: due to the
inertia of the system, the rate achieved in the Petri dish was in the 5–7 ℃/min. range.
Data recording Fluorescence pictures were taken at regular intervals: ﬁrst every 5
seconds for 100 seconds (200 pictures), then every 30 seconds for 900 seconds (30 pictures).
Data processing Fluorescence pictures were analyzed using FiJi (an ImageJ distribution).
After the experiment, the ground level of the camera was recorded at the same exposure
time (30 pictures, averaged with ImageJ). A picture of an homogeneous ﬂuorescent object
was also taken to correct the inhomogeneities of the illumination ﬁeld. In this case, the
homogeneous object was a solution of Rhodamine 123 in glycerol at 0.1 µmol/L, between
2 glass slides sealed with a 120 µm thick Teﬂon spacer. Each picture in the dataset were
processed in this way:
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1. the ground level of the camera is removed by subtracting the adequate picture;
2. the inhomogeneity of the epiﬂuorescence illumination is corrected by dividing the
picture stack pixel-wise with the picture of the homogeneous object.
The ﬂuorescence intensity was measured by outlining the capsule with the threshold tool
and summing the value of each pixel inside this outline with the measure tool.
F.1.2. Assays description
HMDA millimeter-sized capsules
Capsules were prepared according to section F.1.1. The compositions of the aqueous phases
used to build the capsules are reported in the table below. All the preparation steps were
performed at room temperature.
Sample Aqueous phase composition
10mg/L 10mg/L HMDA (96 µmol/L), 0.63mol/L sucrose, PBS
100mg/L 100mg/L HMDA (0.96mmol/L), 0.63mol/L sucrose, PBS
1 g/L 10mg/L HMDA (9.6mmol/L), 0.63mol/L sucrose, PBS
10 g/L 10mg/L HMDA (96mmol/L), 0.63mol/L sucrose, PBS
100 g/L 10mg/L HMDA (0.96mol/L), 0.63mol/L sucrose, PBS
The transfer protocol was developedwith capsulesmade from the aqueous phases reported
below:
Sample Aqueous phase composition
“Sucrose” 10mg/L HMDA (96mmol/L), 0.63mol/L sucrose in PBS
“NaCl” 10mg/L HMDA (96mmol/L), 2.22mol/L sucrose in PBS
Evaluation of the eﬀect of sucrose and NaCl on polyNIPAM capsules
Capsules were prepared according to section F.1.1. The compositions of the aqueous phases
used to build the capsules are reported in the table below.
Sample Aqueous phase composition
“Sucrose” 10 g/L α,ω diamino-terminated polyNIPAM (4600 g/mol), 0.63mol/L sucrose in PBS
“NaCl” 10 g/L α,ω diamino-terminated polyNIPAM (4600 g/mol), 2.22mol/L sucrose in PBS
The processing temperatures are reported below:
Sample 𝑇aq 𝑇oil 𝑇redisp 𝑇start 𝑇end
“Sucrose” 5℃ RT 50℃ 50℃ 15℃
“NaCl” ≈ 0℃ RT 50℃ 50℃ 15℃
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Characterization of polyNIPAM capsule integrity as a function of the
temperature
Capsules were prepared according to section F.1.1, from an aqueous phase made of 10 g/L
α,ω-diamino terminated polyNIPAM (4600 g/mol) and 0.63mol/L sucrose in PBS. The
capsules were characterized as reported in section F.1.1. Phase contrast pictures were taken,
instead of ﬂuorescence ones. The processing temperatures are reported below:
𝑇aq 𝑇oil 𝑇redisp 𝑇start 𝑇end
5℃ RT 50℃ 50℃ 15℃
polyNIPAM capsules release tests
Capsules were prepared according to section F.1.1. The aqueous phases were made of 10 g/L
α,ω-diamino terminated polyNIPAM (4600 g/mol), 0.63mol/L sucrose and a ﬂuorescence
probe, in PBS. The characteristics of the ﬂuorescence probe and its concentration are
reported below:
Encapsulated molecules Molecule concentrations
Sulforhodamine 101 50 µmol/L
Dextran-TexasRed (3 kg/mol) 50mg/L
Dextran-FITC (10 kg/mol) 250mg/L
BSA-TexasRed (66 kg/mol) 1 g/L
Netrin-FITC (68 kg/mol) 60mg/L
Netrin-FITC (68 kg/mol) and BSA Netrin-FITC: 60mg/L, BSA: 1.92 g/L
Antibody-FITC (150 kg/mol) 67mg/L
The capsules were characterized as reported in section F.1.1. The processing temperatures
are reported below:
𝑇aq 𝑇oil 𝑇redisp 𝑇start 𝑇end
5℃ RT 50℃ 50℃ 15℃
Reactive polyNIPAM+HMDA capsule release tests
Capsules were prepared according to section F.1.1. The aqueous phases were made of
HMDA, α,ω-diamino terminated polyNIPAM (4600 g/mol), HMDA, 0.63mmol/L sucrose
and sulforhodamine 101 (50 µmol/L) in PBS. Capsules were transferred in PBS or in PBS
supplemented with 0.64mmol/L glucose. PolyNIPAM and HMDA concentrations and the
presence of glucose in the redispersion medium is shown below:
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Sample name CpolyNIPAM (g/L) CHMDA (g/L) Glucose in redispersion medium
5% 0.5 9.5 Yes
10% 1.0 9.0 Yes
25% 2.5 7.5 Yes
50% 5.0 5.0 No
The capsules were characterized in the redispersion medium, as reported in section F.1.1.
The processing temperatures are reported below:
𝑇aq 𝑇oil 𝑇redisp 𝑇start 𝑇end
5℃ RT 50℃ 50℃ 15℃
Unreactive polyNIPAM+HMDA capsule release tests
Capsules were prepared according to section F.1.1. The aqueous phases were made of
HMDA, α,ω-diamino terminated polyNIPAM (4600 g/mol), HMDA, 0.63mmol/L sucrose
and Dextran-TexasRed (3,000 g/mol, 50mg/L) in PBS. Capsules were transferred in PBS or
in PBS supplemented with 0.64mmol/L glucose. PolyNIPAM and HMDA concentrations
are reported below:
Sample name 5 % 10% 25% 80% 90% 95% 100%
CpolyNIPAM (g/L) 0.5 1.0 2.5 8.0 9.0 9.5 10.0
CHMDA (g/L) 9.5 9.0 7.5 2.0 1.0 0.5 0.0
The capsules were characterized as reported in section F.1.1. The processing temperatures
are reported below:
𝑇aq 𝑇oil 𝑇redisp 𝑇start 𝑇end
5℃ RT 50℃ 50℃ 15℃
Determination of the working UCST+albumin composition
Capsules were prepared according to section F.1.1. All the procedure was conducted at
room temperature. The aqueous phases were made of albumin (BSA or ovalbumin), dextran-
TexasRed (3000 g/mol) and an additive (sucrose or heavy water) in PBS. The composition of
each phase is reported below:
Albumin Calbumin Additive Cadditive Fluorescent probe Cprobe
Ovalbumin 10 g/L Sucrose 20 % w. Dextran Texas Red 100mg/L
Ovalbumin 100 g/L D₂O 71.7 % vol. Dextran Texas Red 10mg/L
BSA 10 g/L Sucrose 20 % w. Dextran Texas Red 100mg/L
BSA 100 g/L D₂O 71.7 % vol. Dextran Texas Red 10mg/L
The capsules were characterized as reported in section F.1.1. Only a few pictures were
taken; the capsules were not submitted to the temperature ramp.
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UCST polymer-based capsules: choice of the fluorophore
Capsules were prepared according to section F.1.1. The aqueous phases were made of
ovalbumin, the 43℃ UCST polymer, 71.7 % vol. D₂O and a ﬂuorescent probe in PBS. The
composition of each phase is reported below:
Dye Cdye Covalbumin (g/L) CUCST polymer (43 °C) (g/L)
BSA-FITC 167mg/L 80 20
Calcein 10 µmol/L 80 20
Dextran-TexasRed (3,000 g/mol 10mg/L 100 10
The capsules were characterized as reported in section F.1.1. The processing temperatures
are reported below:
Sample 𝑇aq 𝑇oil 𝑇redisp 𝑇start 𝑇end
BSA-FITC 55℃ RT RT 55℃
Calcein 55℃ RT 15℃ 55℃
Dextran-TexasRed 55℃ RT 15℃ 70℃
Temperature-sensitivity of UCST:ovalbumin capsules
Capsules were prepared according to section F.1.1. The aqueous phases were made of
ovalbumin, the 43℃ UCST polymer, 71.7 % vol. D₂O and 10 µmol/L calcein in PBS. The
composition of each phase is reported below:
Sample name 0 % 10% 20% 30% 50% 70% 80% 90% 100%
CUCST polymer 43 °C (g/L) 0 10 20 30 50 70 80 90 100
COvalbumin (g/L) 100 90 80 70 50 30 20 10 0
The capsules were characterized as reported in section F.1.1. The burst was inferred from
the evolution of the shape of the capsule, not on the ﬂuorescence intensity in the capsule.
The processing temperatures are reported below:
𝑇aq 𝑇oil 𝑇redisp 𝑇start 𝑇end
55℃ RT RT 15℃ 50℃
Determination of the burst temperature of UCST:ovalbumin capsules
Capsules were prepared according to section F.1.1. The aqueous phases were made of
ovalbumin, a UCST polymer, 71.7 % vol. D₂O and a ﬂuorescent reporter in PBS. The
composition of each phase is reported below:
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Sample Cpolymer
(g/L)
COvalbumin
(g/L)
Fluorescent
probe
CProbe
90% 43 °C UCST polymer/10%
ovalbumin
90 10 calcein 10 µmol/L
80% 43 °C UCST polymer/20%
ovalbumin
80 20 BSA-FITC 10mg/L
90% 35 °C UCST polymer/10%
ovalbumin
90 10 BSA-TexasRed 10mg/L
The capsules were characterized as reported in section F.1.1. The burst was inferred from
the evolution of the shape of the capsule, not on the ﬂuorescence intensity in the capsule.
The processing temperatures are reported below:
Sample 𝑇aq 𝑇oil 𝑇redisp 𝑇start 𝑇end
90% 43 °C UCST polymer/10% ovalbumin 55℃ RT RT 15℃ 55℃
80% 43 °C UCST polymer/20% ovalbumin 55℃ RT RT 15℃ 55℃
90% 35 °C UCST polymer/10% ovalbumin 50℃ RT 10℃ 10℃ 55℃
F.2. Nanometer-sized capsules
F.2.1. HMDA-based capsules
Capsule synthesis
In 9.8mL of anhydrous cyclohexane were added 50 µL of a Span 80/Tween 80 mixture. The
surfactants were dissolved with a vortex mixer for 30 seconds, to yield a translucent or
transparent homogeneous solution, depending of the Span/Tween ratio. To this solution
were added 50 µL of an aqueous phase made of 100 g/L of HMDA in PBS. The biphasic
mixture is pre-emulsiﬁed with a vortex mixer for 2 minutes, to yield a milky emulsion.
This emulsion was submitted to ultrasounds (Vibracell VCX750 Ultrasonic Cell Disrupter,
equipped with a microtip, 40 % power) 20 s on/10 s oﬀ cycles for 3 minutes, in a 10℃
water bath. This yield a translucent emulsion, of which 1mL where reserved for DLS
measurements. The 9mL left were placed under magnetic stirring in a water bath (10℃);
1.5 TDI equivalents per monomer molecules were added in 3.6mL anhydrous cyclohexane,
then poured dropwise in the heated emulsion. The reaction was allowed to proceed for at
least 3 hours.
The Span:Tween volumes used are reported below:
Span:Tween vol. ratio 100:0 90:10 80:20 70:30 60:40 50:50
VSpan 80 (µL) 50 45 40 35 30 25
VTween 80 (µL) 0 5 10 15 20 25
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Transfer of the capsules in the aqueous phase
1mL of a suspension of capsules in the oil were transferred dropwise in a solution of SDS
at 5.77 g/L (20mmol/L) in PBS, under vigorous magnetic stirring, to yield a milky emulsion.
This emulsion was then submitted to ultrasounds (Vibracell with microtip, 40 % power)
for 1 minute, 10 s on/5 s oﬀ cycles. The mixture was heated at 70℃ for 30 minutes under
magnetic stirring to remove the cyclohexane. The obtained suspension was ﬁltered on
cellulose acetate (1.2 µm) prior to DLS measurements.
Characterization of hydrodynamic diameters
The crude emulsion and the suspension of capsules in SDS were processed without dilution,
as reported in appendix C.3.1 General purpose hydrodynamic radii measurements, p. 196.
F.2.2. Synthesis and characterization of polyNIPAM capsules
Capsules synthesis
In 9.8mL of anhydrous cyclohexane were added 30 µL Span 80 and 20 µL Tween 80. The
surfactants were dissolved with a vortex mixer for 30 seconds, to yield a translucent
homogeneous solution. To this solution were added 50 µL of an aqueous phase made of
α,ω diamino-terminated polyNIPAM and HMDA (cf. table below). The biphasic mixture
is cooled at 10℃ with a water bath, and then pre-emulsiﬁed with a vortex mixer for 2
minutes, to yield a milky emulsion. This emulsion was submitted to ultrasounds (Vibracell
VCX750 Ultrasonic Cell Disrupter, equipped with a microtip, 40 % power) 20 s on/10 s oﬀ
cycles for 3 minutes, in a 10℃ water bath. This yield a translucent emulsion, of whom 1mL
where reserved for DLS measurements. The 9mL left were placed in a water bath at 40℃
under magnetic stirring; 1.5 TDI equivalents per monomer molecules were added in 3.6mL
anhydrous cyclohexane, then poured dropwise in the heated emulsion. The reaction was
left to proceed for at least 3 hours.
Sample CpolyNIPAM (g/L) CHMDA (g/L)
polyNIPAM 100% 100 0
polyNIPAM 50%/HMDA 50% 50 50
All the next steps were performed at 50℃. 1mL of a suspension of capsules in the
oil were transferred dropwise in a solution of SDS at 5.77 g/L (20mmol/L) in PBS, under
vigorous magnetic stirring, to yield a milky emulsion. This emulsion was then submitted
to ultrasounds (Vibracell with microtip, 40 % power) for 1 minute, 10 s on/5 s oﬀ cycles.
The mixture was heated at 70℃ for 30 minutes under magnetic stirring to remove the
cyclohexane. The obtained suspensions were ﬁltered on cellulose acetate (1.2 µm) prior to
DLS measurements.
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Capsules characterization
The hydrodynamic radius and the intensity of scattered light was obtained by DLS (cf.
appendix C.3.1, p. 196), at 50℃ immediately after ﬁltration. The temperature of the sample
was decreased to 20℃ (RT, t = 0); 15 minutes after, these measurements were repeated. The
sample was kept at room temperature for 8 days. The hydrodynamic diameter and the
intensity of scattered light were measured at t = 24 h and t = 8 days.
F.2.3. Determination of the temperature of release with the
calcein+cobalt assay
Capsule synthesis
In 9.8mL of anhydrous cyclohexane were added 30 µL Span 80 and 20 µL Tween 80. The
surfactants were dissolved with a vortex mixer for 30 seconds, to yield a translucent
homogeneous solution. To this solution were added 50 µL of an aqueous phase made of
80 g/L α,ω diamino-terminated polyNIPAM, 20 g/L HMDA, 3.2 µmol/L calcein sodium salt
and 7.7 µmol/L cobalt(II) chloride. The biphasic mixture is cooled at 10℃ with a water
bath, then pre-emulsiﬁed with a vortex mixer for 2 minutes, to yield a milky emulsion.
This emulsion was submitted to ultrasounds (Vibracell VCX750 Ultrasonic Cell Disrupter,
equipped with a microtip, 40 % power) 20 s on/10 s oﬀ cycles for 3 minutes, in a 10℃
water bath. This yield a translucent emulsion, of whom 1mL where reserved for DLS
measurements. The 9mL left were placed in a water bath at 40℃ under magnetic stirring;
3.6mL of a solution of TDI at 16.14mmol/L in cyclohexane (5.8⋅10⁻⁸ mol, 1.5 eq. with regard
of HMDA) were added to the emulsion under moderate magnetic stirring (700 rpm). The
reaction was left to proceed for at least 3 hours.
The suspensions of capsules in the oil phase were centrifuged for 2 minutes at 3,000 rpm.
To prevent the dissolution of the membrane, the temperature was kept above 40℃ by
heating the centrifuge rotor in warm water (70℃) for 5–10 minutes prior the centrifuge
step. Immediately at the end of the centrifugation, the supernatant was discarded and
replaced by 1mL cyclohexane at 40℃.
All the suspension of capsules in the oil was transferred dropwise in a solution of SDS at
5.77 g/L (20mmol/L) in PBS, under vigorous magnetic stirring, to yield a milky emulsion.
This emulsion was then submitted to ultrasounds (Vibracell with microtip, 40 % power)
for 1 minute, 10 s on/5 s oﬀ cycles. The mixture was heated at 70℃ for 30 minutes under
magnetic stirring to remove the cyclohexane. It was then kept at 40℃ in closed vials before
any characterization step, still under magnetic stirring.
Release characterization
Experimental device The release was assessed by ﬂuorescence measurements, in the
device reported in appendix C.3.3. The ﬂuorimeter was equipped with a custom LED
based illumination system. A cyan emitting LED (490 nm, Rebel, Philips) was collimated
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with a lens and ﬁltered at 488 ± 10 nm. The LED was driven using a Thorlabs DC4100 set
to deliver a current of 50mA, which allows to irradiate the sample only when required.
The ﬂuorescence signal was recorded at 526 nm; all the excitation slits were set to 4 nm
bandwidth. To avoid photobleaching during acquisition, the sample was homogenized with
a magnetic stirrer, and the ﬂuorescence intensity was only recorded for 4.5 seconds each
30 seconds. The recording of ﬂuorescence intensity was performed during all the release
experiment, at a frequency of 10Hz. The temperature of the sample was recorded manually,
using a K thermocouple based thermometer. The sample was submitted to a decreasing
ramp of temperature, from 42℃ to 5℃, at 0.9℃/min.
Sample preparation 30 µL of the suspension of capsules in SDS were added to 2.7mL
of a solution of EDTA (10mmol/L) in PBS and introduced in a quartz cuvette.
Data processing The ﬂuorescence intensity was corrected from the inﬂuence of the
temperature, using a reference ﬂuorescence curve obtained from a solution of calcein
(100 nmol/L) in PBS, submitted to the same decreasing ramp of temperature.
F.2.4. Morphological study by cryo electronic microscopy
Samples preparation
In 9.8mL of anhydrous cyclohexane were added 30 µL Span 80 and 20 µL Tween 80. The
surfactants were dissolved with a vortex mixer for 30 seconds, to yield a translucent
homogeneous solution. To this solution were added 50 µL of an aqueous phase made of
α,ω diamino-terminated polyNIPAM and HMDA (cf. table below). The biphasic mixture is
cooled at 10℃ with a water bath, then pre-emulsiﬁed with a vortex mixer for 2 minutes, to
yield a milky emulsion. This emulsion was submitted to ultrasounds (Vibracell VCX750
Ultrasonic Cell Disrupter, equipped with a microtip, 40 % power) 20 s on/10 s oﬀ cycles
for 3 minutes, in a 10℃ water bath. This yield a translucent emulsion, of whom 1mL
where reserved for DLS measurements. The 9mL left were placed in a water bath at 40℃
under magnetic stirring; 1.5 TDI equivalents per monomer molecules were added in 3.6mL
anhydrous cyclohexane, then poured dropwise in the heated emulsion. The reaction was
left to proceed for at least 3 hours.
Sample CpolyNIPAM (g/L) CHMDA (g/L)
HMDA 100% 0 100
polyNIPAM 50%/HMDA 50% 50 50
The suspensions of capsules in the oil phase were centrifuged for 2 minutes at 3,000 rpm.
To prevent the dissolution of the membrane, the temperature was kept above 40℃ by
heating the centrifuge rotor in warm water (70℃) for 5–10 minutes prior the centrifuge
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step. Immediately at the end of the centrifugation, the supernatant was discarded and
replaced by 1mL cyclohexane at 40℃.
All the suspension of capsules in the oil was transferred dropwise in a solution of SDS at
5.77 g/L (20mmol/L) in PBS, under vigorous magnetic stirring, to yield a milky emulsion.
This emulsion was then submitted to ultrasounds (Vibracell with microtip, 40 % power)
for 1 minute, 10 s on/5 s oﬀ cycles. The mixture was heated at 70℃ for 30 minutes under
magnetic stirring to remove the cyclohexane. It was then kept at 40℃ in closed vials before
any characterization step, still under magnetic stirring.
The SDS was then removed from the samples by gel permeation chromatography. A
10mL syringe was ﬁlled with Sephacryl 400 HR and equilibrated with 100mL PBS at 50℃.
Immediately after was added 1mL of the capsules suspended in SDS, and eluted with PBS
at 50℃. 1mL fractions were collected on a water bath at 40℃. The absence of SDS in the
collected fractions was assessed with the maximum bubble pressure tensiometer method
(see appendix C.3.4 Quantiﬁcation of the SDS concentration in capsules suspensions, p. 199).
F.2.5. TexasRed fluorescence in presence of albumin
A solution was prepared from dextran Texas Red (3,000 g/mol, 100mg/L), ovalbumin
(100 g/L) and 71.7 % vol. D₂O in PBS. 8 µL of this solution were sealed between two glass
slides, using an adhesive Teﬂon spacer (120 µm thick). This slide was put in the petri Dish
used to characterize the capsules (see ﬁgure F.3, p. 217), in place of the raised glass slide;
the dish was ﬁlled with deionized water.
The ﬂuorescence of the sample was recorded with the epiﬂuorescence microscope, every
5 seconds for 30,000 s. The temperature of the sample was recorded using the probe plunged
into the external water. The sample was submitted to increasing and decreasing ramp of
temperature, cycled alternatively every hour. The slope of the ramps was 10℃/min, from
15℃ to 50℃; the temperature at the end of the ramp was sustained until the next cycle
began.
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measurements
We aim to develop an encapsulation system able to release its content quickly, within one
second after stimulation. Our system should be able to encapsulate and release water-soluble
molecule of various molecular weight, from small molecules like drugs or ﬂuorescent dyes
to bigger ones, like proteins. These objects may or may not be ionized. Techniques relying
on the release of a speciﬁc object, like the one based on conductivity assessment [313] or
on calcein release [249, 250, 314, 315] may not be relevant. The behavior of macromolecules
can diﬀer from calcein or ions, at least by their size diﬀerence.
However, “free” molecules and encapsulated ones can be distinguished by their diﬀusivity.
The “free” molecules have a diﬀusivity in the range of 100 µm²/s, while the encapsulated
ones have the diﬀusivity of the vehicle. For 200 nm capsules, the diﬀusivity will be in the
range of 2 µm²/s. These values can be inferred from their radius by the Stokes-Einstein law:
D =
𝑘B𝑇
6𝜋𝜂𝑅
(G.1)
where D is the diﬀusivity of the species, 𝑘B the Boltzmann constant, 𝑇 the temperature, 𝜂
the viscosity of the medium and𝑅 the radius of the species. We choose here 𝜂PBS = 10⁻³ Pa·s
and 𝑇 = 293K (20℃).
Several techniques exists to determine the diﬀusivity of ﬂuorescent labeled molecules,
amongst them FCS and FRAP. FCS experiments give access to both the diﬀusivity and the
concentration of dye in the medium [316, 317]. While it is non invasive, this technique
requires acquisition times incompatible with the kinetics of release: 10 minutes to 1 hour
of acquisition are required [318, 319], while the capsules are expected to release their
content in less than one second. FRAP is mainly used to determine the isotropic [320] or
anisotropic [321–324] diﬀusivity of molecules. The duration of experiments is dependent of
the acquisition system speed, the size of the bleached area and the diﬀusivity of the studied
species. With current systems, it is possible to acquire the data of a FRAP experiment in
less than one minute. While literature on using FRAP to determine kinetics constants is
somewhat abundant, nothing could be found on concentration measurements of ﬂuorescent
molecules. In this appendix, we present a FRAP-based technique coupled to a Fourier
transform analysis of the data to determine either the diﬀusivity or the concentration of a
given species.
227
G. Quantitative and real-time FRAP measurements
bleached zone
analyzed profile
X
Figure G.1. A ﬂuorescent sample viewed on a confocal microscope. The bleached zone is hatched in blue. The
proﬁle of ﬂuorescence intensity is recorded along the direction of the green arrow.
G.1. System description
The bleaching of sample is usually done using a laser. Confocal microscopes are convenient
tools to perform FRAP experiments, as the reading laser can also be used to bleach the sample.
After bleaching, the concentration of ﬂuorescent molecule will homogenize, according to
the second Fick’s law:
𝜕 C
𝜕𝑡
(𝐱, 𝑡) − D∆C(𝐱, 𝑡) = 0 (G.2)
where C is the concentration of the ﬂuorescent molecule and 𝐷 its diﬀusivity. In our case,
the bleaching pattern is an horizontal line, as shown on ﬁgure G.1. The light intensity proﬁle
of the laser is gaussian, which is responsible for the gaussian proﬁle of the ﬂuorescence
intensity in an orthogonal direction of the bleaching one. If the bleached line is long enough,
the system can be considered as unidimensional. This approximation can be made if the
size of the bleached line is longer than the characteristic size of the diﬀusion process, which
is given here by the width of the gaussian and the diﬀusivity of the considered species. To
simplify the problem, we will consider an inﬁnite long line bleach, giving a gaussian proﬁle
of ﬂuorescence intensity on an orthogonal direction to the line bleach.
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G.2.1. The ideal system: an infinite picture
In a unidimensional conﬁguration, equation (G.2) can be simpliﬁed as follow:
𝜕 C
𝜕𝑡
(𝑥, 𝑡) − D
𝜕2C(𝑥, 𝑡)
𝜕𝑥2
= 0 (G.3)
As the initial distribution of ﬂuorescent molecules is gaussian, the solution of (G.3) is the
following:
C(𝑥, 𝑡) = 𝑛0 −
𝑛
√2𝜋(2D𝑡 + 𝜎20)
e
− u�
2
2(2Du�+u�20) (G.4)
where 𝜎0 is the characteristic width of the gaussian at the time origin, 𝑛 is related to the
amount of ﬂuorophores along the studied proﬁle. The ﬂuorescence intensity measured by
the confocal microscope is linked to the concentration by a linear relation, and depends
on the quantum yield of the molecule and the intensity of excitation light. This intensity,
noted I, veriﬁes:
𝜕 I
𝜕𝑡
(𝑥, 𝑡) − D
𝜕2 I(𝑥, 𝑡)
𝜕𝑥2
= 0 (G.5)
I(𝑥, 𝑡) = 𝐾0 −
𝐾
√2𝜋(2D𝑡 + 𝜎20)
e
− u�
2
2(2Du�+u�20) (G.6)
𝐾 being proportional to 𝑛 from equation (G.4). To simplify the analysis, we will deal only
with the time-dependent part of this expression. From now, the intensity will be expressed
as:
I(𝑥, 𝑡) =
𝐾
√2𝜋(2D𝑡 + 𝜎20)
e
− u�
2
2(2Du�+u�20) (G.7)
In our case, we have at least two species, the free ﬂuorophore called 𝐴free and the ﬂuo-
rophore entrapped in the capsules, called 𝐴capsule. Their respective diﬀusion coeﬃcients are
𝐷free and 𝐷capsule. A part of the ﬂuorophores may also adsorb on the observation chamber
surface, leading to a third population with a diﬀusivity almost equal to 0. To get the con-
centration of the free dye, two problems arise. We need to ﬁt the ﬂuorescence proﬁles by
two or three gaussians, for diﬀerent acquisition time, as shown on equation (G.4). 𝐷 and
𝜎0 are known or can be measured prior the release experiment. However, the robustness of
bi- or tri-gaussian ﬁts is questionable. The second problem concerns the reproducibility
of the bleaching and imaging conditions. As the concentration is directly inferred from
the ﬂuorescence intensity, the imaging conditions must be exactly the same, for example
the position of the observation chamber along the 𝑧 axis. Due to partial bleaching of the
ﬂuorescent molecules and the presence of a possible
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To simplify the data processing procedure and to address the aforementioned problems,
we propose to consider the diﬀusion system in the Fourier space, but only for the spatial
variables. In this case, equation (G.3) becomes:
𝜕 ̂I
𝜕𝑡
(𝑞, 𝑡) + D𝑞2 ̂I(𝑞, 𝑡) = 0 (G.8)
where 𝑞 is the spatial pulsation and ̂I is the Fourier transform of the ﬂuorescence intensity
proﬁle. The solution of this ﬁrst-order diﬀerential equation is:
̂I(𝑞, 𝑡) = ̂I(𝑞, 0) e−Du�
2u� (G.9)
This solution is remarkable: the time evolution of ̂I is exponential and does not depend on
the initial shape of ﬂuorescence intensity. To get the diﬀusivity of the considered species,
only one exponential ﬁt is required. The accuracy of the result can be improved by ﬁtting ̂I
for several values of 𝑞. In our system, the initial proﬁle of ﬂuorescence intensity is gaussian
(cf. equation (G.7)). Its Fourier transform is the following:
̂I(𝑞, 𝑡) = 𝐾 e
−u�2(Du�+
u�20
2
)
(G.10)
The pre-exponential factor is 𝐾 which enables to measure the concentration of the ﬂuo-
rescent species. In our case, as presented page 227, the diﬀerence of diﬀusivity between
the free dye and the encapsulated one is so large (a factor of 50) that the concentration of
one can be considered constant when the other varies. This method should be suﬃcient
to follow the evolution of the concentration as a function of time. However, as explained
before, the quantiﬁcation of the concentration requires reproducible illumination, bleaching
and recording conditions. To overcome this issue, we propose to add to the solution a
free dye serving as a reference. This dye must have comparable spectral characteristics as
the released dye, but not the same diﬀusivity. Ideally, to distinguish them on the Fourier
transform of the ﬂuorescence intensity proﬁle, we need Dfree = 5Dreference, or the opposite.
We have now
Cfree
Creference
∝
𝐾free
𝐾reference
(G.11)
independently of the experimental conditions due to the internal reference. The propor-
tionality factor can be measured in a calibration measurement.
G.2.2. Eﬀect of the size of the recorded picture
To take the Fourier transform of the ﬂuorescent intensity, an inﬁnite picture is needed, as
suggested by the deﬁnition of this transform:
̂I(𝑞, 𝑡) = ∫
ℝ
I(𝑥, 𝑡) e−u�u�u� d𝑥 (G.12)
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This deﬁnition remains true if a ﬁnite picture of I is taken, as long as its value outside the
picture is zero. Unfortunately, this never happens with gaussian function. 𝑋 being the size
of the recorded picture (see picture G.1), equation (G.12) becomes:
̂Ipicture(𝑞, 𝑡) = ∫
u�
2
−u�
2
I(𝑥, 𝑡) e−u�u�u� d𝑥 (G.13)
whose analytical expression in the case of an initial gaussian proﬁle (eq. (G.7)) is:
̂Ipicture(𝑞, 𝑡) = 𝐾 e
−u�2(Du�+
u�20
2
)
⋅ Re
⎛⎜⎜
⎝
erf
⎛⎜⎜
⎝
𝑋+ 𝑖2𝑞(2D𝑡 + 𝜎20)
2√2(2D𝑡 + 𝜎20)
⎞⎟⎟
⎠
⎞⎟⎟
⎠
(G.14)
= ̂I(𝑞, 𝑡) ⋅ Re
⎛⎜⎜
⎝
erf
⎛⎜⎜
⎝
𝑋+ 𝑖2𝑞(2D𝑡 + 𝜎20)
2√2(2D𝑡 + 𝜎20)
⎞⎟⎟
⎠
⎞⎟⎟
⎠
(G.15)
which diﬀers from (G.10) by the error function. The inﬂuence of this function will be
evaluated in the next part.
G.3. System implementation
G.3.1. Setup description
To conﬁrm the equation (G.11), we considered a system made of ﬂuorescein and FITC-
labeled dextran in PBS medium. Their diﬀusion coeﬃcients diﬀers by a factor of 4.4 (see
table G.1). Fluorescein concentration was ﬁxed to 5 µmol/L, to serve as internal reference.
The concentration of FITC-dextran was chosen between 12.5 and 1000 mg/L (see table G.2),
to act as the released dye. For each measurement, 8 µL of the studied mixture were placed
between a microscope slide and a coverslip sealed with 120 µm thick spacer. The samples
were bleached and viewer using a Zeiss LSM 510 confocal microscope, using full power
of the 488 nm line of the argon laser (30mW). Bleaching was conducted for 10 seconds.
Pictures were recorded with a 2 seconds interval, for 7 minutes, with a resolution of 512×512
through a 20× PlanaFluor objective. The parameter set is summarized in table G.1.
G.3.2. Data analysis
To eliminate the eﬀect of the non-homogeneous illumination of the sample on the recorded
data, each picture was normalized by the picture of a homogeneous ﬂuorescent sample taken
in the same experimental conditions. The ﬂuorescence intensity proﬁles were extracted in
the orthogonal direction of the bleach. To reduce the acquisition noise, the width of the
proﬁle was set to 8 pixels. The Fourier transform of the proﬁles was the calculated, and
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Parameter Value
Dﬂuorescein 350 µm²/s
Ddextran 80 µm²/s
𝜎0 ∼ 50 µm²/s
𝑞 4,430m⁻¹ – 13,290m⁻¹
𝑋 (picture size) 1.5mm
Picture resolution 512×512
Table G.1. Experimental parameters for the quantitative FRAP experiment
Batch number 1 2 3 4 5 6
Dextran concentration (mg/L) 12.5 25 50 100 150 200
Batch number 7 8 9 10 11 12
Dextran concentration (mg/L) 250 300 400 600 800 1000
Table G.2. FITC-dextran concentrations used for the calibration procedure
the decay of the Fourier transform was plotted as a function of time, for several values of
𝑞. The data normalization, extraction and transformation were implemented as a set of C
libraries, to do the analysis in real time. As the intensity proﬁle is a discrete signal, only
discrete values of 𝑞 are available: they in the range (𝑘2𝜋/𝑋)u�∈[0,pixel number]. The plots were
then ﬁtted using the following equation:
𝑦 = 𝑦0 +𝐴ﬂuorescein e
−Dﬂuoresceinu�
2u� +𝐴dextran e
−Ddextranu�
2u� (G.16)
where the free ﬁtting parameters were 𝑦0, 𝐴ﬂuorescein and 𝐴dextran. The relation (G.11) was
veriﬁed by plotting u�dextran
u�ﬂuorescein
as a function of Cdextran
Cﬂuorescein
, cf. picture G.2. The linear relationship
is veriﬁed successfully over more than one decade.
G.3.3. Error function eﬀect
As explained in part G.2.2, page 231, the contribution of erf to the Fourier transform
decay may no be negligible. Re erf
u�+u�2u�(2Du�+u�20)
2√2(2Du�+u�20)
is plotted as a function of time, using the
parameters in table G.1, for the FITC-labeled dextran and 𝑞 = 2 ⋅ 4430m⁻¹ (2nd order).
As seen on ﬁgure G.1 for 𝑋 = 1.5mm, the value of the error function moves away from 1
above 200 s. The maximal error in this conﬁguration is less than 4 percent, which seems
reasonable. A simple way to drastically reduce erf impact is to increase the picture size.
Increasing the picture size from 1.5mm to 2mm decreases the error from 4% to 0.8 %, with
a picture size of of 2.5mm the maximal error is as low as 2⋅10⁻⁵.
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Figure G.2. Plot of concentration ratios vs preexponential factor ratios. Preexponential factors were obtained
by ﬁtting the decay for u� = 2⋅4430m⁻¹, also known as the second order. Points were ﬁtted by the
equation u� = u�u�. u� = 3.422 ± 0.075.
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Figure G.3. Value of the real part of the error function, for the FITC-dextran, u� = 2 ⋅ 4430m⁻¹. The other
parameters are taken from table G.1.
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Abbreviations & acronyms
avg average
azo azobenzene
azoTAB azobenzene-containing surfactant
BSA bovine serum albumin
C concentration
CMC critical micellar concentration
cryoTEM cryo-transmission electron microscopy
CTAB cetyl trimetylammonium bromide
CTAC cetyl trimetylammonium chloride
Dh hydrodynamic diameter
DLS dynamic light scattering
DOPC 1,2-dioleoyl-sn-glycero-3-phosphocholine
DOPE 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine
DPPC 1,2-dipalmitoyl-sn-glycero-3-phosphocholine
EDTA ethylenediamine tetracetate
EGF epidermal growth factor
ESI electronic supplementary information
FCS ﬂuorescence correlation spectroscopy
FGF ﬁbroblast growth factor
FITC ﬂuorescein isothiocyanate
fMLP N -formylmethionylleucylphenylalanine
FRAP ﬂuorescence recovery after photobleaching
GABA γ-aminobutyric acid
GUV giant unilamellar vesicle
HLB hydrophilic-lipophilic balance
HMDA hexamethylene diamine
Idiﬀ intensity of scattered light
kcps kilcounts per second
LbL layer-by-layer
LCST lower critical solution temperature
LUV large unilamellar vesicle
NGF nerve growth factor
OVA ovalbumin
PBS phosphate saline buﬀer
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Abbreviations & acronyms
PEG poly(ethylene glycol)
rpm revolutions per minute
RT room temperature
SAXS small-angle X-ray scattering
SDS sodium dodecyl sulfate
SR101 sulforhodamine 101
stddev standard deviation
T temperature
TC critical burst or release temperature
TDI toluene diisocyanate
TEM transmission electron microscopy
TGF transforming growth factor
TNF tumor necrosis factor
TX100 Triton X-100
UCST upper critical solution temperature
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Abstract
Concentration gradients and local delivery of peptides or proteins play a crucial role in intercellular
communication. In vitro, the eﬀects of local activation of cells are studied with constrained or invasive
artiﬁcial protein sources (pipettes, microﬂuidics). Milder and remotely-triggered techniques for the
release of encapsulated biomolecules are highly in demand. To this aim we developed two classes of
capsules able to release macromolecules upon an external stimulation. The ﬁrst system is based on
liposomes sensitized with azobenzene-containing amphiphiles (surfactants or polyelectrolytes) that
can open pores in the membrane upon exposure to light. The dissolution time of lipids/surfactants
assemblies and rate of release (permeability) under light irradiation has been assessed by dynamic
light scattering and ﬂuorescence measurements. The second system is a model of capsules with an
aqueous core and a polymer shell, formed by interfacial polyaddition. We showed that inclusion of
temperature-responsive chains in the membrane, e.g. polyNIPAM, confers temperature-dependant
stability to the capsules; we demonstrated with millimeter-sized capsules loaded with dextran or
proteins that this can be used to trigger the release. Using chains with UCST in water, we obtained
the ﬁrst temperature-sensitive capsules able to release their content upon increasing the temperature
above a threshold. This represents a promising route to the biocompatible delivery of proteins.
Keywords: protein; encapsulation; triggered release; light-sensitive liposomes; temperature-sensitive
capsules; UCST/LCST polymers.
Résumé
Les gradients de concentration de peptides ou de protéines, ou leur relargage localisé, jouent un rôle
primordial dans les voies de communication inter-cellulaire. L’activation locale de cellules est étudiée
in vitro à l’aide de sources artiﬁcielles contraignantes ou invasives de protéines (pipettes, dispositifs
microﬂuidiques). Des méthodes plus douces et moins invasives sont très demandées. À cet eﬀet, nous
avons développé deux types de capsules capables de libérer des macromolécules sous l’eﬀet d’une
stimulation extérieure. Le premier système emploie des liposomes additionnés d’un amphiphile à
azobenzène, tensioactif ou polyélectrolyte, capable de générer des pores à travers la membrane sous
l’eﬀet de la lumière. Les temps de dissolution des assemblages lipides/tensioactifs et les cinétiques de
relargage (perméabilité) sous irradiation lumineuse ont été étudiées par diﬀusion dynamique de la
lumière et ﬂuorescence. Le second système repose sur des capsules à cœur aqueux et à coque polymère,
formées par polyaddition interfaciale. Nous avons montré que l’inclusion de chaînes thermosensibles
dans la membrane (polyNIPAM, par ex.) rendait la stabilité de la capsule dépendante de la température.
Nous avons démontré sur des capsules millimétriques, chargées avec du dextrane ou des protéines,
que cela permettait le contrôle du relargage. L’utilisation de polymère à UCST en milieu aqueux nous a
permis d’obtenir les premières capsules thermosensibles capables de libérer leur contenu par élévation
de la température au dessus d’une valeur critique. Cela ouvre une voie prometteuse au développement
d’un système biocompatible de libération de protéines.
Mots-clefs : protéine ; encapsulation ; libération contrôlée ; liposomes photosensibles ; capsules ther-
mosensibles ; polymères à UCST/LCST.
